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The nutritional environment that an individual is exposed to during development has 
been shown to affect growth and fat deposition as well as disease risk in later life. In 
particular, the effects of a maternal diet high in fat are relatively well characterised in 
animal models and are typically associated with a range of offspring phenotypes, 
including high blood pressure, increased adiposity and impaired insulin and glucose 
homeostasis. These high-fat diets often contain high amounts of saturated fatty acids 
(SFA), however, changes in dietary recommendations over the past 60 years have 
resulted in increased consumption of vegetable oils.  As such, dramatic increases in 
the intake of omega-6 polyunsaturated fatty acids (PUFA), specifically linoleic acid 
(LA), have been observed in Western populations. This increase in omega-6 fatty acid 
consumption has not been matched by an increase in the intakes of omega-3 fatty acids, 
which has remained stable over this period of dietary change. The effect of this dietary 
pattern on offspring risk of obesity and cardiometabolic disturbance is yet to be 
established, however, studies have demonstrated a pro-adipogenic effect of omega-6 
fatty acids suggesting increases in the intake of LA may be linked to the increasing 
prevalence of obesity.   
Broadly, this research aimed to elucidate the effects of a maternal dietary LA to alpha-
linolenic acid (ALA; omega-3) ratio similar to that consumed in the Western diet (9:1) 
compared to a proposed ‘ideal’ ratio of 1:1.5, on offspring growth, fat deposition and 
potential markers of cardiometabolic disturbance. Due to the increasing amount of 
women of reproductive age consuming a high-fat diet and, since total dietary PUFA 
intake also influences PUFA metabolism, we also investigated the effect of feeding 
each dietary fat ratio at either 18% fat w/w (in line with dietary recommendations) or 
at a higher fat level of 36% fat w/w. A rat model was utilised to achieve the study 
objectives by allowing for tight control of dietary manipulation as well as invasive end 
points. 
The main findings of this research have demonstrated that a low LA:ALA ratio in the 
diet was effective at increasing circulating levels of long chain omega-3 PUFA, 
specifically eicosapentaenoic acid (EPA), in the dams which was largely reflected in 
the offspring. However, improving the omega-3 status of the offspring had no 
discernable beneficial effect on adiposity during early-life. In fact, a maternal low LA, 
XVII 
low fat diet was associated with increased fat mass in the offspring. Whether the 
fluctuations in the lipogenic capacity of tissues observed in these studies in the 
offspring during early-life is indicative of later metabolic disturbance remains to be 
established. Further to this, a maternal high fat diet, irrespective of the LA:ALA ratio, 
was associated with a 15% reduction in bodyweight in both male and female offspring 
when compared to a low fat diet (P<0.0001). This was independent of any maternal 
weight gain and was persistent throughout early-life. 
Finally, maternal consumption of a high LA, high fat diet was associated with 
significant upregulation of genes associated with cholesterol packaging and transport 
across the placenta. This implicates the placenta as a potential mechanistic mediator 
of the effects of maternal diet on offspring health. This hypothesis was also tested in 
pregnant women of different body mass index (BMI) classifications. In women, 
however, maternal BMI was associated with fewer inconsistent alterations in gene 
expression. However, the absence of nutritional intake data from these participants 
was a limitation of the study and comparability to rodent data.  
In summary, the results of this thesis indicate that the adipogenic effects previously 
associated with omega-6 fatty acids do not appear to be contributing towards increased 
risk of adiposity in offspring when consumed in the maternal diet. The capacity for 
early-life alterations in tissue function and structure to elicit long-term consequences 
for individuals remains to be established and should be a focus of future studies. 
However, a maternal high fat diet, where the predominant fat source was not saturated 
fats, still elicited unfavourable outcomes in the offspring despite no evidence of 
increased weight gain or adiposity in the mothers. This has the potential to impact on 
recommendations to expectant mothers around reducing the quantity of fat within their 
diet even if it has not had any unfavourable phenotypic effects on the individuals 
themselves. Future studies should consider more mechanistic approaches however, the 
preliminary investigations in this thesis highlight the placenta as a likely contributor 







1.1 Obesity  
1.1.1 Definitions and classifications 
Overweight and obesity are defined by the World Health Organisation (WHO, 2017a) 
as “abnormal or excessive fat accumulation that presents a risk to health”. 
Measurement of a person’s body mass index (BMI), a formulation of weight divided 
by height squared (kg/m2), remains the most common indicator of obesity in adults. 
Current classifications state that an adult with a BMI 25-29.9 kg/m2 is considered 
overweight and obese if their BMI ≥ 30 kg/m2 (WHO, 2017a). The use of BMI as an 
inexpensive population measure is central to its widespread use, however, it does 
possess limitations as a direct proxy for the estimation of obesity. BMI does not take 
into account factors such as sex, age, ethnicity, all of which affect the balance of 
muscle and fat in the body, or fat distribution. A study by Romero-Corral et al. (2008), 
for example, showed that BMI underestimated obesity such that it failed to identify 
50% of participants who were defined as obese through body fat percentage 
measurements. The same study reported that BMI failed to discriminate between body 
fat percentage and lean mass particularly in men and elderly participants, a common 
criticism of the method (Frankenfield et al., 2001). As such, waist circumference and 
body fat percentage are often used in conjunction with BMI for a more accurate 
assessment of overweight or obesity in an individual (Burton, 2010). Due to the 
confounding effect of developmental age on the relationship between weight and the 
distribution of fat and muscle, and thus the accuracy of BMI measurements, they are 
not used for the classification of overweight and obesity in children. Instead, reference 
is made to population based measurements specific for age and sex and classification 
is based on how many standard deviations an individual’s weight falls from the 
population mean (WHO, 2017a). 
1.1.2 Prevalence of obesity and future projections 
Despite disagreements in the measurement criteria for the diagnosis of obesity, BMI 
continues to be the gold-standard for adult diagnosis and the WHO estimated a 
staggering 1.9 billion adults to be overweight or obese as of 2016 (WHO, 2017a). This 
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largely preventable condition, previously considered an issue for high-income 
countries, is now on the rise in low- and middle-income countries and is not only 
affecting adults. Of increasing concern is that 41 million children under the age of 5 
were estimated to be overweight or obese in 2016 (WHO, 2017a). Furthermore, the 
prevalence of obesity worldwide continues to rise (Finucane et al., 2011) and, beyond 
the individual health risks, places a huge social and economic burden on afflicted 
countries.  
Based on current trends, modelling estimates predict that over half of the UK 
population could be overweight or obese by 2030, leading to an economic burden of 
around £1.9-2 billion per year in healthcare costs associated with overweight and 
obesity as well as its co-morbidities (Wang et al., 2011). More recent modelling 
approaches have used available data from longitudinal studies in the US. Using these 
data the researchers were able to simulate growth trajectories of children into 
adulthood and predicted that, based on representative anthropometrics of the 
population, the majority of children within the population (57.3%; based on 2016 data) 
would be obese at the age of 35 years (Ward et al., 2017). Further to this, the same 
study suggested that for roughly half of these individuals, the onset of obesity would 
occur during childhood. Another study in the Australian population predicted that, 
whilst the prevalence of overweight was likely to remain relatively steady until the 
year 2025, the prevalence of obesity and severe obesity was predicted to rise to 35% 
and 13% respectively during this time (Hayes et al., 2017). This equates to a respective 
increase of 8% and 4% based on 2014-2015 data (Australian Institute of Health and 
Welfare, 2017).  
1.1.3 Causes: a nutritional perspective 
The primary cause of obesity is an “energy imbalance between calories consumed and 
calories expended” (WHO, 2017a). A positive energy balance is where energy intake 
is greater than energy expenditure leading to increased energy storage within the body. 
Prolonged exposure to a positive energy balance leads to weight gain and ultimately 
to obesity. Whilst seemingly quite a simplistic explanation, it is important to note that 
obesity is not merely a result of overindulgence and lack of physical activity. There 
are many factors affecting an individual’s susceptibility to weight gain and obesity, 
both biological (genetics, sex, age, and ethnicity) and environmental (e.g. 
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socioeconomic status, stress), that should not be overlooked. Further to this, there 
appears to be evidence to suggest that regulation of body weight is asymmetric (Müller 
et al., 2010). Likely due to the more immediate threat to survival that undernutrition 
possesses, stronger feedback mechanisms exist to restore normal energy balance in 
states of undernutrition as opposed to overnutrition (Blundell and King, 1996).  
Despite the complexity of obesity aetiology, prevention and treatment, nutritional 
status and physical activity remain at the core of this issue and it is often through the 
interference of nutritional status that other external factors associated with obesity act. 
For example, many of the genes associated with a heritable predisposition to obesity 
centre around hunger, satiety and food intake (O'Rahilly and Farooqi, 2008). Similarly, 
the association between low socioeconomic status and increased incidence of obesity 
appears to be due to unhealthier food choices driven by the cost of food items (Pechey 
and Monsivais, 2016).  
Whilst all macronutrients are essential to the diet and should not be excluded, excess 
dietary fat has commonly been associated with weight gain and obesity (Bray et al., 
2002). Dietary fat has a higher energy density than protein and carbohydrate and, 
whilst the storage of protein and carbohydrate is relatively limited, the capacity for fat 
storage is virtually unlimited. Global increases in the incidence of overweight and 
obesity can be attributed to many factors, although global shifts in dietary habits 
tending towards an increased energy intake coupled with a decrease in physical activity 
are often implicated as a primary cause.  
1.1.4 Health consequences of overweight and obesity 
The health consequences associated with obesity are wide reaching, ranging from 
increased risk of premature death to several non-fatal debilitating diseases and 
psychological issues (Table 1.1). Whilst obesity is often considered a disease in its 
own right, overweight and obesity are strongly associated with an increased risk of 
type 2 diabetes (Resnick et al., 2000, Janssen, 2007), various cancers (Bianchini et al., 
2002) and the leading causes of death worldwide, coronary heart disease (CHD) and 
stroke (Kenchaiah et al., 2002, WHO, 2017b). Obese individuals often present with 
one or more co-morbidities including hypertension, glucose intolerance, 
dyslipidaemia, hypertriglyceridemia and decreased high-density lipoprotein (HDL) 
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cholesterol. The presence of at least three of these conditions in an individual is 
referred to as the Metabolic Syndrome (MetS), and is associated with an increased risk 
of type 2 diabetes (Galassi et al., 2006) and a 2-fold higher risk of a cardiovascular 
event (Mottillo et al., 2010). 
Several robust studies have reported a clear relationship between excessive body 
weight and increased mortality (Adams et al., 2006, Berrington de Gonzalez et al., 
2010, Calle et al., 1999, Chen et al., 2013, Whitlock et al., 2009). A comprehensive 
study by the Global Burden of Disease 2015 Obesity Collaborators systematically 
investigated this association in 195 countries worldwide over a 25-year period (Afshin 
et al., 2017). The authors of this study reported that over 4 million deaths worldwide 
were accounted for by overweight and obesity in 2015, 70% of which were due to 
cardiovascular disease (CVD). 
Many of the co-morbidities associated with obesity in adults are now being observed 
more commonly in children (Table 1.1). Further to this, it is estimated that 80% of 
obese adolescents will continue to be obese in adulthood resulting in an increased risk 
of the plethora of issues associated with adult obesity (Simmonds et al., 2016). Obesity 
in adolescence has been directly linked to increased risk of death from CHD and 
atherosclerosis, and this effect is independent of adult weight (Must et al., 1992). 
However, more recent systematic reviews have highlighted that there is little evidence 
to support childhood obesity as an independent risk factor for CVD (Lloyd et al., 2010) 
and MetS (Lloyd et al., 2012) and, in fact, more adverse outcomes are observed when 
individuals are of a normal, or even low, BMI during childhood and become obese in 
adulthood. This highlights the complex relationship between early BMI and adult 
disease risk and that targeting health management practices at overweight and obese 
children only may result in the neglect of a high-risk group of individuals. Adult 
obesity, however, is a major independent risk factor for an abundance of diseases and 
childhood obesity is a major risk factor for adult obesity. As such, whilst it is important 
to maintain interventions targeting weight loss and management in adults in order to 
prevent the neglect of these high-risk groups, prevention in early life may be critical 




Table 1.1 Health consequences associated with obesity in children and adults 
(Adapted from WHO (2000)). 
  Children Adults 
High prevalence  Faster growth 
 Psychosocial problems 
 Persistence into 
adulthood (for late onset 
and severe obesity) 
 Dyslipidaemia 
 Type 2 diabetes 
 Gallbladder disease 
 Dyslipidaemia 
 Insulin resistance 
 Breathlessness 
 Sleep apnoea  
Intermediate 
prevalence 
 Hepatic Steatosis 
 Abnormal glucose 
metabolism 
 Persistence into 
adulthood (depending 




 Osteoarthritis (knees) 
 Hyperuricemia and gout 
Low prevalence  Orthopaedic 
complications 
 Sleep apnoea 
 Polycystic ovary 
syndrome 
 Pseudotumor cerebri 
 Cholelithaiasis 
 Hypertension 
 Cancer (breast, 
endometrial and colon) 
 Reproductive hormone 
abnormalities 
 Polycystic ovary 
syndrome 
 Impaired fertility 
 Lower back pain 
 Increased risk of 
anaesthesia 
complications 
 Fetal defects associated 
with maternal obesity  
1.2 Developmental origins of health and disease (DOHaD) 
1.2.1 An introduction to the DOHaD hypothesis 
Fetal development has previously been considered to be under precise genetic control, 
however, it is now apparent that plasticity of the cells during the developmental period 
presents a window of susceptibility in which, when subject to insult, the offspring can 
undergo physiological changes which can have a lifelong impact (Bateson et al., 
2004). This phenomenon has been termed ‘programming’ (Lucas, 1991, Lucas, 1994). 
Suggestions have been made that the physiological adaptations of the fetus in response 
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to changes in the intrauterine environment, such as alterations in the quality and 
quantity of maternal nutrients, may result in changes in gene expression which can in 
turn impact upon tissue structure. Owing to the fact that tissue structures are generally 
in place at the time of birth, or shortly after, the impact of a relatively short period of 
insult can potentially become permanent. This can in turn lead to a predisposition to 
diseases in later life, and this concept forms the basis of the Developmental Origins of 
Health and Disease (DOHaD) hypothesis, pioneered by the work of David Barker and 
colleagues (Barker et al., 1990, Hales et al., 1991). 
1.2.1.1 Evidence from epidemiological studies 
Support for the DOHaD hypothesis was initially provided by epidemiological studies 
investigating associations between early life factors and a range of diseases in later 
life. Barker et al. (1989) found that in a group of men from Hertfordshire, all of whom 
were born between 1911 and 1930, those with the lowest weights at birth and at one 
year of age had the highest death rates from ischaemic heart disease. Further studies 
in this population, as well as others, provided evidence of inverse associations between 
birthweight and risk of hypertension (Barker et al., 1990), impaired glucose tolerance 
(Hales et al., 1991) and type 2 diabetes (Barker et al., 1993). These findings were 
supported by a series of studies on a group of men and women in Finland that also 
found associations between low birthweight and increased risk of death from CHD 
(Forsén et al., 1997, Forsen et al., 1999). In addition, the Finnish studies also 
demonstrated that the highest risk of CHD was observed in those individuals who were 
lighter at birth but had a greater body mass at 7 years of age (Eriksson et al., 1999). 
As such, the theory emerged that a period of rapid ‘catch-up’ growth in early life 
increased an individual’s risk of adverse outcomes.  
The emergence of further studies demonstrating this same association subsequently 
led to ‘The Thrifty Phenotype’ hypothesis. Introduced by Hales and Barker (1992), 
this hypothesis proposed that poor nutrition in early life was the driver for the 
epidemiological association between poor fetal and infant growth and subsequent 
development of type 2 diabetes. Essentially, poor nutrient supply from the mother 
leads to adaptations within the fetus which protect the individual from the effects of a 
low nutrient postnatal environment (Figure 1.1). It is naïve to think of this reduction 
in birthweight as causal in the disease pathway as birthweight itself is a result of a 
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combination of environmental and genetic factors during fetal life. Whilst reductions 
in intrauterine growth can be attributed to many factors, including maternal stress 
(Rice et al., 2010), smoking (Ward et al., 2007) and air pollution (Pedersen et al., 
2013), this hypothesis placed inadequate maternal nutrition as a key contributor.  
The long-term effects of maternal malnutrition in humans are difficult to study 
experimentally, however, a number of historical cohorts have provided important 
‘natural’ experiments to demonstrate this phenomena. One of the most studied 
populations is the Dutch Hunger Winter cohort. During the winter of 1944-1945, 
western Holland was subject to severe food shortages for approximately 6 months, at 
the height of which daily intake was reduced to just 400-800 calories. This ‘Dutch 
Hunger Winter’ led to a cohort of offspring that had been exposed to severe maternal 
undernutrition at different times in gestation. Retrospective studies of this cohort have 
shown that men exposed to the famine in early gestation were more likely to become 
obese in adulthood, whereas men exposed to the famine in late gestation were less 
likely to become obese (Ravelli et al., 1976). Further studies of this cohort have 
demonstrated that exposure to the famine in early gestation was also associated with 
an atherogenic lipid profile (Roseboom et al., 2000). Several other famine cohorts have 
been investigated and produced similar associations to those observed in the Dutch 
Hunger Winter cohort (Hoffman et al., 2017). Taken together, these studies have 
triggered a cascade of research investigating maternal dietary intake as a central driver 




Figure 1.1 Diagrammatic representation of the thrifty phenotype hypothesis (Taken 
from Hales and Barker (2001)) 
1.2.1.2 Criticisms of epidemiological studies 
The basis on which the DOHaD hypothesis was formed is also the main source of 
criticism directed towards it. The inability of epidemiological studies to properly 
account for confounding factors and potential reporting bias are among its major 
criticisms (Huxley et al., 2002). Further to this, whilst the association between 
birthweight and later disease risk is compelling, it is just that, an association. The lack 
of evidence linking maternal nutrition to anthropometric measurements at birth in 
human cohorts is also a major concern and has led to uncertainty as to whether 
maternal nutrition really is a key component of this hypothesis. Whilst the Dutch 
Hunger Winter cohort suggested that maternal undernutrition can influence 
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birthweight, the dietary insult in these studies was severe whereas changes in 
birthweight were not (Roseboom et al., 2001), raising questions as to how significant 
an influence maternal nutrition actually has on fetal growth. Studies of well-nourished 
populations have also shown that while changes in maternal dietary intakes are 
associated with differences in birthweight, these differences are small and do not shift 
birthweight outside the normal range (Englund-Ögge et al., 2018). It is important to 
note, however, that the nature of DOHaD effects are inherently small, as large 
perturbations in growth and metabolism are often lethal to the developing fetus. As 
such small variations within the normal range may still be physiologically important. 
Nonetheless, overcoming these criticisms required establishment of a direct link 
between maternal nutrition and anthropometric birth measurements or to disease risk 
in later life.  
1.2.1.3 Evidence from animal models  
Whilst epidemiological studies have highlighted a link between early life nutrition and 
adverse health outcomes in humans, establishing causality is challenging as 
experimental manipulation of the maternal diet during pregnancy is difficult and often 
not ethically viable. As a result, animal models have been critical to our understanding 
of the DOHaD hypothesis and provide significant advantages over epidemiological 
studies. A range of animal models have been utilised, however, rodents are most 
commonly used owing to their shorter lifespan and length of gestation, larger litter 
size, the ability to test more specific hypotheses, and an increased degree of nutritional 
and environmental control as well as the measurements of invasive end points 
(McMullen and Mostyn, 2009b). To provide comparability with epidemiological 
studies and in an attempt to establish a link between maternal nutrition and birthweight, 
early studies investigated the effects of global nutrient restriction (Woodall et al., 
1996). These dietary interventions resulted in reduced offspring birthweight and were 
associated with hypertension in later life, a key risk factor for CVD (Woodall et al., 
1996, Vickers et al., 2000). Studies investigating the impact of key nutrient 
deficiencies, including protein (Langley and Jackson, 1994, Jackson et al., 2002) and 
iron (Gambling et al., 2003), have also reported reductions in birthweights and 
increased blood pressure in the offspring in later life.  
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The additional evidence from animal studies led to the expansion of the thrifty 
phenotype hypothesis. The predictive adaptive response (PAR) hypothesis, proposed 
by Gluckman and Hanson (2004), suggested that an individual can make physiological 
adaptations to environmental cues at a time of developmental plasticity. Plasticity is 
highest during early development and so the hypothesis proposes that the fetus can 
make physiological changes in utero to adapt to its predicted postnatal environment. 
Whilst this level of adaptation could be considered an evolutionary advantage, the 
hypothesis proposes that if the actual environment is different to that predicted by 
maternal cues the physiological adaptations of the offspring place them at an increased 





Figure 1.2 Summary of the predictive adaptive response hypothesis. Environmental 
cues, such as maternal undernutrition, stimulate responses within the developing 
offspring to ensure it is best suited for the postnatal environment. If the postnatal 
environment matches the prenatal prediction then the individual is well adapted and is 
at no greater disease risk. If there is a mismatch in the predicted and actual postnatal 
environment then disease risk is increased in later life (Adapted from Low et al. 
(2012)).  
1.2.1.4 Criticisms of animal studies  
Animal studies have provided a much more detailed insight into the associations 
between specific dietary alterations within the maternal diet on offspring health 
outcomes. The different species of animal models used, dietary interventions applied 
and study designs have been extremely diverse (Dickinson et al., 2016). Whilst this is 
often a criticism of animal studies as it makes comparisons between studies difficult, 
and combining data in meta-analyses virtually impossible (Ainge et al., 2011, 
Armitage et al., 2004), it is worth noting that despite these variations the offspring 
outcomes are relatively conserved and appear to converge on a phenotype associated 
with the metabolic syndrome (Armitage et al., 2004). This alludes to the possibility of 
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a few key mechanisms being responsible for the association between the early life 
nutritional environment and offspring health outcomes (McMullen et al., 2012). The 
biggest criticism surrounding animal studies is that, like epidemiological studies, they 
have failed to elucidate an underlying mechanism. 
1.2.1.5 Potential mechanisms 
Identification of the mechanisms by which nutritional factors at key developmental 
stages exert long-term or permanent effects is critical to the development of disease 
prevention strategies. The use of animal models to investigate the DOHaD hypothesis 
have led to the formation of proposed mechanisms responsible for the phenomenon. 
Such mechanistic concepts have been reviewed in great detail elsewhere (Langley-
Evans, 2013, Langley-Evans, 2009, Langley-Evans and McMullen, 2010, McMullen 
and Mostyn, 2009a), therefore, the three most documented hypotheses will be briefly 
considered here.  
(1) Alterations in tissue structure: It has been postulated that exposure to specific 
nutrients during fetal and early postnatal life, i.e. critical stages for organ and 
tissue development, leads to alterations in the proliferation and differentiation 
steps involved in organ and tissue development. This could lead to transient or 
permanent alterations in structure and function and several models have 
demonstrated a reduction in cell number or changes to the composition of cell 
types in response to a range of maternal dietary alterations (Langley-Evans et 
al., 1999, Remacle et al., 2007, Camm et al., 2011, Woods et al., 2004). 
(2) Exposure to maternal glucocorticoids: Glucocorticoids are important 
mediators of stress responses, however, under normal conditions their transport 
across the placenta is closely regulated by 11β-hydroxysteroid dehydrogenase 
2 (11βHSD2) which converts active glucocorticoids to inactive ones to prevent 
excessive accumulation. Fetal exposure to excessive glucocorticoids is 
associated with growth retardation, hypertension and impaired glucose 
homeostasis (Dodic et al., 1998, Nyirenda et al., 1998). Further to this, dietary 
insults have been associated with a reduction in 11βHSD2 expression in the 
placenta (Langley-Evans et al., 1996b, McMullen et al., 2004). It has therefore 
been postulated that dietary stress leads to an increase in glucocorticoid transfer 
to the fetus, through diminished 11βHSD2 capacity, resulting in overexposure 
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of fetal tissues. This can in turn lead to changes in the expression of the many 
genes that contain glucocorticoid response elements and hence lead to the 
alterations in tissue structure and function discussed above. 
(3) Epigenetic modifications: The most recent mechanism that has been suggested 
to play a role in the programming of disease are epigenetic modifications. 
These modifications, which include DNA methylation and histone 
modifications, silence or switch on genes by altering DNA structure and hence 
access of proteins required to initiate transcription. In the Dutch Hunger Winter 
cohort, follow up experiments have identified reduced DNA methylation of the 
insulin-like growth factor 2 (IGF-2) gene in individuals who were exposed to 
maternal nutrient restriction (Heijmans et al., 2008). Importantly, these 
modifications were detected in these individuals 60 years after the nutritional 
insult, suggesting that the effects are permanent, and providing an attractive 
putative mechanism for how early-life factors influence disease risk in later-
life. Further to this, animal studies have shown that maternal nutrient 
restriction, overnutrition, obesity and diabetes are all capable of affecting the 
offspring epigenome (Bianco-Miotto et al., 2017). However, causal 
relationships between epigenetic modifications, gene expression and 
development have proven difficult to establish (Altobelli et al., 2013). 
1.3 Developmental origins of obesity 
The association between maternal diet and offspring disease risk is now considered by 
many to be well supported by evidence from epidemiological and animal studies. 
Maternal undernutrition was the focus of many of the studies that established this 
association. More recently however, undoubtedly due to the increased incidence of 
obesity in Western populations, the effects of maternal overnutrition and obesity on 
offspring health are being increasingly subjected to intense study.  
A wide range of robust epidemiological studies have shown that a high maternal BMI 
is associated with an increased offspring BMI and increased adiposity well into adult 
life (Kaar et al., 2014, Reynolds et al., 2010, Schoppa et al., 2019). There is also 
evidence that obese women (BMI>30 kg/m2) are 2-3 times more likely to give birth to 
a large for gestational age baby (Ehrenberg et al., 2004). Recently, two large scale 
meta-analyses have confirmed this strong association with one identifying a 264% 
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increased risk of childhood obesity if the mother was obese before conception 
(Heslehurst et al., 2019, Voerman et al., 2019).  It has been postulated that the positive 
relationship between maternal BMI and offspring adiposity may, at least in part, be a 
consequence of increased maternal nutrient intake. Thus, the developing fetus and 
infant of the obese mother is exposed to an increased nutrient supply via the placenta 
or through changes in breast milk composition, and this promotes overgrowth and 
increased adiposity.  
In animal models, diets high in saturated fats or high-fat high-sugar ‘cafeteria’ diets 
are commonly used to model maternal obesity and overnutrition. These studies have 
reported that providing animals with these diets during pregnancy and lactation is 
associated with increased blood pressure (Guberman et al., 2013, Samuelsson et al., 
2008), impaired insulin and glucose homeostasis (Taylor et al., 2005, Samuelsson et 
al., 2008, Akyol et al., 2012) and increased adiposity (Guo and Jen, 1995, Khan et al., 
2004, Bayol et al., 2005) in the adult offspring. These observations were supported by 
Menting et al. (2019) who systematically reviewed 145 studies investigating the effect 
of maternal obesity on offspring cardio-metabolic health. Maternal obesity was 
associated with increased adiposity, blood pressure, triglycerides (TAG), cholesterol, 
glucose and insulin levels in the offspring. Interestingly, and despite these associated 
deleterious outcomes, many of these studies reported no effect of these dietary 
exposures on birthweight.  
Whilst these studies provide insight into possible predictors of obesity risk in later life, 
they do not always adequately isolate the effects of maternal obesity from other 
comorbidities, or indeed, isolate the effects of maternal obesity from the impacts of 
maternal nutrition. Further to this, the limitations associated with epidemiological 
research do not always allow for examination of key metabolic disturbances in tissues 
making identification of possible mechanisms difficult. 
1.3.1 Placental influence on nutrient transfer 
The impact of increased nutrition on the developing fetus and role of the placenta is 
clearly demonstrated by studies of infants of mothers with pre-gestational or 
gestational diabetes. In these studies, excess glucose transfer to the developing fetus, 
as a result of maternal hyperglycaemia, is associated with increased birthweight and 
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increased offspring adiposity (Plagemann et al., 1997, Kamana et al., 2015). The 
increased circulating glucose levels in the mother are transferred to the fetus via the 
placenta resulting in increased fetal glucose concentrations. Maternal insulin does not 
cross the placenta, however, so the fetal pancreas is responsible for secreting insulin 
to manage this hyperglycaemia. This results in fetal hyperinsulinemia which has been 
shown to be associated with both excessive fetal growth (Fowden, 1995, Fowden et 
al., 1989) and increased adiposity in later life (Silverman et al., 1993). Importantly, it 
appears that this fetal response is facilitated by physiological changes to the pancreas 
(such as altered β-cell number) during times of cellular plasticity (Zhang et al., 2011). 
The failure of the pancreas to return to normal physiology and function postnatally 
may be one of the major factors responsible for the long-term metabolic issues 
experienced by individuals following exposure to maternal hyperglycaemia. 
Due to the establishment of the processes surrounding maternal hyperglycaemia, a 
large volume of the literature focuses on obese pregnancies complicated by gestational 
diabetes. Interestingly, however, a study by Kabali and Werler (2007) demonstrated 
that non-diabetic obese mothers were also more likely to have babies that were large 
for gestational age and obese pregnancies have also been associated with alterations in 
placental structure and function. A study by Brouwers et al. (2018) on women with 
non-complicated pregnancies in the Netherlands found that increased maternal pre-
pregnancy BMI was associated with increased placental weight and high-grade 
chronic villitis which is often associated with alterations in fetal growth. Further to 
this, studies have shown associations between altered maternal nutrition and placental 
transfer of fatty acids (Brass et al., 2013), cholesterol (Daniel et al., 2016) and amino 
acids (Farley et al., 2009). 
1.4 Adipose tissue development, maintenance and function 
1.4.1 Types of adipose tissue, function and morphology 
Adipose tissue, now considered an organ in its own right, is primarily made up of 
adipocytes but also contains various other cells including blood cells, endothelial cells, 
immune cells, fibroblasts and pre-adipocytes (Ailhaud et al., 1992). In mammals, there 
are two distinct types of adipose tissue, brown adipose tissue (BAT) and white adipose 
tissue (WAT), which differ in their function, morphology, and development.  
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Exclusive to mammals, BAT is responsible for non-shivering thermogenesis and 
contributes to maintenance of normal body temperature. Early studies in humans 
identified that BAT was present in highest quantities during fetal and early life but 
declined into adulthood (Heaton, 1972) where it is mainly confined to subcutaneous 
regions (Sacks and Symonds, 2013). WAT is by far the most abundant adipose tissue 
sub-type in humans and its major role is energy storage in the form of TAG. WAT 
stores are utilised, and hence deplete, in times when energy expenditure exceeds intake 
and increase under reverse conditions. More recently it has been demonstrated that 
WAT has other important physiological roles in addition to energy storage. Thus, 
WAT has been recognised as an organ capable of major endocrine and secretory 
functions and has been demonstrated to play a central role in the regulation of 
inflammatory processes and glucose homeostasis (Trayhurn, 2005, Trayhurn and 
Beattie, 2001). In contrast to BAT adipocytes, which are around 10-25µm in diameter 
and are considered multilocular (i.e. containing many fat vacuoles), WAT adipocytes 
are larger (20-100µm in diameter) and contain one vacuole where TAG are stored as 
a long-term fuel reserve (Stock and Cinti, 2003). BAT is highly vascularised and 
contain many mitochondria. These mitochondria expresses a unique protein, 
uncoupling protein 1 (UCP1), which actively transports protons into the mitochondrial 
matrix. This process is not ‘coupled’ with synthesis of energy in the form of ATP and 
instead produces heat as a bi-product (Cinti et al., 1997). These highly specialised 
adaptations are conducive to its main function of heat production.  
BAT has, in recent years, been investigated as therapeutic target for obesity. This is 
primarily due to early studies in rodents that showed altered BAT activity in response 
to obesity (Trayhurn, 2018). However, it is worth noting that rodent BAT development 
is quite different to that observed in humans. Rodents possess considerable deposits of 
BAT throughout their adult life due to its key role in maintaining body temperature 
during times of hibernation where animals are exposed to prolonged periods of cold 
(Cannon and Nedergaard, 2004). As such, human BAT may play a much less 
significant role in obesity prevention in humans. For this reason, alongside the function 
of WAT as a site of unlimited lipid storage and the observation of significant increases 




1.4.2 White adipose tissue (WAT) development 
Adipocytes have been detected before birth in many species including humans, 
however, in rodents they are not detected until after birth (Ailhaud et al., 1992). The 
development of white adipocytes begins during the second trimester of embryonic 
development in humans where small adipocyte cell clusters begin to develop 
(Poissonnet et al., 1984). These clusters aggregate in distinct locations and increase in 
size as development progresses but the number of clusters remains the same (Ailhaud 
et al., 1992). Adipocytes are of mesodermal origin and embryonic stem cells undergo 
various differentiation steps resulting in cells becoming increasingly committed to the 
adipocyte lineage. Cells committed to the adipocyte lineage are termed pre-adipocytes. 
Differentiation to mature adipocytes (adipogenesis) occurs in several stages and is 
regulated by a plethora of transcription factors and signals. 
1.4.2.1 Transcriptional regulation of adipogenesis 
WAT adipogenesis can occur at any stage during development and adulthood. Studies 
have shown that cell cycle arrest of pre-adipocytes appears to be a requirement for 
differentiation (Pairault and Green, 1979). Early markers of the commitment of cells 
to the adipocyte lineage are members of the CCAAT/enhancer binding protein 
(C/EBP) family. The beta and gamma subtypes (C/EBPβ and C/EBPγ) are expressed 
before the cell cycle arrest phase and appear to stimulate the expression of genes 
required for this pre-requisite (Hwang et al., 1997). In particular, in vivo experiments 
have identified that C/EBPβ up-regulates the mRNA expression of peroxisome 
proliferator activated receptor gamma (PPARγ) (Wu et al., 1995). Binding sites for 
C/EBPβ have been identified in the promoter regions of PPARγ as well as C/EBPα 
(Tang et al., 2004), which have both been shown to be involved with cell cycle arrest 
(Umek et al., 1991, Altiok et al., 1997). Studies have shown that adipocyte 
differentiation in the presence of C/EBPα does not occur if PPARγ is not also present 
(Rosen et al., 2002). However, differentiation does occur in the presence of PPARγ 
without C/EBPα, resulting in PPARγ being branded the master regulator of 
adipogenesis. PPARγ, largely specific to adipose tissue, is a nuclear transcription 
factor that is highly expressed in adipose cells early in development. It acts to promote 
the expression of other adipogenic genes by forming heterodimeric complexes with 
the retinoid X receptor (RXR) which interact directly with DNA regions. Another key 
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adipogenic gene expressed during early adipogenesis is sterol regulatory element-
binding protein variant 1c (SREBP-1c) which stimulates the expression of many genes 
required for lipogenesis (Horton et al., 2002). The ability of adipocytes to carry out 
lipogenesis and accumulate lipid signifies the final phase of maturation. During this 
time, the mRNA expression of genes involved in lipogenesis and fatty acid uptake, 
including fatty acid synthase (FAS), lipoprotein lipase (LPL), glycerol-3-phosphate 
dehydrogenase (GPDH), stearoyl-CoA desaturase (SCD) as well as others, increases 
drastically (Gregoire et al., 1998). Mature adipocytes become increasingly sensitive to 
insulin through up-regulation of glucose transporters and insulin receptors (Garcia de 
Herreros and Birnbaum, 1989) and begin to synthesise adipokines such as leptin and 
adiponectin (Gregoire et al., 1998). 
1.4.2.2 Regulation of adipogenesis by hormones and growth factors 
Studies have shown that the cascade of events that leads to the eventual maturation of 
adipocyte cells is sensitive to signals from growth factors and hormones. Observational 
studies in humans have shown an association between growth hormone (GH) and 
increased body fat mass. This has led to the hypothesis that GH plays a key role in 
adipogenesis which has been supported by studies that confirmed the ability of GH to 
induce differentiation in vitro (Morikawa et al., 1982). GH is also known to stimulate 
gene expression of insulin-like growth factor-1 (IGF-1) which is necessary for 
adipocyte differentiation (Smith et al., 1988). IGF-1 receptors are found on pre-
adipocytes and their abundance increases during adipocyte maturation resulting in the 
increased sensitivity of maturing adipocytes to insulin and IGF-1. Binding of insulin 
and IGF-1 to their receptors triggers an intracellular signalling pathway which results 
in adipocyte differentiation (Kamai et al., 1996). Many other factors have been 
demonstrated to stimulate (glucocorticoids, PGE2 and PGI2) or suppress (EGF, TGFα, 
TGFβ) differentiation (Gregoire et al., 1998) leading to a complex regulation of the 
formation of new adipocytes. It is also important to note, however, that the aggregation 
of large adipose tissue stores is not just as a result of increased adipocyte number 
(hyperplasia), but is in fact primarily due to an increase in cell size (hypertrophy).  
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1.4.3 Lipogenesis and lipolysis 
Whilst the formation of new fat cells revolves around the differentiation of pre-
adipocytes, the amount of fat stored within a mature adipocyte is dependent on three 
processes: (1) lipid synthesis or lipogenesis, (2) lipid breakdown or lipolysis and (3) 
fatty acid uptake from the circulation. Fatty acids are essential cellular constituents 
with critical roles in signalling, energy supply and cell structure. They are the 
functional units of fat and are stored within adipocytes within TAG molecules, a 
glycerol backbone bound to three fatty acids. Lipogenesis refers to the formation of 
TAG from fatty acids consumed within the diet and/or produced endogenously. The 
latter is more specifically termed de novo lipogenesis and utilises carbohydrates as a 
source of glucose which is then converted into fatty acids in a multistep pathway 
summarised in Figure 1.3. Lipolysis refers to the breakdown of TAG into glycerol and 
free fatty acids which can then be further broken down to yield energy in the form of 
ATP in a process termed β-oxidation. When the rate of lipogenesis exceeds the rate of 
lipolysis then lipid storage, and hence fat mass, increases. Lipogenesis, predominantly 
occurring in adipose tissue but also in the liver, skeletal muscle, heart and pancreas, is 
under precise control by many metabolic and hormonal factors.  
De novo lipogenesis is chiefly under the enzymatic control of acetyl-CoA carboxylase 
(ACC) and fatty acid synthase (FAS) (Volpe and Vagelos, 1976, Bloch and Vance, 
1977). These enzymes act on acetyl-CoA and malonyl-CoA respectively to produce 
palmitic acid which can then be stored or used to produce other fatty acids. Many 
enzymes involved in de novo lipogenesis are under the transcriptional control of sterol 
regulatory element binding proteins (SREBP) of which there are three-subtypes: 
SREBP-2, SREBP-1a and SREBP-1c. SREBP-1c has been shown to be the dominant 
isoform associated with lipogenesis (Horton et al., 2002) and activates many lipogenic 
genes (Figure 1.3). 
Figure 1.3 (Overleaf) Overview of de novo lipogenesis (DNL) which occurs in the 
cytoplasm of most cells, particularly adipocytes and hepatocytes. Fatty acids are 
produced via the synthesis of palmitic acid from metabolites produced in the citric acid 
cycle. Dietary glucose and/or fatty acids are transported into cells via their respective 
transporters where they can enter the citric acid cycle. Citrate is converted in acetyl-
CoA by ATP citrate lyase (ACLY). The two central enzymes responsible for DNL, 
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acetyl-CoA carboxylase (ACC) and fatty acid synthase (FAS), then further synthesise 
palmitic acid (C16:0). A range of fatty acids can then be made from palmitic acid 
through multi-step processes requiring various different enzymes, one of which is the 
rate limiting enzyme Stearoyl-CoA desaturase-1 (SCD1) which is responsible for the 
production of monounsaturated fatty acids. The enzymes involved in DNL are under 
the transcriptional control of sterol regulatory element-binding protein 1 (SREBP-1c) 
due to the presence of SREBP response elements (SRE) in the promotor regions of 
these genes. The biological activity of SREBP-1c relies on its maturation and release 
from the membranes of the endoplasmic reticulum (ER) and the Golgi apparatus. It is 
well understood that this process is inhibited by sterols such as cholesterol, however, 
insulin (Soyal et al., 2015) as well as some fatty acids (Xu et al., 2001) are also thought 







1.5 An introduction to dietary fatty acids 
1.5.1 Types of dietary fatty acids  
Fatty acids are carboxylic acids consisting of a hydrocarbon chain of varying length 
and a terminal carboxyl group. Fatty acids mainly exist in an esterified form such as 
those found in oils, animal fats and waxes and they can be classified based on the 
number of double bonds within the hydrocarbon chain. Saturated fatty acids (SFA) 
contain no double bonds and are found in animal products such as meat and dairy, as 
well as some tropical oils (e.g. coconut and palm oil). Monounsaturated fatty acids 
(MUFA) contain a single double bond and are found in high quantities in olive oil, 
macadamia oil and a number of other nuts and seeds. Polyunsaturated fatty acids 
(PUFA) contain more than one double bond. PUFA are further subcategorised into 
omega-3, omega-6 and omega-9 families based on the location of the double bonds 
and it is becoming increasingly clear that individual fatty acids within their broad 
classifications carry unique biological characteristics and health effects.  
Whilst all three PUFA families carry biological importance, it is the omega-3 and 
omega-6 families that are of greatest interest to research as they are considered 
essential fatty acids (Burr and Burr, 1930). Specifically the 18 carbon omega-6 family 
precursor linoleic acid (LA), found in high amounts in soy, corn, safflower and 
sunflower oils, and the omega-3 family precursor alpha-linolenic acid (ALA), found 
in leafy green vegetables as well as flaxseed and canola oil, cannot be synthesised 
within the human body and must be consumed in the diet and failure to do so is fatal 
(Burr and Burr, 1930).  
1.5.2 Setting the scene for dietary PUFA 
It is well established that poor dietary habits result in excessive weight gain in children 
and adults. A key characteristic of obesity is increased central and visceral adiposity, 
and dietary fats are often implicated as a key driver. It is clear, however, that not all 
dietary fats are equal in their biological structure and function and so some may 
contribute to obesity and its associated health outcomes more than others. Efforts have 
been made to identify those components in an attempt to address the obesity epidemic 
on a population level. 
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Obesity is a major risk factor for CVD (see section 1.1) and early studies found an 
association between circulating cholesterol levels and risk of death from CHD. A study 
by Keys (1970) also found a strong correlation between dietary intake of saturated fat 
and blood cholesterol concentrations (Keys, 1970). At around the same time, dietary 
PUFA were shown to reduce cholesterol levels (Keys et al., 1965). This resulted in the 
hypothesis that SFA were a key driver of CVD and consequently governments 
recommended that SFA in the diet, particularly animal fats, be replaced with PUFA 
(vegetable oils) in order to decrease the risk of CHD. For the UK, as well as other 
developed countries, this led to a substantial decrease in animal fat consumption in the 
last 40 years (SACN, 2019). Interestingly, however, the dramatic reduction in the 
consumption of SFA, and corresponding increase in the intakes of PUFA, at a 
population level was not associated with any reduction in the deaths from CVD. In 
fact, ischaemic heart disease still remains the leading cause of death worldwide, 
particularly in middle- and high-income countries where such government level 
recommendations were made (WHO, 2017b). Regardless of this, saturated fat 
continues to be regarded as a potential cause of the increased rates of CVD in 
populations worldwide, despite evidence that some SFA exert cardio-protective 
effects. Dairy products such as cheese have been labelled as harmful due to their high 
saturated fat content despite having relatively high levels of monounsaturated fats and 
despite studies that show some level of cardio-protection associated with higher levels 
of cheese consumption (Gholami et al., 2017). There is little doubt that cholesterol 
levels can be reduced in some individuals by substituting saturated fats with PUFA, 
however, this does not always translate to reductions in rates of death from CVD 
(Ramsden et al., 2013c) and this topic needs to be continually reassessed. However, 
despite these new insights and re-evaluation of the role of saturated fat within the diet, 
dietary patterns over the past 60 years have shifted dramatically in Western countries 
towards a reduction in saturated fat and an increase in dietary PUFA.  
1.5.3 Current recommendations and intakes of dietary PUFA  
1.5.3.1 Recommended intakes 
Broad government recommendations to replace SFA with PUFA in the diet have led 
to a population-level shift in the fatty acid composition of Western diets such as those 
consumed in the UK, USA and Australia. Primarily this shift has been caused by the 
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replacement of butter and other saturated fats (e.g. lard) with plant-based cooking oils 
such as canola and sunflower oils, which are high in LA, the omega-6 precursor. 
Whilst this replacement successfully reduced the SFA intake within the diet (WHO 
and FAO, 1994), the use of PUFA as an umbrella term can be misleading since 
different families, and indeed individual fatty acids, can exhibit quite different 
biological roles (see section 1.5.4.1). Whilst the recommended intakes of dietary 
PUFA vary between countries (Ailhaud et al., 2006), a joint report from the FAO and 
WHO (2008) recommended that total omega-6 intake represents 2.5-9% energy (%en) 
of the diet whilst total omega-3 represents 0.5-2%en, translating to a ratio of ~5:1 for 
total-omega-6 and total omega-3 respectively. The report also suggested that the intake 
of long chain polyunsaturated fatty acid (LCPUFA) derived from omega-3 (i.e.  
eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)) should be increased 
for pregnant and lactating women, no increase in any omega-6 fatty acids were 
suggested. The minimum values in this report are based on the avoidance of deficiency 
symptoms, whilst the maximum values were set in accordance with research 
highlighting the capacity for LCPUFA, particularly omega-3 LCPUFA, to reduce 
CVD risk. It is therefore apparent that many of the biological benefits associated with 
omega-3 PUFA are as a result of conversion to longer chain derivatives. Some studies 
in animals have shown that a LA:ALA ratio of <5:1 is most appropriate for enhanced 
omega-3 LCPUFA synthesis and accumulation in tissues (Blank et al., 2002, Gibson 
et al., 2011). Other studies have further specified that maximal conversion of ALA to 
EPA and DHA occurs when the dietary ratio of LA:ALA is set at 1-2:1 but overall 
intake of dietary PUFA is low (Tu et al., 2010). It is suggested that this dietary ratio is 
associated with CVD mortality at one-fourth the current rate in the USA (Lands, 2000). 
1.5.3.2 Estimated intakes 
Increasing the use of vegetable oils has resulted in a dramatic increase in the intake of 
omega-6 PUFA, with LA being the most abundant fatty acid consumed in a Western 
diet (Ramsden et al., 2013c, Wood et al., 2014). This increase in omega-6 consumption 
has not been matched by an increase in omega-3 which has remained stable over this 
period of dietary change (Figure 1.4) (Ailhaud et al., 2006). The ratio of omega-6 to 
omega-3 in current Western diets is reported to be around 8-10:1 (Blasbalg et al., 2011, 
Meyer et al., 2003) or higher (Simopoulos, 2016). This is higher than 
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recommendations and studies investigating the rate of conversion to long chain 
derivatives. The consequence of this high omega-6 to omega-3 ratio of dietary PUFA 
for public health is unclear. 
 
Figure 1.4 Temporal changes in (A) apparent consumption of linoleic acid in Western 
countries and (B) linoleic acid (18:2n-6) and alpha-linolenic acid (18:3n-3) content in 




1.5.4 Omega-6 and omega-3 PUFA 
1.5.4.1 Metabolism and function 
The biological functions of the omega-6 and omega-3 classes are primarily undertaken 
by the long-chain derivatives of the parent compounds, LA and ALA, and so there is 
a requirement for them to be converted to these derivatives in order to mediate many 
of their biological effects. This multistep process, established by Holman (1986) and 
further refined by Sprecher et al. (1995), relies on the addition of carbon molecules to 
increase chain length (elongation) and the addition of double bonds within the carbon 
chain (desaturation). As summarised in Figure 1.5, LA (18:2 n-6) and ALA (18:3 n-3) 
are converted to 18:3 n-6 and 18:4 n-3 respectively by the enzyme Δ6 desaturase 
encoded by the Fads2 gene. These desaturation products are further converted into 
arachidonic acid (AA; 20:4 n-6) and eicosapentaenoic acid (EPA; 20:5 n-3) 
respectively through the action of Δ5 desaturase, encoded by the Fads1 gene, and a 
series of elongation steps. EPA is further converted into docosapentaenoic acid (DPA; 
22:5 n-3) via elongation. A further desaturation, which utilises Δ6 desaturase once 
more, and a final β-oxidation step produces docosahexaenoic acid (DHA; 22:6 n-3). It 
is these longer chain fatty acids that carry important biological roles.  
Both omega-3 and omega-6 PUFA are involved in many important biological 
functions, demonstrated by the absolute requirement of LA and ALA in the diet. They 
are an important constituent of cell membranes (Spector, 1999) and so influence cell 
membrane fluidity as well as the behaviour of membrane bound enzymes and receptors 
(Buettner et al., 2007). They also play a role in controlling blood pressure and are key 
to proper brain and neural development (Wall et al., 2010). The long chain derivatives 
of both families, AA in the omega-6 pathway and EPA and DHA in the omega-3 
pathway, also have important roles in inflammation and immune regulation through 
the actions of their own derivatives known as eicosanoids (Calder, 2006, Patterson et 
al., 2012).  
1.5.4.2 Eicosanoids and their role in inflammation 
Eicosanoids are biologically active lipids and include a variety of molecules which 
generally fall into the subcategory of prostaglandins (PG), thromboxanes (TX), 
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leukotrienes, resolvins or lipoxins. Eicosanoids are derived from 20-carbon fatty acids 
(such as AA and EPA) which are liberated from the plasma membrane by 
phospholipases (Figure 1.5). Eicosanoids are then metabolised through the sequential 
actions of various enzymes including cyclooxygenases (COX) and lipoxygenases 
(LOX). Metabolism of AA by the COX enzymes results in the synthesis of 2-series 
prostaglandins (PGE2, PGI2, PGD2 and PGF2α) and thromboxanes (TXA2 and TXB2) 
and 4-series leukotrienes (Patterson et al., 2012). When EPA is used as a substrate for 
COX and LOX enzymes, as opposed to AA, prostaglandins and thromboxanes of the 
3-series and the 5-series of leukotrienes are produced (Patterson et al., 2012). 
Eicosanoids play a critical role in many processes involved in inflammation, which in 
healthy individuals facilitates a natural bodily defence against infection and injury 
(Ricciotti and FitzGerald, 2011). Inflammation of this kind is caused by induction of 
a pro-inflammatory signalling cascade that is rapidly mediated by a host of anti-
inflammatory mediators acting through a negative feedback mechanism resulting in an 
acute inflammatory response, with relatively rapid resolution. However, when these 
regulatory mechanisms falter, or there is an imbalance in pro-inflammatory and anti-
inflammatory signals, excessive and ongoing inflammation can occur (Calder, 2015). 
As such, the dysregulation of eicosanoid production has been implicated in diseases 
with an inflammatory component such as CVD, obesity, inflammatory bowel diseases, 
rheumatoid arthritis and cancer (Patterson et al., 2012).  
Eicosanoids derived from AA and EPA have varied properties, both pro-inflammatory 
and anti-inflammatory in nature and all play an important role in the regulation of 
inflammation. However, it is generally considered that eicosanoids derived from AA 
are more pro-inflammatory in nature whilst those derived from EPA are more anti-
inflammatory. PGI2 and PGE2, generated from AA, have pro-arrhythmic effects 
whereas PGI3 and PGE3 are anti-arrhythmic (Li et al., 1997). Similarly, AA derived 
TBX2 is a potent vasoconstrictor and platelet activator whereas TBX3, derived from 
EPA, has few physiological effects. AA derived eicosanoids also activate the 
production of inflammatory cytokines, including TNFα, IL-1 and IL-6 (Schmitz and 
Ecker, 2008). Resolvins derived from EPA (E-series) and DHA (D-series) also exert 
anti-inflammatory effects by suppressing the activation of NFΚβ, resulting in 
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decreased synthesis of inflammatory cytokines, a process that appears to be dependent 
on PPARγ activation (Liao et al., 2012). 
EPA, DHA and AA are competitive substrates for enzymes involved in the synthesis 
of eicosanoids and diets high in omega-3 PUFA have been shown to decrease 
production of PGE2, TXB2, TNFα and IL-1 in humans (Caughey et al., 1996). The 
utilisation of either AA or EPA/DHA as a precursor for eicosanoid production relies 
on their synthesis and incorporation into cell membranes. The formation of the 
LCPUFA from LA and ALA utilises the same enzymes for elongation and desaturation 
(Figure 1.5). This sharing of enzymes for this multistep process results in competition 
between the two families for substrate binding and thus, a differing ratio of dietary 
precursors can lead to an imbalanced production of long chain derivatives and hence 
a more pro-inflammatory or anti-inflammatory eicosanoid profile. 
Figure 1.5 (Overleaf) The metabolism of dietary linoleic acid (LA) and alpha-
linolenic acid (ALA) to long-chain fatty acid derivatives and eicosanoid biosynthesis 







1.5.5 Enzymes and competition between families 
1.5.5.1 Desaturase and elongase enzymes 
Desaturase enzymes Fads1 and Fads2 are found in a variety of tissues but are present 
at highest levels in the liver. They are responsible for the addition of double bonds to 
fatty acids in the LCPUFA synthesis pathway (Figure 1.5). Fads2 is considered a key 
regulatory enzyme in the synthesis of LCPUFA as it is used twice in the conversion of 
ALA to DHA (Sprecher et al., 1995). The importance of the Fads2 gene in synthesis 
of LCPUFA has been clearly demonstrated in mice as Fads2 knockout mice lack the 
ability to carry out the initial step of LCPUFA synthesis which results in downstream 
consequences for PUFA metabolites manifesting in sterility in both males and females 
(Stoffel et al., 2008, Stroud et al., 2009). Stroud et al. (2009) also demonstrated the 
importance of the Fads1 gene in LCPUFA synthesis with radiolabelled administration 
of LA and ALA. Fads2 knockout mice accumulated levels of 20:3 n-6 and 20:4 n-3, 
fatty acid metabolites produced from LA and ALA respectively. This suggests that 
Fads1 has some desaturation capacity when expression of Fads2 is suppressed. 
Fatty acid elongation is carried out by the elongation of very long chain fatty acids 
proteins (ELOVL), of which 7 subtypes have been identified in humans and rodents. 
ELOVL2 and ELOVL5 are the key elongase enzymes associated with LCPUFA 
synthesis in mammals and are expressed in high amounts in the liver (Jakobsson et al., 
2006). Knockout experiments have highlighted that the initial elongation step is 
dependent on ELOVL5 but increased activity of ELOVL2 in ELOVL5 knockout mice 
also suggests a compensatory mechanism whereby ELOVL2 acts to ensure LCPUFA 
synthesis (Moon et al., 2009). Interestingly, mRNA expression of SREBP-1c was up-
regulated in ELOVL5 knockout mice due to the decreases in cellular concentrations 
of DHA and AA. This up-regulation led to the up-regulation of SREBP-1c target genes 
responsible for lipogenesis which consequently resulted in hepatic steatosis i.e. fat 
accumulation in the liver (Moon et al., 2009).  
The expression of the desaturase and elongase enzymes have been shown to be 
sensitive to dietary intakes. In vivo and in vitro studies have demonstrated that both 
Fads1 and Fads2 mRNA expression and enzyme activity are suppressed in the 
presence of adequate omega-3 and omega-6 dietary PUFA and elevated when dietary 
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PUFA is low (Cho et al., 1999a, Cho et al., 1999b, Tu et al., 2010). Expression of 
ELOVL5 is also sensitive to nutritional status such that high levels of omega-3 
suppress mRNA expression, however, ELOVL2 expression does not appear to be 
regulated by dietary fat intake (Wang et al., 2005).  
1.5.5.2 Pathway competition  
Animal studies have demonstrated that, if they are not directly consumed in the diet, 
the abundance of the 20-carbon fatty acids (i.e. AA and EPA) is determined by the 
ratio of their precursors, LA and ALA in the diet. Blank et al. (2002) demonstrated 
that in piglets fed a varying LA:ALA ratio the predominant LCPUFA in plasma 
phospholipids of those receiving a low LA:ALA ratio was EPA and in those receiving 
a high LA:ALA ratio was AA. Similar observations were made in the livers of rats 
receiving diets containing increasing amounts of ALA (%en) and thus a decreasing 
LA:ALA ratio. A dose-response relationship was observed such that EPA levels 
increased as the LA:ALA ratio in the diet decreased (Tu et al., 2010). This has also 
been demonstrated in humans where decreasing dietary intakes of LA, with no changes 
in omega-3 intake, resulted in an increase in omega-3 LCPUFA in plasma 
phospholipids (Wood et al., 2014). These studies highlight that a LA dominant diet 
results in AA as the major 20-carbon fatty acid in tissues and accumulation of EPA 
can only occur when the LA:ALA ratio of diets is low.  
This imbalance in LCPUFA synthesis can partially be explained by simple substrate 
competition. Brenner and Peluffo (1966) demonstrated an inverse relationship 
between the conversion of LA to 18:3 n-6 and the amount of ALA added, implying 
that ALA and LA compete for the same desaturation enzyme and this is likely to be at 
the initial step where LA and ALA utilise Fads2. This same study also demonstrated 
that the Fads2 enzyme had a higher affinity for ALA compared to LA adding further 
complication to the competition between these two substrates. This suggests that 
conversion of omega-3 fatty acids to LCPUFA is preferential over conversion of 
omega-6 fatty acids and by lowering the amount of omega-6 substrate, i.e. LA, the 
amount of omega-3 LCPUFA being synthesised would increase. The competition 
between LA and ALA for conversion to their longer-chain derivatives was also 
demonstrated in a study by Clark et al. (1992), in which they lowered the LA:ALA 
ratio of formula milk (19:1) by either increasing the amount of ALA (4:1) or 
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decreasing the amount of LA (3:1). Decreasing the LA:ALA ratio by either means was 
associated with an increased incorporation of omega-3 LCPUFA into erythrocytes 
when compared with formula milk. This further highlights the importance of the 
LA:ALA ratio in determining the LCPUFA status of humans but also demonstrated 
that reducing the amount of LA in the diet is a practical method for increasing omega-
3 LCPUFA status.  
That the pathway utilises the Fads2 enzyme twice in the synthesis of LCPUFA 
suggests another potential competition point between fatty acids for enzyme substrate 
activity (Figure 1.5). A linear relationship between substrate supply, i.e. LA and ALA, 
and accumulation of 20-carbon chain fatty acids, AA and EPA, has been demonstrated 
in pigs (Blank et al., 2002), rats (Tu et al., 2010) and repeatedly in human studies 
(Wood et al., 2015, Mantzioris et al., 1994, Chan et al., 1993). However, what these 
studies, as well as others (Cleland et al., 2005), have also highlighted was that the 
relationship between the dietary intake of LA and ALA and circulating and tissue 
accumulation of DHA was more complicated. Increasing dietary levels of ALA 
increased levels of DHA in a curvilinear fashion such that DHA accumulation was 
maximal when dietary ALA was at 1-2%en (Tu et al., 2010, Blank et al., 2002). As 
such, it has been postulated that competition exists between the first step of LCPUFA 
synthesis and the final steps to produce DHA such that DHA production is limited 
when dietary ALA is high (Mantzioris et al., 1994, Chan et al., 1993).  
Further to this, fatty acids of both families rely on incorporation into cell membranes 
to carry out many of their biological functions. A study in non-human primates fed 
preformed EPA to isolate and investigate competition at the incorporation stage as 
opposed to synthesis stage. This study found that EPA incorporation into erythrocyte 
phospholipids was greatest when dietary LA was reduced (McMurchie et al., 1990), 
thus, suggesting another point of competition between the two families of fatty acids.  
These studies highlight the complexity of the interactions between fatty acids and 
enzymes in this pathway and the importance of the dietary LA:ALA ratio as well as 
the overall fat and PUFA content of diets in determining the synthesis of omega-3 
LCPUFA, and their incorporation into tissues.  
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1.6 Fetal requirements for fatty acids and lipids 
Both omega-3 and omega-6 fatty acids are required by the developing fetus for the 
maintenance of cell membrane fluidity and permeability, as precursors of important 
bioactive molecules and as a key source of energy.  
Fat deposition within the fetus increases dramatically with gestational age in humans 
and indeed, some of the fatty acids deposited in adipose tissue will be generated 
through fetal lipogenesis (Cetin et al., 2009). The majority of the fatty acids in fetal 
lipid, however, and all of the omega-6 and omega-3 fatty acid precursors, are derived 
from the maternal circulation. Transfer of these fatty acids from maternal to fetal blood 
supply requires transport across the placenta. The placenta, as well as the fetal liver 
during early gestation, has been shown to lack the necessary enzymes to convert LA 
and ALA to their longer chain derivatives (Mercuri et al., 1979b). As such, it can be 
assumed that fetal supply of both the omega-6 and omega-3 precursors as well as their 
longer chain derivatives is dependent on the levels of these factors in the maternal 
circulation, and hence in the maternal diet. This could lead one to expect that fetal 
PUFA concentrations would mimic that of the mother. It has been shown, however, 
that concentrations of AA and DHA are higher in all of the major lipid classes in the 
fetus when compared to maternal blood, a process termed biomagnification (Haggarty 
et al., 1999, Larque et al., 2003). This suggests a level of preferential transfer of some 
fatty acids over others. Perfusion studies have identified such a hierarchy and placental 
preference for uptake of fatty acids is as follows AA>DHA>ALA>LA>oleic. AA, 
however, is preferentially retained by the placenta for prostaglandin synthesis (Kuhn 
and Crawford, 1986) and so the hierarchy of fatty acids transferred to fetal circulation 
therefore becomes DHA>ALA>LA>oleic>AA (Haggarty et al., 1997). 
The fact that DHA concentrations are higher in the fetal circulation compared to the 
maternal circulation, as well as the finding that this fatty acid is preferentially 
transferred across the placenta in comparison to other fatty acids, suggests an increased 
fetal requirement and hence important biological function of this fatty acid in fetal 
development. The critical role of omega-3 fatty acids, in particular DHA, during fetal 
development was first established in studies on non-human primates. Neuringer et al. 
(1986) demonstrated that mothers consuming an omega-3 deficient diet gave birth to 
offspring with impaired cognitive function and visual acuity which could not be 
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corrected by omega-3 supplementation in later life. This was supported by the finding 
that the fetal brain and retinal phospholipids incorporate DHA ten times faster than LA 
and ALA (Cetin et al., 2009).  
1.7 PUFA and associated disease risk  
1.7.1 Dietary PUFA and disease risk in adults 
The increasing intakes of LA in the Western diet (Figure 1.4), coupled with the pro-
inflammatory action of omega-6 fatty acids, has led to the hypothesis that LA may be 
contributing to the upwards trends in obesity, metabolic syndrome and risk of CVD in 
human populations worldwide.  
1.7.1.1 Cardiovascular diseases 
Human studies on patients at risk of coronary artery disease (CAD) found that 
supplementation with omega-3 LCPUFA led to a reduction in mortality from CAD 
and CVD (Dolecek and Granditis, 1991), as well as a reduction in cardiac events 
(Singh et al., 1997), when compared to control groups. Similarly, dietary omega-3 
intake was associated with decreased risk of CHD and CHD mortality in a group of 
80000 female nurses (Hu et al., 2002). However, the cardio-protective properties of 
omega-3 LCPUFA have not been demonstrated in all studies, with several large scale 
robust randomised control trials finding no effect of omega-3 supplementation on 
cardiovascular events in high (Bosch et al., 2012, Bowman et al., 2018) and average 
risk patients (Manson et al., 2018). 
While these recent findings have generated a degree of controversy about the role of 
omega-3 fatty acids in the prevention and treatment of CVD, a report released by the 
FAO and WHO (2008) still concluded that there was convincing evidence that omega-
3 LCPUFA may decrease the risk of death from CHD. The report does not suggest 
there are data linking increased intake of LA to CVD outcomes despite evidence from 
the Sydney Diet Heart Study (SDHS) where saturated fats were replaced with 
concentrated sources of LA, and an association between the dietary intervention and 
increased risk of death from CHD was observed (Ramsden et al., 2013b). However, 
with the established complexity of the interactions and competition between omega-3 
and omega-6 fatty acids, it may be naïve to look at their effects on disease risk in 
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isolation as consumption of one family undoubtedly affects the metabolism and 
functional capacity of the other.  
1.7.1.2 Obesity  
The above text has discussed the capacity for AA to produce pro-inflammatory 
metabolites, however, some of these have also been shown to be pro-adipogenic. The 
metabolites 9-HODE and 13-HODE increase PPARγ expression resulting in increased 
adipocyte differentiation. Similarly, 20-HETE can induce oxidative stress associated 
with increased adiposity through its ability to up-regulate adipocyte differentiation 
(Kim et al., 2013). AA has also been shown to be capable of stimulating adipogenesis 
and lipogenesis in vitro (Massiera et al., 2003). This capacity appears to be mediated 
via the conversion of AA to PGI2 which is a known ligand of PPARβ/δ and capable of 
stimulating adipogenesis through PPARγ activation (see section 1.4). Omega-6 PUFA 
have also been shown to affect the expression of key lipogenic genes. A study by 
Muhlhausler et al. (2010a), where rats were fed diets containing increasing levels of 
ALA against a consistent LA content, showed a positive correlation between the 
adipose tissue expression of SREBP-1c and FAS and erythrocyte omega-6 PUFA 
concentrations. Increased expression of these genes suggests an increase in lipogenic 
capacity of these tissues and hence increased lipid storage which may contribute to 
obesity.  
These in vivo animal studies highlight the capacity for a role of LA in the pathogenesis 
of obesity, however, at a population level this link remains controversial. It is difficult 
to isolate the effects of single nutrients in human studies and appropriately take into 
consideration lifestyle, genetic and dietary factors that contribute to the development 
of obesity. Some studies have attempted to investigate this and a study on German men 
and women found an association between LA intake and weight gain in women over 
a 6.5 year period (Nimptsch et al., 2010). Whilst this study relied on the accurate self-
reporting of food frequency via questionnaires, Wang et al. (2016) found a correlation 
between baseline erythrocyte LA levels and weight gain resulting in overweight or 
obesity after a 10 year follow-up. Using erythrocyte LA levels as a proxy for intake 
addresses the criticisms for relying on self-reported intakes. 
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1.7.2 Dietary PUFA and disease: A DOHaD perspective 
Whilst there is some characterisation of the effects of omega-3 and omega-6 PUFA in 
adults, less is known about how this might impact on the programming of disease in 
the next generation. The prevalence of obesity in children is increasing at an alarming 
rate. Given that obesity is believed to track from childhood to adulthood this may 
predispose individuals to adverse health issues in later life. The nutritional 
environment that an individual is exposed to during development has been shown to 
affect growth and fat deposition as well as disease risk in later life (see section 1.2). In 
particular, the effects of a maternal diet high in fat are relatively well characterised in 
animal models and are typically associated with a range of offspring phenotypes, 
including high blood pressure, increased adiposity and impaired insulin and glucose 
homeostasis. With obesity being a major risk factor for metabolic syndrome, type 2 
diabetes and risk of CVD, identifying possible contributors and windows for 
prevention of the occurrence of obesity is a major global priority. Obesity is 
characterised by an increase in lipid storage and as a chronic inflammatory state. The 
biological actions of LA and its derivatives (see section 1.5.4.2) as pro-adipogenic and 
pro-inflammatory, their ability to affect genes involved in lipogenesis and evidence 
from studies in adults, all suggest a link between the intake of LA and obesity and may 
provide a clear biological basis for the hypothesis that current dietary trends are 
contributing to the intergenerational cycle of obesity.  
1.7.2.1 Animal studies 
Animal studies have provided the fundamental basis for exploring this hypothesis. 
Massiera et al. (2003) fed a diet rich in LA to mice during pregnancy and lactation. 
The adult progeny exhibited increased weight and adiposity compared to those fed a 
diet with lower levels of LA alongside a dietary source of ALA. Interestingly, when 
PGI2 receptor knockout mice were fed the same diets, no difference in body weight or 
fat mass was observed (Massiera et al., 2003). This elegantly highlights the critical 
role of omega-6 fatty acids and the PGI2 pathway in the accumulation of fat. More 
recently Massiera et al. (2010) demonstrated that continually feeding a diet high in LA 
(19%en) resulted in a progressive increase in body fat mass over four successive 
generations, and this occurred in the absence of any differences in SFA intake between 
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groups. This increased fat mass was as a result of increased adipocyte hypertrophy and 
hyperplasia through the up-regulation of genes associated with these mechanisms.  
The importance of dietary influences during post-natal and lactation periods has also 
been demonstrated. In the guinea pig, often considered the best rodent model of human 
adipose tissue development, newborns that were fed a low LA:ALA (2:1) milk formula 
and pellets up until postnatal day 21 had a significantly lower fat mass in later life than 
those fed a high ratio (36:1) (Pouteau et al., 2010). Importantly, the dietary 
intervention only lasted until day 21, after which they were fed the same diet. At day 
21 there were no differences in fat mass between groups highlighting the importance 
of this early window in the progression of obesity in later life. Another study by 
Korotkova et al. (2002) investigated the effects of an omega-6/omega-3 balanced 
maternal diet compared to either an omega-3 enriched diet or an omega-6 enriched diet 
on suckling offspring. The fatty acid profile of the milk as well as adipose tissue of the 
offspring largely reflected maternal dietary intakes. The results of this study also 
demonstrated that increased maternal intake of omega-3 fatty acids led to decreased 
growth rate and reduced adipose tissue mass in offspring at 3 weeks of age. This study 
highlighted the importance of the lactation period and capacity for the diet to affect 
breast milk fatty acid composition and it has in fact been shown that human breast milk 
fatty acid composition has shifted in the last 60 years (Figure 1.4) to reflect increasing 
dietary LA intake (Ailhaud et al., 2006). 
However, some confusion still remains around the effect of dietary PUFA on offspring 
adiposity as a study by Muhlhausler et al. (2011a) showed that offspring of rats fed a 
high omega-3 diet during pregnancy and lactation showed an increased total 
percentage body fat in both male and females. Few studies have investigated this 
hypothesis and it is clear that disparity between the results may be attributable to 
differences in species and study design (Muhlhausler et al., 2011a). 
1.7.2.2 Human studies 
Few studies have focussed on the direct effects of increasing maternal omega-6 PUFA 
on offspring health. Instead, the majority of randomised control trials have investigated 
the effects of increasing omega-3 intake. One study by Donahue et al. (2011) reported 
a positive correlation between the omega-6:omega-3 ratio of cord blood and indicators 
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of increased fat mass (subscapular skinfold thickness and triceps skinfold thickness) 
in children at 3 years of age. A systematic review revealed very few studies examined 
the effect of PUFA supplementation during pregnancy on offspring body composition 
and results were highly variable (Muhlhausler et al., 2011a). A more recent study, 
however, investigated the effect of maternal DHA supplementation on body fat mass 
and BMI in children at 7 years of age and found no differences between control and 
intervention groups (Wood et al., 2018). Another more recent article reporting results 
from the INFAT study investigating the role of dietary PUFA during pregnancy and 
lactation on offspring adiposity, found no evidence that LCPUFA in maternal blood, 
cord blood or breast milk is predictive of offspring adiposity in a 5-year follow-up 
(Meyer et al., 2019). This study is ongoing and will provide longitudinal insights into 




1.8 Objectives and hypotheses 
Whilst studies have highlighted the possible effect of varying the PUFA composition 
of the maternal diet on offspring body composition, often the ratio of omega-6:omega-
3 is not representative of current intakes in human populations. In studies reporting 
increased offspring adiposity in response to a maternal diet high in omega-6, some 
ratios have been as high as 216:1 (Korotkova et al., 2002) which is considerably higher 
than current estimated intakes.  
Therefore, the primary objective of this research was to determine the effect of altering 
the quantity and quality of fat within the maternal diet on offspring body composition 
and health outcomes. Specifically we aimed to identify the effect of a maternal dietary 
LA:ALA ratio, similar to that consumed in the typical Western diet, against a more 
‘ideal’ ratio on offspring growth and body composition. We hypothesised that a 
maternal diet high in LA would lead to increased offspring adiposity through increased 
adipogenic and lipogenic capacity of tissues and markers of this would be apparent in 
early life. We also aimed to identify whether any beneficial or detrimental effects 
observed with these two fatty acid profiles were exacerbated by increasing the total 
dietary PUFA content.  
Objective 1: To investigate the effects of increasing the LA:ALA ratio, as well as total 
fat content, in the diet of rats during the gestational period only, on maternal weight 
gain, placental and fetal growth and the expression of lipogenic and adipokine genes 
in maternal and fetal tissues. 
Objective 2: To investigate the effects of feeding an increasing maternal dietary 
LA:ALA ratio, as well as total fat content, on growth and fat deposition of the offspring 
who are directly exposed to experimental diets during pregnancy and lactation.  
Objective 3: To investigate the effects of feeding an increasing maternal dietary 
LA:ALA ratio, as well as total fat content, on offspring adiposity and markers of CVD 
risk in young adulthood. This study will focus specifically on the effects of the 
maternal diet on offspring health post-lactation, where offspring have been weaned 
onto a standardised diet, and hence, investigate the longer-term consequences of 
possible early life programming of metabolic disturbance. 
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2 MATERIALS AND METHODS 
2.1 Animal Diets 
Animal diets were prepared in house at the University of Nottingham Bio-Support 
Unit. Diets were designed to provide a LA:ALA ratio of 9:1 (high LA) or 1:1.5 (low 
LA) which was achieved by altering the amounts of flaxseed and sunflower oil 
included in the fat component of the feed. The amount of SFA and MUFA were 
comparable in all diets, achieved by the manipulation of coconut (SFA source) and 
macadamia (MUFA source) oils in the diets. The fatty acid composition of each oil, as 
well as oil blends, was analysed using gas chromatography (see section 2.3.1.4) to 
ensure the correct fatty acid ratios were achieved (Table 2.1). For each level of LA, 
diets were made to contain either 18% or 36% fat by weight. Thus, resulting in four 
experimental diets; high LA (18% fat), high LA (36% fat), low LA (18% fat) and low 
LA (36% fat). The gross composition of each diet is shown in Table 2.2. Diets were 
analysed in-house for energy content, fatty acid composition and protein content 
(Table 2.3). Protein content of experimental feeds was analysed using a Thermo 
Scientific nitrogen (N)/protein analyser (Flash EA1112). Percentage nitrogen was 
directly measured and protein (%) was estimated under the assumption of a 16% N 
content of proteins. Mineral and vitamin mixes were also produced in house according 
to the American Institute of Nutrition AIN-76A formulation (American Institute of 
Nutrition, 1977), compositions of which are shown in Table 2.4 and Table 2.5 
respectively. For general maintenance and for weanling animals (where applicable) 
animals were provided with the 2018 Teklad Global 18% protein rodent diet (chow). 
The manufacturer’s description of the composition can be found in Appendix A. 
Similarly to the experimental diets, an in-house analysis of fatty acid profile was also 
carried out for the chow diet, the results of which can be found in Appendix B.  
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Table 2.1 Fatty acid composition of oils and blends used in experimental diet 
Fatty Acid 















8:0 - - - 5.33 1.01 0.94 
10:0 - - - 5.17 0.99 0.91 
12:0 - - - 48.02 9.26 8.39 
14:0 0.04 0.08 0.47 20.38 4.09 3.72 
16:0 5.27 6.89 11.48 10.13 9.43 9.63 
17:0 0.07 0.04 0.04 0.01 0.04 0.04 
18:0 3.64 3.28 3.18 3.06 3.27 3.30 
20:0 0.44 0.25 1.31 0.09 0.65 0.82 
22:0 0.11 0.74 0.68 0.02 0.56 0.44 
24:0 0.09 0.26 0.28 0.04 0.22 0.20 
Total SFA 9.66 11.54 17.44 92.27 29.52 28.38 
18:1n-9 16.83 28.40 63.57 6.10 38.28 41.19 
20:1n-9 0.13 0.17 1.12 0.04 0.54 0.66 
22:1n-9 0.00 0.00 0.10 0.00 0.05 0.06 
16:1n-7 0.04 0.12 8.66 0.01 3.52 4.72 
18:1n-7 0.74 1.01 2.63 0.12 1.54 1.88 
Total MUFA 17.74 29.70 76.09 6.28 43.92 48.50 
18:3n-3 58.18 0.18 0.11 0.00 2.56 13.47 
18:2n-6 14.31 58.50 6.24 1.43 23.94 9.59 
Total PUFA 72.48 58.69 6.36 1.43 26.50 23.05 
LA, linoleic acid; ALA, alpha linolenic acid; SFA, saturated fatty acids; MUFA, 
monounsaturated fatty acids; PUFA, polyunsaturated fatty acids.  
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Table 2.2 Composition of experimental diets 
Component 









Casein 16.0 16.0 16.0 16.0 
Cornflour 31.8 20.0 31.8 20.0 
Sucrose 16.0 10.0 16.0 10.0 
Cellulose 15.6 15.6 15.6 15.6 
Mineral Mixa 1.8 1.8 1.8 1.8 
Vitamin Mixa 0.4 0.4 0.4 0.4 
Choline Chloride 0.2 0.2 0.2 0.2 
Methionine 0.4 0.4 0.4 0.4 
Flaxseed Oil 0.9 1.7 4.2 8.5 
Sunflower Oil 6.6 13.1 0.8 1.7 
Macadamia Oil 6.9 13.8 9.5 19.0 
Coconut Oil 3.4 6.9 3.2 6.3 
Total Fat 17.8 35.6 17.8 35.5 
aVitamin and mineral mixes were prepared according to the American Institute of 
Nutrition AIN-76A formulation (American Institute of Nutrition, 1977). LA, linoleic 
acid. 
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Table 2.3 Macronutrient content and major fatty acid composition of experimental 
diets 








Macronutrientsa     
Carbohydrates (% Energy) 46.0 23.8 46.0 23.8 
Protein (% Energy) 15.4 12.7 15.4 12.7 
Fat (% Energy) 38.6 63.5 38.6 63.5 
Energy (MJ/kg) 21.2 24.5 21.3 24.8 
Fatty Acidsb     
Total SFA 20.7 20.3 21.1 20.0 
Total TFA 0.1 0.1 0.1 0.1 
Total MUFA 48.8 49.0 53.3 54.9 
Total Omega-6 (LA only) 27.3 27.4 11.1 10.5 
Total Omega-3 (ALA only) 3.1 3.2 14.4 14.4 
Total PUFA 30.4 30.6 25.5 25.0 
ALA (%Energy) 1.2 2.0 5.6 9.1 
LA (%Energy) 10.5 17.3 4.3 6.7 
LA:ALA Ratio 9.0 9.0 0.75 0.75 
aMacronutrient %energy was calculated using Atwater factors 
bData represent fatty acid percentage of total fatty acids.  
LA, linoleic acid; ALA, alpha linolenic acid; SFA, saturated fatty acids; TFA, trans 
fatty acids;  MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids.  
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Table 2.4 Composition of mineral mix (AIN-76) used in rodent experimental diets 
Table 2.5 Composition of vitamin mix (AIN-76) used in rodent experimental diets 
Mineral Weight (g/kg) 
Calcium phosphate dibasic 500.00 
Sodium chloride 74.00 
Potassium citrate 220.00 
Sucrose 118.03 
Potassium sulphate 52.00 
Magnesium oxide 24.00 
Ferric citrate 6.00 
Manganese chloride 3.50 
Zinc carbonate 1.60 
Chromium potassium sulphate 0.55 
Copper carbonate 0.30 
Potassium iodate 0.01 
Sodium selenite 0.01 
Vitamin Weight (g/kg) 
Thiamine hydrochloride 0.60 
Riboflavin 0.60 
Pyridoxine hydrochloride 0.70 
Niacin 3.00 
Calcium pantothenate 1.60 
Folic acid 0.20 
Biotin 0.02 
Vitamin B12 (0.1%) 1.00 
Vitamin A (500000IU/g) 0.80 
Vitamin D3 (400000IU/g) 0.25 
Vitamin E acetate (500IU/g) 10.0 
Menadione neon bisulfite 0.08 
Sucrose 981.15 
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2.2 Animal Trial Designs 
All animal procedures were performed in accordance with the Animals (Scientific 
Procedures) Act 1986 under Home Office licence and were approved by the Animal 
Ethics Committee of the University of Nottingham, UK. Virgin female Wistar rats (75-
100g) were obtained from Charles River Laboratories (UK) and were housed in plastic 
individually ventilated cages (IVC) and subjected to a 12 h light–12 h dark cycle at a 
temperature of 20–22°C and 45-65% humidity. The animals were housed on wood 
shavings and had ad libitum access to food and water at all times. All experiments 
were performed within the University of Nottingham Bio-Support Unit (Sutton 
Bonington Campus, UK).  
Animals were allowed to acclimatise to the unit for 2 weeks after arrival; during this 
time they were maintained on a standard laboratory chow diet (2018 Teklad Global 
18% protein rodent diet). After two weeks, a tail vein blood sample was taken from rat 
dams using a needle to pierce the skin. This was done 10 minutes after the application 
of an anaesthetic cream. The initial blood drop was discarded and further drops were 
placed onto dried blood spot (DBS) cards (see section 2.3.1.1) for further analysis. 
Animals were then randomly allocated to their experimental diets and maintained on 
these for 4 weeks, during which time animals were pair-housed. A second tail vein 
blood sample was taken before animals were mated. After mating, animals followed 
the design of either trial I (see section 2.2.1) or trial II (see section 2.2.2). The two 
trials were run in parallel and four unrelated males were used for mating. 
2.2.1 Trial I: Altered maternal diet and fetal outcomes 
Trial I aimed to assess the effect of altered maternal fatty acid ratio and total fat content 
on fetal development. 
2.2.1.1 Animal breeding and maintenance 
Conception was confirmed by the appearance of a semen plug and this was noted as 
day 0 of pregnancy. Average time in mating pairs was 2.5 days and all but one female 
conceived within their first oestrous cycle housed with the male. After conception, 
animals were individually housed and remained on their respective diets until day 20 
of gestation (full term = 22 days) where dams and fetuses were culled and tissues were 
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collected (see section 2.2.1.2). A schematic summary of the trial design can be seen in 
Figure 2.1. Dams were weighed daily, had feed intake measured and protein intake 
was estimated based on the protein content of the experimental diets (Table 2.3). 
 
Figure 2.1 Schematic summary of animal trial I experimental design. *indicates 
collection of a tail vein blood sample for measurement of circulating fatty acids. 
2.2.1.2 Cull and tissue collection 
Animals were culled according to Schedule 1 of the Animals (Scientific Procedures) 
Act 1986.  Briefly, adult rats (>500g) were culled in rising carbon dioxide and death 
was confirmed by cervical dislocation. Fetuses were removed from the uterine horn, 
separated from the placenta and weighed, sexed via measurement of anogenital 
distance and then culled via decapitation; death was confirmed by exsanguination. 
Truncal blood samples were collected from two randomly selected male and two 
randomly selected female fetuses from each litter at this time. The whole blood 
samples (~30µl) were spotted onto DBS collection paper, allowed to dry at room 
temperature and were then stored at −20°C for subsequent fatty acid analysis. Fetal 
liver and placentas were weighed and samples of selected male placental and liver 
samples were collected. All tissue samples were snap-frozen in liquid nitrogen and 
stored at −80°C. Male fetuses selected for collection of tissue samples also had tail 
samples collected for sex-genotyping by PCR for the SRY gene (McClive and Sinclair, 
2001). Any samples found to be female or inconclusive (n = 5) were not included in 
further analyses. Maternal tissues were weighed and samples of liver and 
MATERIALS AND METHODS 
47 
retroperitoneal adipose tissue were collected. Blood was collected from dams via 
cardiac puncture. Whole blood (~30µl) was spotted onto DBS cards and the rest was 
placed into heparinised tubes (Sarstedt) and centrifuged at 13000 rpm for 10 minutes 
at 4°C. The plasma was isolated from the whole blood samples and stored at -80°C 
until further analysis. All harvested organs were weighed and snap frozen in liquid 
nitrogen prior to storage at -80°C. 
2.2.2 Trial II: Altered maternal diet and offspring outcomes up to 8 weeks of age 
Trial II aimed to assess the effect of altered maternal fatty acid ratio and total fat 
content on offspring development up to 8 weeks of age. 
2.2.2.1 Animal breeding and maintenance  
Conception was confirmed by the appearance of a semen plug and this was noted as 
day 0 of pregnancy. Average time in mating pairs was 2.8 days and all but two females 
conceived within their first oestrous cycle housed with the male. After conception, 
animals were individually housed and remained on their respective diets until 
completion of the experiment. Litters were standardised to 8 pups within 24 hours of 
birth (4 males and 4 females where possible). At 1 and 2 weeks of age, one randomly 
selected male and one randomly selected female from each litter was culled. At 3 
weeks of age, offspring were weaned away from the mother onto a chow diet. Animals 
were group housed with littermates according to sex. After the offspring were weaned 
the dams were culled. All remaining animals had blood pressure measurements taken 
at 4 weeks of age, after which one male and one female were randomly chosen and 
culled. At 8 weeks of age, all remaining offspring had another blood pressure 
measurement taken and were then culled. A schematic summary of the trial design can 
be seen in Figure 2.2. Dams were weighed daily, had feed intake measured and protein 
intake was estimated based on the protein content of the experimental diets (Table 2.3). 
All neonates were weighed at birth and sex was determined by measurement of 
anogenital distance. Offspring were then weighed weekly until the end of the 
experiment.  
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Figure 2.2 Schematic summary of animal trial II experimental design. *indicates 
collection of a tail vein blood sample for measurement of circulating fatty acids. Where 
offspring were culled (at 1, 2, 4 and 8 weeks of age), one male and one female were 
chosen at random from each litter.  
2.2.2.2 Blood pressure measurements 
This experiment relied on the use of a non-invasive, non-surgical method for the 
measurement of blood pressure. Non-invasive measurements of laboratory animals are 
usually taken in one of three ways: all involve the use of an occlusion cuff placed on 
the tail alongside either a LED sensor (photoplethysmography), a piezoelectric sensor 
(piezoplethysmography) or a volume pressure recording (VPR) sensor. This 
experiment utilised a VPR sensor which measured tail blood volume to deduce 
systolic, diastolic and mean arterial blood pressure as well as heart rate. This method 
was validated by Feng et al. (2008) against surgical telemetry methods, which are often 
considered the gold-standard for blood pressure measurements in laboratory animals. 
Tail-cuff measurements provided accurate measurements of blood pressure when 
compared with telemetry and only underestimated blood pressure by 0.25mmHg on 
average.  
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Prior to blood pressure measurements, animals were placed in a heat box set to 30°C 
for 15 minutes to enhance blood flow to the tail. Animals were then restrained in 
individual restraint tubes with adjustable nose cone, fitted with the deflated occlusion 
and VPR cuff (CODA System, Kent Scientific, Torrington, CT) and left to acclimatise 
to the restraint tube for 10 minutes to minimise the impact of stress before 
measurements began. After acclimatisation, animals underwent 10 cycles of blood 
pressure measurements. Of these 10 cycles, the first three were disregarded as 
acclimatisation cycles and an average for each measurement was taken from the 
remaining seven. Animals were restrained for no longer than 30 minutes and removed 
if individuals presented with signs of stress.  
2.2.2.3 Cull and tissue collection 
Animals were culled according to Schedule 1 of the Animals (Scientific Procedures) 
Act 1986.  Briefly, adult rats (>500g) were culled in rising carbon dioxide and death 
was confirmed by cervical dislocation. Adolescent rats (<500g) were culled via 
cervical dislocation and death was confirmed by exsanguination. Truncal blood was 
collected from offspring using glass capillary tubes and spotted onto DBS cards 
(~30µl) at 1 and 2 weeks of age. Blood was collected from dams and offspring at 4 
and 8 weeks of age via cardiac puncture. Whole blood (~30µl) was spotted onto DBS 
cards and the remaining sample was placed in heparinised tubes (Sarstedt) and 
centrifuged at 13000 rpm for 10 minutes at 4°C. The plasma was isolated from the 
whole blood samples and stored at -80°C until further analysis. All harvested organs 
were weighed and snap frozen in liquid nitrogen prior to storage at -80°C. 
2.3 Laboratory Methods 
2.3.1 Lipid analysis 
2.3.1.1 The use and validation of dried blood spot (DBS) cards for the measurement 
of fatty acids  
The DBS technique is a sampling method where blood is spotted onto filter paper and 
allowed to dry. This drying stabilises the blood sample for further analysis and the 
technique has been in use since the 1960s where it was first used to screen for 
phenylketonuria in infants (Guthrie and Susi, 1963). Since then it has been used as a 
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screening method for biomarkers for a range of disorders such as HIV (Parker and 
Cubitt, 1999), cystic fibrosis (Wilcken et al., 1983) and sickle-cell anaemia (Garrick 
et al., 1973). Advances in the sensitivity and specificity of techniques associated with 
analysing small volumes of blood have resulted in the DBS technique becoming a 
significant tool, particularly in newborn screening.  
When compared with conventional blood collection and measurement techniques, the 
DBS technique has many advantages (Parker and Cubitt, 1999). One such advantage 
is that the DBS technique only requires the collection of capillary blood, a significant 
benefit especially in neonates and elderly patients where venous blood collection can 
be very difficult. The technique also eliminates the need for immediate processing of 
blood samples to separate blood fractions for long-term stability and storage. Because 
of the immediate stability to samples that the DBS technique provides, blood samples 
can be collected ‘in field’ and shipped, at room temperature, for analysis at a later time. 
Most of the advantages that the DBS technique confers over traditional venepuncture 
methods centre on the immediate stability of the blood samples, more specifically, the 
stability of the metabolite of interest within the blood sample. The use of the DBS 
technique to measure fatty acid status was first described by Nishio et al. (1986) but 
required a relatively large volume (~100µl) of blood and was validated for specific 
fatty acid biomarkers of adrenoleukodystrophy which are inherently stable in air 
(C22:0, C24:0 and C26:0). Since then, improvements have been made in the technique, 
however, the inability to measure fatty acids in all lipid fractions (Ichihar et al., 2002) 
and significant variability in measurements of LCPUFA when compared to 
conventional techniques (Marangoni et al., 2004), limited the application of this 
method for the measurement of the complete fatty acid profile. The oxidation of fatty 
acids, particularly LCPUFA, when exposed to air was postulated as a potential reason 
for this high variability (Ichihar et al., 2002). As such, to stabilise the LCPUFA, studies 
took the approach of either processing the samples immediately (Agostoni et al., 2008) 
or storing them at -20°C (Bell et al., 2011), both of which negate the advantage of the 
method as a convenient and stable technique.   
Previous research in our laboratory by Liu et al. (2014) established and validated a 
method for the measurement of the complete fatty acid profile in whole blood (PUFA 
coat™). This work tested fatty acid stability on various commercially available filter 
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papers all of which exhibited significant oxidation of LCPUFA. Coating the paper in 
silica gel increased fatty acid binding and the treatment of filter paper with an 
antioxidant and a chelating agent significantly reduced the oxidation effect of 
LCPUFA observed in previous studies. The stability of fatty acids was established for 
storage at room temperature for up to 2 months. Liu et al. (2014) validated the method 
in 50 human subjects and found strong correlations of all fatty acids when compared 
to conventional techniques. As well as the accurate determination of total lipid content 
within a sample, the amount of separate lipid classes can also be determined including 
phospholipids, free fatty acids, triglycerides and cholesterol esters. 
This method was used for the analysis of fatty acids in blood samples in this study due 
to its convenience over conventional techniques. Further to this, it allowed for the 
measurement of small volumes  of blood which was critical for determining fetal and 
early postnatal fatty acid profiles where sufficient amounts of blood could not be 
collected for conventional processing techniques (Figure 2.3). It also minimised pain 
and distress where blood samples were taken from live animals. Blood samples were 
spotted onto PUFA-coat™ DBS collection cards (FOODplus Research Centre, 
University of Adelaide) and stored at 4°C for a maximum of 2 weeks before postage 
to the Waite Lipid Analysis Service, University of Adelaide, where samples were 
stored at -80°C until further analysis. 
 
Figure 2.3 Example of dried blood spot (DBS) sample obtained from newborn rat 
offspring on a PUFA-coat™ DBS collection card (Liu et al., 2014). 
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2.3.1.2 Fatty acid extraction from DBS cards and synthesis of fatty acid methyl esters 
(FAME) 
Fatty acid composition of DBS samples was determined as described by Liu et al. 
(2014). DBS samples were cut from the protective card (Figure 2.3) and directly 
transesterified with 2ml of 1%H2SO4 in methanol at 70°C for 3 hours. Samples were 
vortexed every 30 minutes during this time. After cooling, 250µl of distilled water and 
0.6ml of heptane were added to each sample. Samples were vortexed and then allowed 
to stand for 10 minutes to allow for separation of layers. The top heptane layer 
containing FAME was pipetted into a fresh glass vial containing anhydrous sodium 
sulphate (Na2SO4) as a desiccant. Samples were then analysed using gas 
chromatography (see section 2.3.1.4) 
2.3.1.3 Fatty acid extraction from tissues and FAME synthesis 
Total lipids were extracted from placental samples in chloroform/isopropanol (2:1 v/v) 
using an adaptation of the Folch method (Folch et al., 1957). Crushed, frozen placenta 
was weighed (~300mg) and added to 2ml of 0.9% saline solution. The solution was 
homogenised on ice before the addition of 3ml isopropanol. The solution was vortexed 
and left to stand for 5 minutes. After this, 6ml of chloroform was added and the 
solution was vortexed. The samples were then centrifuged at 3000 rpm for 15 minutes 
and the bottom chloroform layer containing the extracted lipid was transferred into a 
fresh tube. This was then dried down under nitrogen before being reconstituted in 
chloroform/methanol (9:1 v/v). For logistical reasons 20µl of the sample was then 
spotted onto PUFA-coat™ DBS collection cards and FAME synthesis was carried out 
as per section 2.3.1.2. 
Total lipids were extracted from liver samples of 4 and 8-week-old offspring. For each 
sample, ~300mg of crushed, frozen liver was homogenised in 1.6ml of 0.5M Na2SO4. 
The homogenate was decanted into 5.4ml of hexane-isopropanol (3:2, v/v) and 2ml of 
0.5M Na2SO4 was added. Samples were vortexed and then centrifuged at 3000 rpm for 
15 minutes. The supernatant was removed into a fresh tube, dried under nitrogen and 
the resultant lipid content was weighed. Samples were resuspended in 1ml of hexane 
and 100µl of resuspended sample was removed into a fresh tube, re-dried under 
nitrogen and resuspended in 100µl of isopropanol for the determination of cholesterol 
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and triglyceride content (see section 2.3.3.4 and 2.3.3.5). The remaining sample was 
stored at -20°C for fatty acid analysis (see section 2.3.1.4). 
2.3.1.4 Gas chromatography (GC) analysis of fatty acid methyl esters (FAME) 
Samples containing FAME were analysed at the University of Adelaide. Samples were 
separated and analysed by a Hewlett-Packard 6890 gas chromatograph (GC) equipped 
with a capillary column (30m x 0.25mm) coated with 70% cyanopropyl 
polysilphenylene-siloxane (BPX-70; 0.25µm film thickness) which was fitted with a 
flame ionisation detector (FID). Helium was utilised as the carrier gas and a split ratio 
was set at 20:1. Injector temperature was set at 250°C and FID temperature at 300°C. 
FAME were identified in unknown samples based on the comparison of retention times 
with an external lipid standard (Standard 463, Nu-check prep Inc. MN, USA) using 
Agilent Chemstation software. Individual fatty acid content was calculated based on 
peak area and response factors normalised to total fatty acid content and expressed as 
a percentage of total fatty acids across lipid classes. 
2.3.2 Gene expression analysis 
2.3.2.1 Isolation and preparation of ribonucleic acid (RNA) from liver 
RNA was isolated from liver using Roche High Pure Tissue kits (Roche Diagnostics 
Ltd, UK). Lysis buffer (400µl) was added to ~25mg of crushed snap-frozen liver tissue 
in a clean, autoclaved Eppendorf tube. Samples were further homogenised by passing 
the tissue and buffer through a 21-gauge needle 5-10 times. The lysate was then 
centrifuged for 2 minutes at 13000 rpm and the supernatant was removed and placed 
into a fresh sterile Eppendorf tube with 200µl of absolute ethanol. A Roche high pure 
filter tube was combined with the collection tube and the entire solution was pipetted 
into the upper chamber of the filter/collection assembly. The samples were then 
centrifuged for 30 seconds at 13000 rpm and the filtered flow-through was discarded. 
For each sample, 90µl of DNase incubation buffer was mixed with 10µl DNase and 
the solution was added to the upper chamber of the filter/collection assembly in order 
to remove any contaminating genomic DNA. After an incubation step of 15 minutes 
at room temperature, the assembly was sequentially washed with wash buffers I and 
II. The upper chamber was then removed and placed in a fresh sterile Eppendorf tube 
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and 100µl of elution buffer was passed through (centrifuged at 8000 rpm) and the 
resultant solution in the Eppendorf contained the extracted RNA. 
2.3.2.2 Isolation and preparation of RNA from adipose tissue 
RNA was isolated from adipose tissue samples using a QIAGEN RNeasy Mini-kit 
(QIAGEN Ltd., UK) alongside MagNA Lyser green beads and instrument (Roche 
Diagnostics Ltd.). Lysis buffer (600µl; containing 1% beta-mercaptoethanol) was 
added to ~100mg of crushed snap frozen adipose tissue in a sterile tube containing the 
MagNA Lyser green beads. Samples were vortexed for 10 seconds and placed in the 
MagNA Lyser instrument for 40 seconds at 6500 rpm. Samples were then centrifuged 
at 8000 rpm for 3 minutes. After centrifugation, 400µl of the infranatant was removed 
(carefully avoiding the top lipid layer) into a fresh sterile Eppendorf tube and kept on 
ice. To increase RNA yield, the previous steps were repeated after adding 350µl of 
lysis buffer to the remaining solution in the tube containing the MagNA Lyser green 
beads. The resulting infranatant was then combined with that collected previously. The 
sample was then centrifuged for 5 minutes at 13000 rpm and 700µl of the supernatant 
removed and added to an equal volume of 70% ethanol. The resulting solution was 
then incrementally passed through the RNeasy filter column (centrifuged at 800 rpm 
for 15 seconds) and flow-through discarded. After a wash step, 70µl of buffer was 
combined with 10µl of DNase and pipetted into the top chamber of the RNeasy column 
where it was incubated for 15 minutes at room temperature. After multiple subsequent 
wash steps, the upper chamber of the RNeasy column was placed in a fresh sterile 
Eppendorf tube and 30µl of RNase-free water was added. The assembly was 
centrifuged for 1 minute at 8000 rpm and the resulting solution in the Eppendorf 
contained the eluted RNA.  
2.3.2.3 Testing RNA concentration and purity 
All RNA samples were tested for RNA concentration (ng/µl) using a Nanodrop 2000 
spectrophotometer (Thermo Scientific). Samples were measured at 260nm for nucleic 
acids and at 280nm for proteins. The 260/280 ratio gave an indication of any protein 
contamination within the samples and those failing to achieve a ratio value between 
1.8 and 2.0 and/or concentration lower than 50ng/µl were discarded and RNA 
extraction was repeated as in section 2.3.2.1 or 2.3.2.2. 
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2.3.2.4 Agarose gel electrophoresis 
RNA quality was assessed by agarose gel electrophoresis. All samples were diluted to 
a concentration of 50 ng/µl with RNAse free water based on the concentrations 
measured in section 2.3.2.3. A 1% agarose gel was prepared by diluting 1.5g agarose 
in 150ml 1xTris-acetate-EDTA (TAE) buffer. The solution was microwaved until the 
agarose was completely dissolved, cooled briefly under running water, and 
immediately poured into a gel tray with a 20 well comb inserted. Gels were left to set 
for 45 minutes after which the comb was removed and the gel was placed in the gel 
tank and submerged with 1xTAE buffer. Sample was loaded (10µl) alongside 2µl of 
loading dye into each well. The gel was electrophoresed at 100v for approximately 30 
minutes or until the bands were ~2cm from the bottom of the gel. The gel was then 
stained in ethidium bromide for 20 minutes and imaged under UV light (Gel Doc 2000, 
Bio-Rad Laboratories Inc.). After visual inspection of the gel, samples with two clear 
bands were considered acceptable. Any samples presenting with bands that were 
unclear, absent or smeared were discarded and RNA extraction was repeated as in 
section 2.3.2.1 or 2.3.2.2.  
2.3.2.5 Complementary DNA (cDNA) synthesis 
Qualifying RNA samples were synthesised into first strand complementary DNA 
(cDNA) using RevertAid™ Reverse Transcription kit (Thermo Fisher Scientific Inc.).  
Reaction mixes were prepared according to manufacturer’s instructions. A master mix 
containing random hexamer primers and nuclease free water was added to RNA into 
a fresh 96 well plate (Table 2.6) and incubated at 65°C for 5 minutes (GeneAmp PCR 
system 9700, Applied Biosystems). A ‘no template control’ was also added to each 
plate where RNA was replaced with water to ensure there was no contamination of the 
reagents. The plate was then immediately placed on ice to halt any further reactions. 
A second master mix was prepared (Table 2.6) and 8µl was added to each well and the 
plate was then incubated once more for 5 minutes at 25°C followed by 60 minutes at 
42°C. The reaction was terminated by heating the plate to 70°C for 5 minutes. A further 
80µl of RNase free water was added to each sample to make each well up to a 100µl 
total volume. A further dilution of the cDNA (1:8) was made and the plate was stored 
at -20°C until further analysis.  
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Table 2.6 Components of the master mixes prepared for the RevertAid™ reverse 
transcription reaction 
Component Volume 
Master mix I 
Total RNA (50ng/ml) 10µl 
Random hexamer primer 1µl 
RNase free water 1µl 
Master mix II 
5x Reaction buffer 4µl 
RiboLock RNase inhibitor 1µl 
10mM dNTP mix  2µl 
RevertAid™ RT 1µl 
 
2.3.2.6 Designing of primer pairs and primer sequences 
Oligonucleotide primers were designed for each experiment using online databases 
and Primer Express software, with the exception of Fads1 and Fads2 primers which 
were purchased from Qiagen (Fads1; Rn_Fads1_1_SG QuantiTect Primer Assay, 
Qiagen; Fads2; Rn_Fads2_1_SG QuantiTect Primer Assay, Qiagen). The gene 
sequence was selected in NCBI (National Centre for Biotechnology Information), and 
the exon-intron boundaries identified using Ensembl Genome Browser. This sequence 
information was inserted into Primer Express in FASTA format (Software Version 
3.0; Applied Biosystems) and primers generated that cross an exon-intron junction to 
increase specificity. Newly designed primer pairs were checked using an online Basic 
Local Alignment Search Tool (BLAST) for alignment with the sequence of interest 
and to ensure no other sequences were detected by the primers. Selected primers were 
ordered via Sigma-Aldrich Custom Oligos. Primer sequences can be found in relevant 
results chapters.  
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2.3.2.7 Quantitative real-time polymerase chain reaction (qRT-PCR) 
Although the basic principle is similar, the polymerase chain reaction (PCR) can be 
performed in a variety of ways to measure gene expression in various biological 
samples. Single stranded cDNA is heated with a specific primer pair, designed to bind 
and amplify a target sequence i.e. the gene of interest. This amplification occurs over 
a number of amplification cycles. During each cycle, each single stranded cDNA 
sample is denatured by increasing the temperature. The temperature is then lowered 
again to allow for primer annealing. Finally the temperature is raised again to allow a 
thermally stable DNA polymerase to amplify the target sequence. The quantity of 
amplification is relative to the amount of starting sequence within the sample giving 
an indication of the overall abundance of the gene of interest.  
This research relied on a specific method for the measurement of gene expression, 
quantitative real-time PCR (qRT-PCR). This method utilises a fluorescent dye which 
binds to double stranded nucleic acids. As PCR progresses, the fluorescent signal will 
increase. With each cycle, the number of copies of the gene of interest doubles and so 
in theory the fluorescent signal should double also. At the start of the reaction however, 
as there are only a few template strands, the signal is not strong enough to be detected 
(lag phase). After a few more cycles the gene of interested is amplified in a higher 
quantity and the fluorescent signal can be detected above the background noise 
(exponential phase). After a few more cycles, the reaction will then begin to slow down 
as the reagents are used up (plateau phase). As such, it is important to ensure that 
quantification of expression and any analysis performed is based upon data generated 
during the exponential phase, measurements during the lag or plateau phase are not 
entirely representative of starting quantities as they are limited by reagent quantity. 
The cycle in the exponential phase where the fluorescent signal moves into the 
detectable range is called the threshold cycle (CT). The amount of starting material 
within each sample will dictate how long it takes for the reaction to enter its CT: a 
lower amount of starting material would require more cycles and so the CT would be 
higher. 
For this research, a ‘master mix’ containing SYBR green fluorescent dye (Roche 
Diagnostics), forward and reverse primers for the target gene and RNAse free water 
were made. Exactly 10µl of the master mix and 5µl of the cDNA sample were pipetted 
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into each well of a 384-well LightCycler® plate (Roche diagnostics) in triplicate. 
Plates were covered and set to run on a LightCycler®480 instrument (Roche 
diagnostics) with the programme outlined in Table 2.7.  
Table 2.7 Phases of the qRT-PCR programme 
 Phase of reaction Number of cycles Settings per cycle 
Pre-incubation 1 95°C (5 minutes) 
Amplification 45 95°C (10 seconds) 
60°C (15seconds) 
72°C (15 seconds) 
Melting curve 1 95°C (5 seconds) 
60°C (1 second) 
90°C (cont.) 
Cooling 1 40°C 
  
To ensure there was no contamination, each data-set of cDNA was analysed alongside 
their respective RNA samples. If any amplification was detected in the RNA during 
the PCR cycles then this RNA/cDNA sample was excluded. In order to obtain 
quantitative data, subsequent samples were run alongside a standard curve of serially 
diluted cDNA pool, ranging from neat to 1:128 dilution. The cDNA pool was made up 
by adding 10µl of neat cDNA from each sample to make a stock. The qRT-PCR 
experiments were normalised to housekeeper genes that were not affected by dietary 
treatment. Further details can be found within the respective results chapters.  
2.3.3 Assays 
2.3.3.1 Determination of liver DNA concentration 
Motivated by differences in liver weight, DNA content of the liver was assessed in 
Chapter 4 to elucidate whether changes in tissue weight were attributable to differences 
in cell number (hyperplasia). The DNA concentration of liver samples was analysed 
using an adaptation of the Hoechst fluorometric assay method. Samples were crushed 
under liquid nitrogen and ~10mg of crushed tissue was added to 100µl of 0.05M 
trisodium citrate buffer. The solution was homogenised thoroughly and centrifuged at 
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2500 rpm for 10 minutes at 4°C. The supernatant was removed and the pellet was 
discarded. 
Serial dilutions of the stock DNA (DNA from calf thymus (1mg/ml); Sigma-Aldrich, 
UK) were prepared to give standards ranging from 0.3125-20µg/ml. After this, 100µl 
of distilled water (blank), standard or sample (10µl homogenate in 90µl H2O) was 
added to a 96-well plate. The dye solution (100µl of Hoechst 33258 dye (1mg/ml) in 
15ml 2x TNE buffer) was added to each well and fluorescence was measured using a 
FLUOstar Omega microplate reader (BMG Labtech Ltd.) with an excitation 
wavelength of 355nm and emission wavelength of 460nm. Standards and samples 
were analysed in duplicate and the DNA concentration was quantified against the 
standard curve and normalised to tissue weight. The inter-assay and intra-assay 
coefficients of variation were 10.4% and 2.1% respectively. A composite standard 
curve is shown in Figure 2.4. 
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Figure 2.4 Composite standard curve from four DNA assays. Data presented are mean 
± SD. 
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2.3.3.2 Determination of liver protein concentration 
Motivated by differences in liver weight, protein content of the liver was assessed in 
Chapter 4 to elucidate whether changes in tissue weight were attributable to differences 
in cell size (hypertrophy). The concentration of liver protein was analysed as a marker 
of cell size. Liver protein samples were prepared as described in section 2.3.3.1 and 
protein concentration was determined using a colorimetric method as described by 
Lowry et al. (1951), modified for a 96 well plate format. Serial dilutions of bovine 
serum albumin stock (5mg/ml) were prepared to give standards ranging from 0.2-
1.2mg/ml. Either 50µl of standard or sample (2µl homogenate in 48µl H2O) was added 
to each well with 150µl of 0.1M NaOH and 50µl of freshly prepared solution 1 (Table 
2.8). The plate was then incubated for 5 minutes at room temperature. After this, 50µl 
of freshly prepared solution 2 (Table 2.8) was added and samples were incubated again 
at room temperature for 20 minutes. The absorbance was measured at 655nm on a 
microplate reader (Bio-Rad 680-XR). Standards and samples were analysed in 
duplicate and the protein concentration was quantified against the standard curve and 
normalised to tissue weight. The inter-assay and intra-assay coefficients of variation 
were 11.7% and 2.5% respectively. A composite standard curve is shown in Figure 
2.5. 
Table 2.8 Working solutions for the quantification of protein in liver samples. 
Component Volume (ml) 
Solution 1 
Na2CO3 (2%w/v) in 0.1M NaOH 5 
CuSO4 (1% w/v) 0.5 
KNa Tartrate (2%w/v) 0.5 
Solution 2 
0.1M NaOH 5 
Folin–Ciocalteu reagent 0.5 
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Figure 2.5 Composite standard curve from four protein assays. Data presented are 
mean ± SD. 
2.3.3.3 Determination of liver glycogen concentration 
Liver glycogen was measured using the Colorimetric Glycogen Assay Kit II (Abcam 
Ltd.) according to manufacturer’s instructions. This assay relies on glycogen being 
hydrolysed to glucose, which is then oxidized to form an intermediate that reduces a 
colourless probe to a coloured product. As such, it is not possible to distinguish 
between the glucose derived from glycogen and any glucose that was originally in the 
sample. As such, for every sample a blank was also prepared alongside that lacked the 
enzyme required for the hydrolysis of glycogen to glucose.  
Samples were crushed under liquid nitrogen and ~20mg of tissue was added to 400µl 
of distilled water. Samples were homogenised (60 seconds at 6500rpm) using a 
MagNA Lyser instrument and MagNA Lyser green beads (Roche Life Science) and 
then immediately boiled at 100°C for 10 minutes. Samples were then centrifuged at 
13000rpm for 10 minutes at 4°C. The supernatant was collected (200µl) into a fresh 
tube.  
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Standards were prepared from a glycogen standard stock (2mg/ml). This stock was 
diluted to 0.2mg/ml in water and then 0-10µl of the stock was added to each well (made 
up to 50µl with glycogen hydrolysis buffer) to produce a standard curve ranging from 
8-40µg/ml. The supernatant from homogenised tissue was diluted 1:10 and 10µl of 
this dilution was used for the assay to give approximately 50µg/well and wells were 
made up to 50µl with glycogen hydrolysis buffer. After this, 2µl of the hydrolysis 
enzyme mix was added to all standard and sample wells but was not added to sample 
blanks. The plate was then incubated at room temperature for 30 minutes.  
During this time, a reaction mix was prepared for the standards and samples and a 
background control mix was prepared for the sample blanks (Table 2.9). To all 
standard and sample wells, 48µl of the reaction mix was added and 50µl of the 
background control mix was added to all sample blanks. The assay was incubated at 
room temperature for 30 minutes and then absorbance was measured using a 
microplate reader (FLUOstar Omega, BMG Labtech Ltd.) at 450nm. Standards and 
samples were analysed in duplicate and the glycogen concentration was quantified 
against the standard curve and normalised to tissue weight. The inter-assay and intra-
assay coefficients of variation were 2.8% and 8.7% respectively. A composite standard 
curve is shown in Figure 2.5. 
Table 2.9 Glycogen assay reaction and background control mix working solutions 
 Reaction mix 
(µl) 
Background 
control mix (µl) 
Glycogen development buffer 44 46 
Development enzyme mix 2 2 
Probe 2 2 
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Figure 2.6 Composite standard curve from five glycogen assays. Data presented are 
mean ± SD. 
2.3.3.4 Determination of plasma and liver cholesterol concentration 
Total lipid was extracted from liver samples as described in section 2.3.1.3. 
Cholesterol concentration was determined using an Infinity™ cholesterol liquid stable 
reagent (Thermo Fisher Scientific) based on a formulation by Allain et al. (1974) later 
modified by Roeschlau et al. (1974). Serial dilutions of a 5.7mmol/L sCal calibrator 
solution (Thermo Fisher Scientific) were prepared to give a standard curve ranging 
from 0.36-5.7mmol/L. Exactly 10µl of standard or sample was pipetted onto a 96 well 
microplate and 250µl of Infinity™ cholesterol reagent was added. The plate was 
incubated for 5 minutes at 37°C and absorbance was read at 550nm in a microplate 
reader (Bio-Rad 680XR). Standards and samples were analysed in duplicate and the 
cholesterol concentration was quantified against the standard curve and liver 
cholesterol was normalised to tissue weight. The inter-assay and intra-assay 
coefficients of variation were 11.4% and 4.5% respectively. A composite standard 
curve is shown in Figure 2.7. 
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Figure 2.7 Composite standard curve from eight cholesterol assays. Data presented 
are mean ± SD. 
2.3.3.5 Determination of plasma and liver triglyceride concentration  
Total lipid was extracted from liver samples as described in section 2.3.1.3. 
Triglyceride concentration was determined using an Infinity™ triglyceride liquid 
stable reagent (Thermo Fisher Scientific) based on methods outlined by Fossati and 
Prencipe (1982) and McGowan et al. (1983). Serial dilutions of a 2.14mmol/L sCal 
calibrator solution (Thermo Fisher Scientific) were prepared to give a standard curve 
ranging from 0.13-2.14mmol/L. Exactly 10µl of standard or sample was pipetted onto 
a 96 well microplate and 250µl of Infinity™ triglyceride reagent was added. The plate 
was incubated for 5 minutes at 37°C and absorbance was read at 550nm in a microplate 
reader (Bio-Rad 680XR). Standards and samples were analysed in duplicate and the 
triglyceride concentration was quantified against the standard curve and liver 
triglyceride was normalised to tissue weight. The inter-assay and intra-assay 
coefficients of variation were 4.9% and 3.7% respectively. A composite standard curve 
is shown in Figure 2.8. 
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Figure 2.8 Composite standard curve from eight triglyceride assays. Data presented 
are mean ± SD.
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3 MANUSCRIPT 1: THE ROLE OF MATERNAL DIETARY LA:ALA 
RATIO ON FETAL AND PLACENTAL GROWTH 
 
Draycott, SAV, Liu, G, Daniel, ZC, Elmes, MJ, Muhlhausler, BS & Langley-Evans, 
SC (2019). Maternal dietary ratio of linoleic acid to alpha-linolenic acid during 
pregnancy has sex-specific effects on placental and fetal weights in the rat. 
Nutrition & Metabolism, 16(1), 1. 
Author contributions can be found in Appendix C and the published article can be 









Background: Increased consumption of linoleic acid (LA, omega-6) in Western diets 
coupled with the pro-inflammatory and adipogenic properties of its derivatives has led 
to suggestions that fetal exposure to this dietary pattern could be contributing to the 
intergenerational cycle of obesity.  
Method: This study aimed to evaluate the effects of maternal consumption of a LA to 
alpha-linolenic acid (ALA) ratio similar to modern Western diets (9:1) compared to a 
lower ratio (1:1.5) on placental and fetal growth, and to determine any cumulative 
effects by feeding both diets at two total fat levels (18% vs 36% fat w/w). Female 
Wistar rats (n=5-7/group) were assigned to one of the four experimental diets prior to 
mating until 20d of gestation.  
Results: Fatty acid profiles of maternal and fetal blood and placental tissue at 20d 
gestation were different between dietary groups, and largely reflected dietary fatty acid 
composition. Female fetuses were heavier (2.98±0.06g vs 3.36±0.07g, P<0.01) and 
male placental weight was increased (0.51±0.02g vs 0.58±0.02g, P<0.05) in the low 
LA:ALA groups. Female fetuses of dams exposed to a 36% fat diet had a reduced 
relative liver weight irrespective of LA:ALA ratio (7.61±0.22% vs 6.93±0.19%, 
P<0.05). These effects occurred in the absence of any effect of the dietary treatments 
on maternal bodyweight, fat deposition or expression of key lipogenic genes in 
maternal and fetal liver or maternal adipose tissue.  
Conclusion: These findings suggest that both the total fat content as well as the 
LA:ALA ratio of the maternal diet have sex-specific implications for the growth of the 




The prevalence of obesity, a major risk factor for cardiovascular disease and type 2 
diabetes, continues to rise in both low-, middle- and high-income countries, with 1.9 
billion adults worldwide estimated to be overweight or obese as of 2016 (WHO, 
2017a). Of particular concern is that 41 million children under the age of 5 were 
estimated to be overweight or obese globally in 2016 (WHO, 2017a), and often present 
with early onset of cardiometabolic diseases including type 2 diabetes and 
hypertension (Owen et al., 2009, Mayer-Davis et al., 2017).  
Exposure to either an inappropriately high or inappropriately low plane of nutrition 
before birth and/or in early infancy is a major risk factor for the development of obesity 
and type 2 diabetes through the life course (Gale et al., 2007, Catalano and Ehrenberg, 
2006, Muhlhausler et al., 2006, Langley-Evans, 2015). Maternal high-fat diets have 
consistently been associated with an increased risk of obesity and poor 
cardiometabolic health in the offspring (Armitage et al., 2005). It is increasingly 
recognised, however, that the impact of maternal fat consumption is dependent not 
only on the amount of fat consumed but also the specific fat type. The ratio of omega-
6 and omega-3 polyunsaturated fatty acids (PUFA) in the diet appears to be of 
particular importance, likely due to the opposing roles of these two classes of PUFA 
on metabolic and inflammatory processes within the body (Schmitz and Ecker, 2008). 
Thus, omega-3 PUFA, including alpha-linolenic acid (ALA) and its long chain PUFA 
(LCPUFA) derivatives, eicosapentaenoic acid (EPA) and docosahexaenoic acid 
(DHA) inhibit inflammation, adipogenesis and lipogenesis (Massiera et al., 2003, 
Madsen et al., 2005). Conversely, the omega-6 PUFA, linoleic acid (LA) and its long 
chain derivative, arachidonic acid (AA) have pro-inflammatory actions and promote 
adipogenesis and lipogenesis in vitro and in vivo (Shillabeer et al., 1998, Ailhaud et 
al., 2006). Consequently, excess consumption of omega-6 relative to omega-3 fatty 
acids would be expected to be associated with increased incidence of inflammatory 
conditions, increased adiposity and heightened risk of cardiometabolic diseases. 
The opposing roles of the omega-3 and omega-6 fatty acids have particular relevance 
due to a substantial increase in the intake of the omega-6 essential fatty acid, LA, in 
the Western diet over the past few decades, with very little change in the intake of 
omega-3 PUFA. The ratio of LA:ALA in typical Western diets has been reported at 
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~8-10:1 (Blasbalg et al., 2011, Meyer et al., 2003) or higher (Simopoulos, 2016), 
which is substantially higher than the proposed ‘ideal’ ratio of ~1-2:1 based on levels 
required to achieve maximal conversion of ALA to its longer chain derivatives (Lands, 
2008, Tu et al., 2010, Gibson et al., 2011). Previous studies have shown that the high 
omega-6:omega-3 ratio in the modern Western diets is reflected in the blood and tissue 
fatty acid profiles of pregnant and lactating women, as well as breast milk (Ailhaud et 
al., 2006), however, the effect of perinatal exposure to an increased omega-6:omega-
3 PUFA ratio remains unclear. Massiera et al. (2010) demonstrated that increasing 
omega-6 PUFA intake induced a gradual enhancement in fat mass over generations. 
However, the level of LA (~19% energy) and LA:ALA ratio (28:1) in their study were 
much higher than those found in typical Western diets, and the impact of different 
dietary fat levels was not evaluated. In addition, no studies to date have examined the 
effects of an increased maternal omega-6:omega-3 ratio on maternal, placental and 
fetal outcomes before birth.  
The aim of the current study was to determine the effects of increasing the LA:ALA 
ratio (9:1 vs 1:1.5) in the diet of rats, on maternal weight gain, placental and fetal 
growth and the expression of lipogenic and adipokine genes in maternal and fetal liver 
and maternal adipose tissue. To determine any additive effects of altering the maternal 
dietary LA:ALA ratio, each diet was fed at either 18% fat w/w, to reflect dietary 
recommendations of fat intake (SACN, 2018), or at a higher fat content of 36% fat 
w/w.   
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3.3 Materials and Methods 
3.3.1 Animals 
All animal procedures were performed in accordance with the Animals (Scientific 
Procedures) Act 1986 under Home Office licence and were approved by the Animal 
Ethics Committee of the University of Nottingham, UK. Virgin female Wistar rats (n 
= 24; 75-100g; Charles River, UK) were housed on wood shavings in individually 
ventilated cages under a 12 hour light/12 hour dark cycle at a temperature of 20-22°C 
and had ad libitum access to food and water throughout the experiment. Animals were 
pair housed from the start of the experiment until mating; after confirmation of 
conception, animals were individually housed until completion of the experiment. 
Female rats were allowed to acclimatise to the unit for 1-2 weeks, during which time 
they were fed on standard laboratory chow (2018 Teklad Global 18% Protein Rodent 
Diet, Harlan Laboratories, UK). After acclimatisation, a tail vein blood sample was 
taken from each animal for the determination of fatty acid status. The rats were then 
randomly assigned to one of 4 dietary groups, details of which are provided below. 
Animals were maintained on their allocated diet for a four week ‘feed-in’ period after 
which they were mated. Conception was confirmed by the presence of a semen plug 
and this was recorded as day 0 of pregnancy. Average time in mating pairs was 2.5 
days and all but one female conceived within their first oestrous cycle housed with the 
male. Female rats remained on their respective diets until day 20 of gestation (full term 
= 22 days) at which time rat dams were euthanised by CO2 asphyxiation and cervical 
dislocation and fetuses by cervical dislocation and exsanguination for collection of 
maternal, fetal and placental tissues. All female rats were weighed and had feed intake 
measured daily throughout the experiment and protein intake was estimated based on 
the protein content of the experimental diets. 
3.3.2 Diets 
Diets were designed to provide either a high (9:1, high LA) or low (1:1.5 low LA) ratio 
of LA to ALA, achieved by altering the amounts of flaxseed and sunflower oil included 
in the fat component of the feed. The levels of saturated fatty acids (SFA) and 
monounsaturated fatty acids (MUFA) were comparable in all diets, achieved by 
adjusting the amounts of coconut (SFA source) and macadamia (MUFA source) oils 
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in the diets. For each level of LA, diets containing either 18% or 36% fat by weight 
were developed. This resulted in four experimental diets; high LA (18% fat), high LA 
(36% fat), low LA (18% fat) and low LA (36% fat; n=5-7 per dietary group). The lists 
of ingredients and final fatty acid composition of the four experimental diets are 
presented in Table 3.1 and Table 3.2 respectively. Protein content of experimental 
feeds was analysed using a Thermo Scientific nitrogen (N)/protein analyser (Flash 
EA1112). %N was directly measured and protein (%) was estimated under the 
assumption of a 16% N content of proteins.  
3.3.3 Blood sample and tissue collection 
Blood samples were collected from dams prior to the start of the experiment and after 
the 4 week ‘feed-in’ period (tail vein) and at day 20 of gestation (cardiac puncture 
following CO2 asphyxiation and cervical dislocation). Truncal blood samples were 
also collected from two randomly selected male and 2 randomly selected female 
fetuses from each litter at this time. The whole blood samples (~30µl) were spotted 
onto PUFAcoat™ dried blood spot (DBS) collection paper (Liu et al., 2014), allowed 
to dry at room temperature and were then stored at -20°C for subsequent fatty acid 
analysis. Maternal tissues were weighed and samples of liver and retroperitoneal 
adipose tissue were collected. All fetuses were weighed and sexed via measurement of 
anogenital distance. Fetal liver and placentas were weighed and samples of selected 
male placental and liver samples were collected. All tissue samples were snap-frozen 
in liquid nitrogen and stored at -80°C until determination of gene expression by reverse 
transcriptase quantitative PCR (RT-qPCR). Male fetuses selected for collection of 
tissue samples also had tail samples collected for sex-genotyping by PCR for the SRY 
gene (McClive and Sinclair, 2001). Any samples found to be female or inconclusive 
(n=5) were not included in hepatic gene expression analyses.  
3.3.4 Lipid extraction  
Total lipids were extracted from male placental tissue with chloroform/isopropanol 
(2:1 v/v), an adapted method from Folch (Folch et al., 1957). Briefly, ~300mg of 
crushed frozen placenta was weighed out and 2ml of 0.9% saline was added. The 
solution was homogenised on ice; 3ml of isopropanol was added and vortexed and the 
solution was left to stand for 5 minutes. After this, 6ml of chloroform was added and 
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the solution was shaken, centrifuged and the chloroform (bottom phase) containing the 
lipid was transferred into a fresh tube. This was dried under nitrogen and resuspended 
in chloroform/methanol (9:1 v/v) and 20µl of the sample was then spotted onto 
PUFAcoat™ DBS collection paper (Liu et al., 2014), allowed to dry at room 
temperature and stored at -20°C for subsequent fatty acid analysis. 
3.3.5 Fatty acid methylation and analysis 
Fatty acid composition in maternal and fetal DBS were determined as previously 
described (Liu et al., 2014). Briefly, whole DBS samples were directly transesterified 
with 2ml of 1%H2SO4 in methanol at 70°C for 3 hours. Samples were allowed to cool 
and the fatty acid methyl esters (FAME) were then extracted with heptane and 
transferred into a glass vial containing anhydrous sodium sulphate (Na2SO4) as a 
desiccant. Samples were separated and analysed by a Hewlett-Packard 6890 gas 
chromatograph (GC) equipped with a capillary column (30m x 0.25mm) coated with 
70% cyanopropyl polysilphenylene-siloxane (BPX-70; 0.25µm film thickness) which 
was fitted with a flame ionization detector (FID). Helium was utilised as the carrier 
gas and the split ratio was set at 20:1. Injector temperature was set at 250°C and FID 
temperature at 300°C. FAMEs were identified in unknown samples based on the 
comparison of retention times with an external lipid standard (Standard 463, Nu-check 
prep Inc., MN, USA) using Agilent Chemstation software. Individual fatty acid 
content was calculated based on peak area and response factors, normalised to total 
fatty acid content and expressed as a percentage of total fatty acids across lipid classes. 
3.3.6 Isolation of RNA, cDNA synthesis and reverse transcription quantitative 
real-time PCR (RT-qPCR) 
RNA was isolated from crushed snap-frozen samples of ~25mg of liver using the 
Roche High Pure Tissue kit (Roche Diagnostics Ltd., UK). Adipose RNA was 
extracted using MagNA Lyser green beads and instrument (Roche Diagnostics Ltd.) 
in combination with the RNeasy Mini Kit (QIAGEN Ltd., UK) with the following 
modifications. Between 100-150mg of snap frozen tissue was homogenised using 
green beads in 600µl Buffer RTL (including β-mercaptoethanol); the sample was 
centrifuged for 3 minutes at 8000 rpm and the resulting infranatant was transferred 
into a fresh tube. The remaining tissue sample was homogenised in a further 350µl of 
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lysis buffer, centrifuged as before and this infranatant was combined with that from 
the initial extraction. This extract was centrifuged for 5 minutes at 13000 rpm, cleared 
lysate removed and mixed with an equal volume of 70% ethanol and transferred to an 
RNeasy column and from this point the standard manufacturer’s protocol was applied. 
RNA concentration was determined using a Nanodrop 2000 (Thermo Scientific) and 
RNA quality was evaluated by agarose gel electrophoresis. cDNA was synthesised 
using a RevertAid™ reverse transcriptase kit (Thermo Fisher Scientific, UK) with 
random hexamer primers. 
Lipogenic pathway and adipokine target genes included: peroxisome proliferator-
activated receptor gamma (Pparg), sterol regulatory element-binding protein (variant 
1c; Srebf1), fatty acid synthase (Fasn), lipoprotein lipase (Lpl) and leptin (Lep), with 
β-actin (Actb) as the housekeeper (Table 3). Adipocyte and hepatic gene expression 
was quantified using SYBR Green (Roche Diagnostics) in a Light-Cycler 480 (Roche 
Diagnostics). Samples were analysed against a standard curve of a serially diluted 
cDNA pool to produce quantitative data and expression was normalised to the 
housekeeping gene using LightCycler® 480 software (version 1.5.1) as previously 
described (Rhinn et al., 2008). The expression of the housekeeper gene was not 
different between treatment groups.  
3.3.7 Statistical analysis 
Data are presented as mean ± SEM. Data were analysed using the Statistical Package 
for Social Sciences (Version 24, SPSS Inc.). The effect of maternal dietary fatty acid 
ratio and maternal dietary fat content on maternal dependent variables was assessed 
using a two-way ANOVA, with dietary fat level and LA:ALA ratio as factors. Where 
longitudinal data were analysed, as with maternal feed, protein and energy intake as 
well as maternal bodyweight, the impact of maternal dietary fat level and LA:ALA 
ratio was analysed using a two-way repeated-measures ANOVA. Fetal data were 
analysed using a two-way ANOVA, separating males and females, with maternal 
dietary LA:ALA ratio and fat content as factors. The experiment was designed to 
detect a 0.5g difference in fetal weight with a power of 0.8; a value of P<0.05 was 





3.4.1 Maternal food intake 
Dams receiving the 36% fat diets had a significantly lower food intake in the 4 weeks 
prior to mating independent of the LA:ALA ratio (P<0.01). During pregnancy, there 
was no effect of dietary fat content or fatty acid ratio on maternal food intake although, 
as expected, food intake in all groups increased as pregnancy progressed (P<0.05; 
Figure 3.1.A). Energy intake was similar between groups prior to pregnancy. During 
gestation, energy intake was higher in dams consuming the 36% fat diets, irrespective 
of dietary LA:ALA ratio (P<0.01). Similar to food intake, energy intake also increased 
with increasing gestational age in all dietary groups (P<0.05; Figure 3.1.B). Protein 
intake was lower in the 36% fat groups when compared to the 18% fat groups prior to 
mating (P<0.001) and throughout gestation (P<0.01). Protein intake was relatively 
consistent for the 4 weeks prior to mating but increased with increasing gestational age 
during pregnancy (P<0.05; Figure 3.1). There was no significant effect of dietary 
LA:ALA ratio on food, energy or protein intake at any time during the study. 
3.4.2 Maternal fatty acid profile 
There were no differences in the blood fatty acid profiles of the rats assigned to the 
different experimental diets before commencement of the dietary intervention, and the 
proportions of SFA, MUFA, omega-6 (Figure 3.2.A) and omega-3 PUFA (Figure 
3.2.B) were all similar between groups. After 4 weeks on their respective diets, 
however, maternal fatty acid profiles were significantly different between treatments 
and largely reflected the composition of the experimental diets. Whole blood 
proportions of LA and AA were lower in the low LA compared to the high LA groups 
(P<0.001; Figure 3.2.C). Dams fed the low LA diets had four-fold higher ALA levels 
compared to the high LA groups, independent of dietary fat content (P<0.001). Whole 
blood proportions of DHA were also significantly higher (P<0.01) in dams fed the low 
LA diet, but the magnitude of this effect was relatively small (1.3-fold; Figure 3.2.D). 
The proportion of EPA was ten-fold higher and DPA two-fold higher in dams 
consuming the low LA diets. However, relative EPA and DPA levels were both lower 
in the low LA, 36% fat diet group compared to the low LA, 18% fat group, but were 
not different between the 36% and 18% fat diet levels in rats fed the high LA diets 
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(EPA: fat content, P<0.05; fatty acid ratio, P<0.001; interaction, P<0.05. DPA: fat 
content, P<0.01; fatty acid ratio, P<0.001; interaction, P<0.05; Figure 3.2.D). There 
was no effect of dietary fat content on the proportions of EPA and DPA at the end of 
the experiment. The remaining effects of both total fat level and dietary fat ratio on 
maternal fatty acid profile were, however, maintained until the end of the study (day 
20 of gestation; Figure 3.2.E and F).  
3.4.3 Maternal weight and body composition 
Bodyweight immediately prior to commencement of feeding the experimental diets 
was not different between rats assigned to the four respective treatment groups (Figure 
3.3). There was no effect of either LA:ALA ratio or dietary fat content on maternal 
weight prior to mating or throughout pregnancy (Figure 3.3) and maternal weight at 
day 20 of pregnancy was similar between groups (Figure 3.3; Table 3.4). Dams in the 
low LA groups had larger hearts relative to body weight at day 20 of gestation 
(P<0.05), but there were no differences in the relative weight of other major organs, 
including the liver, kidney, lung and brain, between groups (Table 3.4). There were no 
significant differences in the mass of the gonadal and retroperitoneal fat depots 
between experimental groups (Table 3.4). There were also no differences in the 
expression of any of the genes measured in the hepatic or adipose tissue between 
dietary groups (Table 3.4). 
3.4.4 Placental fatty acid profile 
The placental fatty acid profile at day 20 of gestation (Figure 3.4.A and B) was similar 
to dam whole blood fatty acid profile at this time point (Figure 3.2.E and F). Placentas 
of dams fed a high LA diet had 1.3 fold higher LA, AA and total omega-6 PUFA 
irrespective of dietary fat content (P<0.001; Figure 3.4.A). Conversely, total omega-3 
PUFA (1.9 fold), ALA (5.5 fold) and EPA (6.5 fold) proportions were increased in 
placentas of dams consuming a low LA diet, regardless of dietary fat content 
(P<0.001). The relative levels of DPA in the placenta were higher in dams receiving a 
low LA diet but were also influenced by total dietary fat content, such that the 
proportion of DPA was lower in dams fed the 36% vs. 18% fat diets in the low LA 
ratio groups only (fat content, P<0.01; fatty acid ratio, P<0.001; interaction, P<0.01). 
DHA proportions were also influenced by both the fat content and LA:ALA ratio of 
MANUSCRIPT 1 
76 
the diet, such that dams exposed to the low LA diets had higher placental DHA 
compared to those fed on high LA diets (P<0.001) and dams fed the 36% fat diet had 
higher relative levels of placental DHA compared to dams consuming either of the 
18% fat diets (P<0.05; Figure 3.4.B). Placental total MUFA proportions were higher 
in the low LA compared to the high LA groups (P<0.001) but were not affected by 
dietary fat content. Placental SFA were lower in dams exposed to a low LA diet 
(P<0.05) as well as in dams exposed to a high (36%) fat diet (P<0.05), however the 
magnitude of this difference was very small (Figure 3.4.A).  
3.4.5 Fetal whole blood fatty acid profile 
There was no effect of sex on fetal fatty acid profile and so male and female samples 
were combined for subsequent analysis. Blood ALA (five-fold) and EPA (seven-fold) 
were higher in fetuses of dams exposed to the low LA diets. However, there was a 
significant interaction between maternal dietary LA:ALA ratio and maternal dietary 
fat content for these fatty acids, such that increasing dietary fat content from 18% to 
36% fat was associated with relatively higher ALA (fat content, P<0.001; fatty acid 
ratio, P<0.001; interaction, P<0.001) and lower EPA levels (fat content, P=0.721; fatty 
acid ratio, P<0.001; interaction, P<0.05) in the low LA groups only.  DPA (three-fold) 
and DHA (1.3-fold) blood proportions were also increased in fetuses of dams exposed 
to the low LA diets, independent of dietary fat content (P<0.001; Figure 3.4.D). 
Conversely, fetuses of dams consuming the low LA diets had relatively lower 
circulating LA (1.2-fold) and AA (1.4-fold) compared to fetuses of dams fed high LA 
diets (P<0.001; Figure 3.4.C). Interestingly, fetal LA proportions were also influenced 
by dietary fat content, such that fetuses of dams consuming the 36% fat diets had 
higher relative circulating LA (P<0.001) levels compared to fetuses of dams fed the 
18% fat diet. Fetal blood MUFA were influenced by both maternal dietary LA:ALA 
ratio and dietary fat content. Thus, fetuses of dams exposed to a low LA diet exhibited 
elevated MUFA proportions compared to high LA groups (P<0.001) and fetuses of 
dams exposed to a 36% fat diet had proportionately lower circulating MUFA levels 
compared to fetuses of dams fed the 18% fat diets (P<0.001; Figure 3.4.C).  
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3.4.6 Fetal and placental weight and hepatic gene expression 
The impact of maternal dietary fat content and LA:ALA ratio on placental and fetal 
weights was different for males and females. Thus, placental weight was higher in 
male, but not female, fetuses of dams consuming low LA diets (P<0.05). In females, 
however, fetuses of dams consuming the low LA diet were heavier (P<0.01) than those 
of dams fed the high LA diets, irrespective of dietary fat content; this effect was not 
seen in males. Despite these differences in fetal and placental weights, however, the 
fetal-placental weight ratio was not different between treatment groups in either males 
or females. Female, but not male, fetuses of dams consuming 36% fat diets also had 
smaller livers relative to bodyweight, independent of the dietary LA:ALA ratio 
(P<0.05; Table 3.5). Hepatic gene expression was not assessed in female fetuses, but 
hepatic mRNA expression of Fasn, Lpl, Pparg and Srebf1 in male fetuses was not 
different between groups (Table 3.6).  
3.5 Discussion 
The results of the current study demonstrate that varying the fat content and LA:ALA 
ratio in the diet during pregnancy results in significant shifts in the fatty acid profile 
of the dam, placenta and fetus in late pregnancy with dietary LA:ALA ratio eliciting 
potentially sex-specific effects on placental and fetal weights. Importantly, these 
effects occurred in the absence of any impact of dietary LA:ALA ratio on maternal 
energy intake, bodyweight or fat deposition. Doubling the fat content of these 
experimental diets had the expected impact on maternal food and energy intake but 
was not associated with any significant alterations in maternal, placental or fetal 
weights or maternal fat deposition.  
Maternal fatty acid profiles after 4 weeks on the experimental diets, and at the end of 
pregnancy, confirmed that the experimental diets had the desired effect on maternal 
fatty acid composition. Consistent with previous studies, increasing dietary ALA 
content had the greatest effect on maternal ALA and EPA proportions whereas relative 
DHA levels were only slightly higher than controls (Gibson et al., 2013, Mantzioris et 
al., 1994, Finnegan et al., 2003, Wood et al., 2015). However, despite the significant 
shifts in maternal fatty acid profiles, and differences in energy intake between dams in 
the 36% and 18% fat groups during gestation, we found no difference in maternal body 
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weight or fat deposition between these groups. This was unexpected as previous 
studies with comparable fat contents have reported significant increases in maternal 
bodyweight and fat mass in dams fed on diets containing higher amounts of total fat 
(Chalkley et al., 2002, Buettner et al., 2007). Consistent with previous studies (Keesey 
and Hirvonen, 1997), dams fed on the 36% fat diets in this study reduced their feed 
intake to compensate for the higher energy density of the feed and it may be that this 
adaptive response was sufficient to prevent excessive weight gain and fat deposition 
in dams fed the higher fat diet.  
Our finding that placental and fetal fatty acid profiles were similar to those in the dams 
was consistent with our hypothesis that variations in maternal fatty acid profile would 
be reflected in the fetal compartment. Thus, our results confirm that shifts in maternal 
dietary fatty acid intake are associated with corresponding shifts in fetal fatty acid 
supply. It is, however, important to note that the relative proportions of some fatty 
acids, most notably LA and MUFA, in the fetal compartment also appeared to be 
influenced by total dietary fat content, independent of the dietary fat ratio. This effect 
was not observed to the same extent for maternal and placental fatty acid profiles and 
implies that not only the ratio, but also absolute amounts of fatty acids is a key 
determinant of placental fatty acid transfer. Our finding that fetal, but not maternal or 
placental, LA proportions were higher in the 36% fat vs 18% fat groups implies that 
placental LA transfer is favoured as dietary fat content increases. Placental capacity to 
store fatty acids as triglycerides has been well documented (Lewis and Desoye, 2017), 
and placental triglyceride levels are increased in conditions where maternal circulating 
triglyceride and fatty acid concentrations are high (Diamant et al., 1982). However, 
this storage capacity is limited and, in cases of excess maternal dietary fat, has the 
potential to result in a greater proportion of fatty acids being transferred from maternal 
to fetal circulation. One possibility, therefore, is that the capacity of the placenta for 
LA storage is exceeded in the 36% fat groups in our current study and that this resulted 
in a greater amount of this fatty acid being transferred to the fetal compartment. In 
contrast to LA, however, fetal MUFA proportions in the current study were lower in 
the 36% fat compared to the 18% fat groups. Thus, the results of our study indicate 
that the effect of increased dietary fat content on placental fatty acid transfer varies 
substantially between individual fatty acids. 
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That the human placenta preferentially transfer specific fatty acids over others, 
following the hierarchy of AA>DHA>ALA>LA>oleic acid, has been previously 
demonstrated (Haggarty et al., 1997). The findings from the present study suggest that 
this selective transfer effect may be exacerbated in the presence of an increased dietary 
fat load, such that the higher total amounts of LA and ALA in the 36% fat diets lead 
to greater transfer of LA and ALA to the fetal compartment, at the expense of MUFA, 
particularly oleic acid. If this is the case, it would imply that the quality of dietary fat 
intake during pregnancy may be more important, and thus have a greater potential to 
influence fetal growth and development, at higher levels of total dietary fat intakes. 
The fatty acid data in our study are expressed as a proportion of total lipids rather than 
absolute concentrations, and the relatively small proportionate change in fetal LA 
could translate into a much greater, and physiologically relevant, change in absolute 
concentrations.  
In contrast to previous studies, we found no effect of maternal total fat intake on 
placental or fetal bodyweight, and our results in fact suggest that maternal LA:ALA 
ratio had a greater effect on these measures. The increased placental weight of male 
fetuses in the low LA groups suggests that an increase in maternal omega-3 status may 
potentially increase placental growth. One possibility for this increase in weight is that 
omega-3 fatty acids are preferentially deposited in the placenta. This, however, seems 
unlikely given that previous studies have suggested that while there is preferential 
placental uptake of DHA from the maternal circulation, the majority is transferred 
across the placenta to the fetal circulation (Ferchaud-Roucher et al., 2017, Haggarty et 
al., 1997). In addition, a considerable amount of omega-3 fatty acids (~75mg) would 
have to accumulate in the placenta to solely account for the difference in placental 
weight between high and low LA groups, making it unlikely that this mechanism could 
fully account for the observed increase in placental weight. An alternative possibility 
is that omega-3 PUFA, in particular DHA, acted to promote placental growth. Why 
the increased placental weight in our study was only seen in male placentas is not 
completely clear, however, female placental weight appeared to follow the same 
trajectory but did not reach statistical significance. Differences in gene expression 
between male and female placentas have been documented (Rosenfeld, 2015).  
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Given that the effects on placental weight only reached significance in males, it is 
interesting that maternal consumption of the low LA diet was associated with increased 
fetal weight only in females. Maternal omega-3 LCPUFA supplementation during 
pregnancy has been associated with increases in birth weight in human randomised 
controlled trials (Makrides et al., 2006). However, this is generally considered to be 
secondary to an increase in the duration of gestation and therefore cannot explain the 
higher fetal weights observed in this study, since all fetuses were weighed at the same 
gestational age. There are, however, previous reports indicating that upregulation of 
omega-3 LCPUFA-responsive genes following maternal omega-3 LCPUFA 
supplementation is more pronounced in female compared to male placentas in humans, 
and is associated with increases in infant birth weight, but not placental weight 
(Sedlmeier et al., 2014). Our finding of lower female fetal liver weight in the 36% fat 
groups is consistent with some (Krasnow et al., 2011), but not all (Guo and Jen, 1995, 
McCurdy et al., 2009), studies that have previously reported the effects of maternal 
high fat diets on neonatal liver weight. Whether the reduced liver weight in fetuses of 
dams consuming the high fat diet persists after birth, and whether it has functional 
consequences for hepatic metabolism, remain to be determined.   
It was interesting that despite the significant changes in the fatty acid profiles of both 
dams and fetuses, no changes in maternal (hepatic and adipose tissue) or fetal (hepatic) 
expression of lipogenic genes were observed in this study. This was despite evidence 
from previous studies that omega-3 PUFA can suppress, while omega-6 PUFA can 
promote, expression of Srebf1 and downstream lipogenic genes (Al-Hasani and Joost, 
2005, Muhlhausler et al., 2010a). It is possible, however, that any changes in maternal 
gene expression and corresponding increases in lipogenesis could be masked by the 
normal physiological adaptations that occur during pregnancy, particularly between 
day 19 and 20 of gestation when the pregnant rat experiences a marked increase in 
total body fat mass (Lopez-Luna et al., 1991). Similarly, due to the immaturity of 
hepatic signalling pathways within the fetus, changes in gene expression occurring as 
a result of altered maternal dietary LA:ALA ratio may be too subtle to be detected.  
In conclusion, we have demonstrated that both the total amount of fat and the ratio of 
LA and ALA in the maternal diet have significant effects on placental and fetal weight, 
supporting the hypothesis that the quality, as well as the quantity, of fat in the maternal 
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diet can impact on fetal growth and development. Importantly, the LA:ALA ratio in 
the current study was designed to reflect that of typical Western diets of many 
countries, and our results show that consuming this high LA diet was associated with 
alterations in placental and fetal weight in comparison to a LA:ALA ratio considered 
to be ‘optimal’ for human nutrition (Blasbalg et al., 2011). The observed changes in 
placental and fetal weight may contribute to future metabolic and physiological 
function of the offspring, given the established association between reduced fetal and 
placental growth and increased future risk of obesity and poor metabolic health 
(Parsons et al., 2001, Murtaugh et al., 2003, Tian et al., 2006). However, further 
studies are required in order to determine the longer-term impacts of maternal dietary 
LA:ALA ratio and total fat load on the growth, body composition and cardiometabolic 
health of the offspring. Human studies that have assessed the potential implication of 
a higher omega-6:omega-3 ratio and/or elevated maternal omega-6 intakes on growth, 
body composition or metabolic health of the children are also limited (Much et al., 
2013) and further studies (or re-evaluation of existing studies) are needed. The results 
of the current study have also demonstrated that at least some of the effects of maternal 
dietary fat load/LA:ALA ratio elicited sex-specific responses, which may in part be 
due to differences in the placental response to omega-3 LCPUFA between male and 
female placentas. Further research is required to assess the placental responses to shifts 
in maternal dietary fat content and composition in both males and females and the “sex 
of the placenta” should be considered in future studies.  
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 Tables and Figures 
 Table 3.1 Ingredients in the experimental diets 
LA, linoleic acid. *Composition of vitamin and mineral mixes based on AIN-76 
formulation (American Institute of Nutrition, 1977). 
  
Component 









Casein 16.0 16.0 16.0 16.0 
Cornflour 31.8 20.0 31.8 20.0 
Sucrose 16.0 10.0 16.0 10.0 
Cellulose 15.6 15.6 15.6 15.6 
Mineral Mix* 1.8 1.8 1.8 1.8 
Vitamin Mix* 0.4 0.4 0.4 0.4 
Choline Chloride 0.2 0.2 0.2 0.2 
Methionine 0.4 0.4 0.4 0.4 
Flaxseed Oil 0.9 1.7 4.2 8.5 
Sunflower Oil 6.6 13.1 0.8 1.7 
Macadamia Oil 6.9 13.8 9.5 19.0 
Coconut Oil 3.4 6.9 3.2 6.3 




 Table 3.2 Fatty acid composition of the experimental diets 
LA, linoleic acid; SFA, saturated fatty acids; TFA, trans fatty acids; MUFA, 
monounsaturated fatty acids; ALA, alpha-linolenic acid; PUFA, polyunsaturated fatty 
acids.  
Fatty Acid 









Total SFA 20.7 20.3 21.1 20.0 
Total TFA 0.1 0.1 0.1 0.1 
Total MUFA 48.8 49.0 53.3 54.9 
Total Omega-6 (LA only) 27.3 27.4 11.1 10.5 
Total Omega-3 (ALA only) 3.1 3.2 14.4 14.4 
Total PUFA 30.4 30.6 25.5 25.0 
LA:ALA Ratio 9.0 9.0 0.75 0.75 
ALA %Energy 1.2 2.0 5.6 9.1 
LA %Energy 10.5 17.3 4.3 6.7 
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 Table 3.3 Primer sequences used for the determination of gene expression by RT-
qPCR 
Fasn, fatty acid synthase; Lpl, lipoprotein lipase; Pparg, peroxisome proliferator-
activated receptor gamma; Srebf1, sterol regulatory element-binding protein 1; Lep, 








Fasn FWD: TGCTCCCAGCTGCAGGC 
REV: GCCCGGTAGCTCTGGGTGTA 
107 NM_017332 
Lpl FWD: TTCCTGGATTAGCAGACTCTGTGT 
REV: TCCTGTCACCGTCCATCCAT 
89 NM_012598 
Pparg FWD: CTCAGTGGAGACCGCCCA 
REV: CAGGGCCTGCAGCAGGT 
75 NM_013124 
Srebf1 FWD: GATTGCACATTTGAAGACATGCTT 
REV: CCTGTCTCACCCCCAGCATA 
95 NM_001276708 
Lep FWD: AGACCATTGTCACCAGGATCAAT 
REV: CCCGGGAATGAAGTCCAAA 
89 NM_013076 





Table 3.4 Maternal organ weight and gene expression  
Data are presented as mean values ± SEM (n=4-6 per group). LA, linoleic acid; BW, 
bodyweight; mRNA, messenger ribonucleic acid; Fasn, fatty acid synthase; Lpl, 
lipoprotein lipase; Pparg, peroxisome proliferator-activated receptor gamma; Srebf1, 
sterol regulatory element-binding protein 1; Lep, leptin. Mean values with unlike 
superscript letters were significantly different (P<0.05).  








Bodyweight (g) 376.4 ± 4.65 384.41 ± 11.00 384.34 ± 16.90 353.63 ± 9.55 
Heart (%BW) 0.25 ± 0.01a 0.26 ± 0.01a 0.28 ± 0.02b 0.28 ± 0.01b 
Lungs (%BW) 0.37 ± 0.05 0.36 ± 0.03 0.38 ± 0.05 0.36 ± 0.04 
Kidney (%BW) 0.53 ± 0.02 0.50 ± 0.01 0.53 ± 0.02 0.54 ± 0.02 
Liver (%BW) 4.01 ± 0.14 3.95 ± 0.07 4.10 ± 0.10 3.94 ± 0.10 
Brain (%BW) 0.47 ± 0.02 0.46 ± 0.01 0.50 ± 0.03 0.53 ± 0.02 
Gonadal Fat (%BW) 2.95 ± 0.03 2.38 ± 0.18 2.33 ± 0.18 3.04 ± 0.58 
Retroperitoneal Fat (%BW) 1.18 ± 0.17 1.18 ± 0.17 1.18 ± 0.011 1.79 ± 0.24 
Liver mRNA Expression 
Fasn 5.51 ± 1.33 2.83 ± 0.59 6.08 ± 2.31 4.24 ± 1.21 
Lpl 3.13 ± 1.00 2.39 ± 0.75 2.52 ± 0.80 1.74 ± 0.71 
Pparg 5.81 ± 1.85 2.30 ± 0.77 3.38 ±0.78 2.09 ± 0.73 
Srebf1 1.33 ± 0.31 1.20 ± 0.22 1.23 ± 0.50 2.67 ± 1.14 
Retroperitoneal Fat mRNA Expression  
Fasn 0.12 ± 0.05 0.07 ± 0.04 0.15 ± 0.05 0.13 ± 0.07 
Lpl 2.18 ± 0.66 1.82 ± 0.81 2.18 ± 0.72 1.48 ± 0.16 
Pparg 1.15 ± 0.47 1.40 ± 0.59 1.76 ± 0.48 1.03 ± 0.17 
Srebf1 1.17 ± 0.40 1.16 ± 0.41 1.38 ± 0.42 1.11 ± 0.13 
Lep 2.59 ± 0.67 2.73 ± 0.99 2.31 ± 0.69 1.83 ± 0.34 
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Table 3.5 Fetal and placental weights and fetal organs 
Data are presented as mean values ± SEM (n=4-6 per group). LA, linoleic acid; BW, 
bodyweight. Mean values with unlike superscript letters were significantly different 
(P<0.05).  










Male 3.33 ± 0.04 3.25 ± 0.08 3.55 ± 0.09 3.32 ± 0.09 
Female 3.01 ± 0.06a 2.95 ± 0.09a 3.36 ± 0.12b 3.21 ± 0.08b 
Placenta weight (g) Male 0.50 ± 0.02a 0.52 ± 0.03a 0.56 ± 0.03b 0.61 ± 0.02b 
Female 0.48 ± 0.02 0.48 ± 0.04 0.52 ± 0.02 0.51 ± 0.03 
Fetal liver weight 
(% BW) 
Male 7.43 ± 0.42 6.52 ± 0.11 6.81 ± 0.58 6.97 ± 0.25 
Female 7.51 ± 0.38a 6.99 ± 0.29b 7.73 ± 0.22a 6.86 ± 0.28b 
Fetal-placental ratio Male 6.79 ± 0.24 6.37 ± 0.33 6.51 ± 0.41 5.99 ± 0.41 
Female 6.38 ± 0.32 6.35 ± 0.48 7.72 ± 0.96 6.13 ± 0.36 
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Table 3.6 Fetal liver gene expression 








Fasn 0.59 ± 0.19 0.30 ± 0.03 0.37 ± 0.06 0.49 ± 0.13 
Lpl 1.79 ± 0.55 1.41 ± 0.27 1.11 ± 0.33 1.17 ± 0.46 
Pparg 0.36 ± 0.12 0.42 ± 0.05 0.34 ± 0.07 0.48 ± 0.16 
Srebf1 1.21 ± 0.61 0.65 ± 0.30 0.27 ± 0.04 0.82 ± 0.30 
Data are presented as mean values ± SEM (n=4-6 per group). LA, linoleic acid; Fasn, 
fatty acid synthase; Lpl, lipoprotein lipase; Pparg, peroxisome proliferator-activated 




Figure 3.1 Maternal average daily (A) food intake, (B) energy intake and (C) protein 
intake before mating and up to day 20 of gestation fed on either a high LA (18% fat) 
diet (closed circles), high LA (36% fat) diet (open circles), low LA (18% fat) diet 
(closed squares) and a low LA (36% fat) diet (open squares). Values are means ± SEM 
and n=5-7 per group. The effects of dietary fatty acid ratio and dietary fat content were 
determined using a two-way repeated measures ANOVA. * indicates a significant 
effect of dietary fat content (** P<0.01, *** P<0.001). 
Figure 3.2 Maternal whole blood fatty acids profile at (A/B) baseline (C/D) after 4 
weeks on experimental diet and (E/F) at day 20 of gestation. Values are means ± SEM 
and n=5-7 per group. The effects of dietary fatty acid ratio and dietary fat content were 
determined using a two-way ANOVA (*P<0.05, **P<0.01, ***P<0.001). † indicates 
a significant interaction between dietary fat content and LA:ALA ratio (P<0.05). 
Figure 3.3 Maternal weight gain of rats during pre-feeding and up to day 20 of 
gestation fed on either a high LA (18% fat) diet (closed circles), high LA (36% fat) 
diet (open circles), low LA (18% fat) diet (closed squares) and a low LA (36% fat) diet 
(open squares). Values are means ± SEM and n=5-7 per group. The effects of dietary 
fatty acid ratio and dietary fat content were determined using a two-way repeated 
measures ANOVA and no significant differences were found between groups. 
Figure 3.4 Placental (A/B) and fetal whole blood (C/D) fatty acid profile at gestational 
day 20. Values are means ± SEM and n=10-14 per group. The effects of maternal 
dietary fatty acid ratio and maternal dietary fat content were determined using a two-
way ANOVA (*P<0.05, **P<0.01, ***P<0.001). † indicates a significant interaction 
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Omega-6 fatty acids have been shown to exert pro-adipogenic effects whereas omega-
3 fatty acids appear to work in opposition. Increasing intakes of LA (linoleic acid; 
omega-6) vs ALA (alpha-linolenic acid; omega-3) in Western diets has led to the 
hypothesis that consumption of this diet during pregnancy may be contributing to 
adverse offspring health. This study investigated the effects of feeding a maternal 
dietary LA:ALA ratio similar to that of the Western diet (9:1) compared to a proposed 
‘ideal’ ratio (~1:1.5), at two total fat levels (18% vs 36% fat w/w), on growth and 
lipogenic gene expression in the offspring. Female Wistar rats were assigned to one of 
the four experimental groups throughout gestation and lactation. Offspring were culled 
at 1 and 2 weeks of age for blood and tissue sample collection. Offspring of dams 
consuming a 36% fat diet were ~20% lighter than those exposed to an 18% fat diet 
(P<0.001). Male, but not female, liver weight at 1 week was ~13% heavier, and had 
increased glycogen (P<0.05), in offspring exposed to high LA (P<0.01). Hepatic 
expression of lipogenic genes suggested an increase in lipogenesis in male offspring 
exposed to a 36% fat maternal diet and in female offspring exposed to a low LA diet, 
via increases in the expression of Fasn and Srebf1. Sexually dimorphic responses to 
altered maternal diet appeared to persist until two weeks-of-age. In conclusion, whilst 
maternal total fat content predominantly affected offspring growth, fatty acid ratio and 
total fat content had sexually dimorphic effects on offspring liver weight and 




Accumulating evidence suggests that the nutritional environment experienced by an 
individual during fetal and early infant development has long-lasting impacts on their 
metabolic health (Langley-Evans, 2015). In the context of the global epidemic of 
obesity and nutritional excess, there has been considerable interest in determining the 
effects of maternal overnutrition on the metabolic health of the offspring. The majority 
of these studies have utilised animal models and have consistently reported that 
maternal high-fat feeding during pregnancy has detrimental effects on the metabolic 
health of both the mother and her offspring (Ribaroff et al., 2017, Ainge et al., 2011). 
As a result, excess maternal fat consumption has been implicated as a key contributor 
to metabolic programming of long-term health and disease risk.  
There is increasing evidence, however, that the impact of a high-fat diet on the 
metabolic health of the offspring depends not only on the amount of fat in the diet, but 
also on the fatty acid composition (Muhlhausler and Ailhaud, 2013, Draycott et al., 
2019). There has been particular interest in the role of two classes of polyunsaturated 
fatty acids (PUFA), due to the substantive increase in the amounts of omega-6 PUFA, 
predominately linoleic acid (LA), being consumed in the diets of many Western 
countries over the past few decades (Blasbalg et al., 2011, Sioen et al., 2017). This 
increase in the intake of LA has not been accompanied by substantial changes in the 
consumption of omega-3 PUFA such as alpha-linolenic acid (ALA) and has therefore 
resulted in increases in the ratio of omega-6:omega-3 PUFA consumed in the diets of 
many Western countries (Ailhaud et al., 2006, Blasbalg et al., 2011).  
The increasing dominance of omega-6 over omega-3 PUFA in modern Western diets 
has considerable biological significance, since the omega-6 and omega-3 fatty acid 
families utilise the same enzymes for production of longer chain bioactive derivatives 
such as arachidonic acid (AA; omega-6), eicosapentaenoic acid (EPA; omega-3), 
docosapentaenoic acid (DPA; omega-3) and docosahexaenoic acid (DHA; omega-3), 
and also compete for incorporation into cell membranes. As a result, excess 
consumption of LA leads to a decrease in the production and incorporation of omega-
3 fatty acids through simple substrate competition, and this effect is exacerbated when 
total dietary PUFA is high (Tu et al., 2010, Gibson et al., 2013). The omega-3 and 
omega-6 long-chain polyunsaturated fatty acids (LCPUFA) derivatives also have 
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opposing physiological actions, with those from the omega-3 family predominately 
exhibiting anti-inflammatory properties (for example via the suppression of the pro-
inflammatory transcription factor nuclear factor kappa B and activation of the anti-
inflammatory transcription factor peroxisome proliferator activated receptor γ (Calder, 
2015)) and those from the omega-6 family exhibiting more pro-inflammatory and pro-
adipogenic properties (Massiera et al., 2003). This has led to the hypothesis that the 
increasing ratio of omega-6 to omega-3 fatty acids in modern Western diets may have 
negative effects on conditions characterised by low-grade inflammation, including 
obesity and the metabolic syndrome, and may potentially be contributing to an 
intergenerational cycle of obesity (Ailhaud et al., 2006).  
Data from observational studies in humans and animal models provide supporting 
evidence that suggests high intakes of omega-6 PUFA during pregnancy could have 
negative effects on metabolic health of the progeny (Massiera et al., 2010, Korotkova 
et al., 2002, Much et al., 2013). However, the results of these studies have not been 
consistent. The results of pre-clinical studies are also limited by the use of diets with 
much higher omega-6:omega-3 PUFA ratios and/or absolute PUFA contents than 
those encountered in typical human diets. Furthermore, offspring often continue to 
have access to the same diet as their mother so that any effects observed cannot be 
clearly attributed to dietary fatty acid exposure during the gestation and lactation 
periods (Muhlhausler et al., 2011b, Ibrahim et al., 2009, Muhlhausler et al., 2011a).  
The aim of this study, therefore, was to investigate the effects of feeding a maternal 
dietary LA:ALA ratio similar to that of the Western diet (9:1) (Blasbalg et al., 2011), 
compared to a proposed ‘ideal’ ratio of ~1:1.5 (Gibson et al., 2011, Lands, 2000) on 
growth and lipogenic gene expression in the offspring. Since total dietary PUFA intake 
also influences PUFA metabolism (Tu et al., 2010, Gibson et al., 2013), we also 
investigated the effect of feeding each dietary fat ratio at either 18% fat w/w (in line 
with dietary recommendations (SACN, 2018)) or at a higher fat level of 36% fat w/w. 
A rat model was utilised to achieve the study objectives by allowing for tight control 
of dietary manipulation as well as invasive end points. 
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4.3 Materials and Methods 
4.3.1 Animals 
All animal procedures were performed in accordance with the Animals (Scientific 
Procedures) Act 1986 under Home Office licence and were approved by the Animal 
Ethics Committee of the University of Nottingham, UK. Virgin female Wistar rats 
(n=30; 75-100g; Charles River, UK) were housed on wood shavings in individually 
ventilated cages under a 12 hour light/12 hour dark cycle at a temperature of 20-22°C 
and had ad libitum access to food and water throughout the experiment. Female rats 
were allowed to acclimatise to the unit for 1-2 weeks, during which time they were fed 
standard laboratory chow (2018 Teklad Global 18% Protein Rodent Diet, Harlan 
Laboratories, UK). After acclimatisation, a tail vein blood sample was taken from each 
animal for the determination of fatty acid status. The rats were then randomly assigned 
to one of 4 dietary groups (details provided below). Animals were maintained on their 
allocated diet for a four week ‘pre-feeding’ period, after which they were mated. 
Conception was confirmed by the presence of a semen plug and this was recorded as 
day 0 of pregnancy. Animals were housed in individual cages and remained on their 
respective diets throughout pregnancy and lactation.  
Litters were standardised to 8 pups within 24 hours of birth (4 males and 4 females, 
where possible). At 1 and 2 weeks of age, one randomly selected male and one 
randomly selected female from each litter were culled via cervical dislocation and 
exsanguination for blood and tissue collection. At 3 weeks of age, the remaining 
offspring were weaned and dams were then euthanised by CO2 asphyxiation and 
cervical dislocation for collection of maternal blood and tissues. All dams were 
weighed and had feed intake measured daily throughout the experiment and offspring 
bodyweight was measured weekly.  
4.3.2 Diets 
Diets were designed to provide either a high (9:1, high LA) or low (1:1.5, low LA) 
ratio of LA (cis/cis isomer) to ALA, achieved by altering the amounts of flaxseed and 
sunflower oil included in the fat component of the feed. The levels of saturated and 
monounsaturated fatty acids were comparable in all diets, achieved by adjusting the 
amounts of coconut (saturated fat source) and macadamia (monounsaturated fat 
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source) oils in the diets. For each level of LA, diets were developed to contain either 
18% fat (w/w), in line with government recommendations (SACN, 2018), or 36% fat 
(w/w) to highlight any additive effects (38.6 vs 63.5% of dietary energy respectively). 
This resulted in four experimental diets; high LA (18% fat), high LA (36% fat), low 
LA (18% fat) and low LA (36% fat; n=6-9 per dietary group). The list of ingredients 
and final fatty acid composition of the four experimental diets have been reported 
previously (Draycott et al., 2019). 
4.3.3 Blood sample and tissue collection 
Blood samples were collected from dams prior to the start of the experiment and after 
the 4 week ‘feed-in’ period (tail vein sample) and at the end of lactation (via cardiac 
puncture following CO2 asphyxiation and cervical dislocation). Truncal blood samples 
were also collected from one randomly selected male and one randomly selected 
female at 1 and 2 weeks of age. In all cases, samples of whole blood (~30µl) from non-
fasted animals were spotted onto PUFAcoat™ dried blood spot (DBS) collection paper 
(Liu et al., 2014), allowed to dry at room temperature and stored at -20°C for 
subsequent fatty acid analysis. Maternal tissues were weighed and samples of whole 
liver, retroperitoneal and gonadal adipose tissues collected. Offspring body and organ 
weights were measured and whole liver samples were collected from one randomly 
selected male and female pup at both time points. At 2 weeks of age, samples of 
gonadal and retroperitoneal fat were also collected from one male and one female pup 
per litter. All tissue samples were snap-frozen in liquid nitrogen and stored at -80°C 
until determination of gene expression by quantitative reverse transcriptase PCR 
(qRT-PCR). 
4.3.4 Fatty acid methylation and analysis 
Fatty acid composition in maternal and fetal blood was determined as previously 
described (Liu et al., 2014). Briefly, whole DBS samples were directly transesterified 
with 2ml of 1% H2SO4 in methanol and the fatty acid methyl esters (FAME) were 
extracted with heptane. Samples were separated and analysed by a Hewlett-Packard 
6890 gas chromatograph (GC) equipped with a capillary column (30m x 0.25mm) 
coated with 70% cyanopropyl polysilphenylene-siloxane (BPX-70; 0.25µm film 
thickness) which was fitted with a flame ionization detector (FID). FAMEs were 
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identified in unknown samples based on the comparison of retention times with an 
external lipid standard (Standard 463, Nu-check prep Inc., MN, USA) using Agilent 
Chemstation software (Agilent Technologies Australia Pty Ltd). Individual fatty acid 
content was calculated based on peak area and response factors normalised to total 
fatty acid content and expressed as a percentage of total fatty acids. 
4.3.5 Isolation of RNA and cDNA synthesis and reverse transcription quantitative 
real-time PCR (qRT-PCR) 
RNA was isolated from crushed snap-frozen samples of ~25mg of liver using the 
Roche High Pure Tissue kit (Roche Diagnostics Ltd., UK). Adipose RNA was 
extracted, after homogenisation of ~100mg of tissue with MagNA Lyser green beads 
and instrument (Roche Diagnostics Ltd.), using the RNeasy Mini Kit (QIAGEN Ltd., 
UK). RNA concentration was determined using a Nanodrop 2000 (Thermo Scientific) 
and RNA quality was evaluated by agarose gel electrophoresis. cDNA was synthesised 
using a RevertAid™ reverse transcriptase kit (Thermo Fisher Scientific, UK) with 
random hexamer primers. 
Lipogenic pathway and adipokine target genes included were chosen based on 
previous data from our laboratory that indicated that these genes were sensitive to 
changes in the maternal diet (Erhuma et al., 2007b) and included; peroxisome 
proliferator-activated receptor gamma (Pparg), sterol regulatory element-binding 
protein (variant 1c; Srebf1), fatty acid synthase (Fasn), lipoprotein lipase (Lpl) and 
leptin (Lep), with β-actin (Actb) as the housekeeper. Primer efficiency ranged from 
85%-108% and sequences have previously been published elsewhere (Draycott et al., 
2019). Adipocyte and hepatic gene expression was quantified using SYBR Green 
(Roche Diagnostics) in a Light-Cycler 480 (Roche Diagnostics). Samples were 
analysed against a standard curve of a serially diluted cDNA pool to produce 
quantitative data and expression was normalised to the housekeeping gene using 
LightCycler® 480 software (version 1.5.1) as previously described (Rhinn et al., 




4.3.6 Determination of liver DNA, protein and glycogen content 
For determination of DNA and protein content of liver samples, approximately 100mg 
of frozen crushed sample was added to 1ml of 0.05M trisodium citrate buffer. Samples 
were homogenised and centrifuged at 2500rpm for 10 minutes at 4°C. Supernatant was 
used for further analyses. DNA concentration (µg/ml) was measured using a Hoechst 
fluorometric method and protein concentration (mg/ml), modified for a 96 well plate 
format, was measured as described by Lowry et al. (1951). Measurements were 
normalised to the exact amount of tissue used for measurements. Liver glycogen was 
measured using the Colorimetric Glycogen Assay Kit II (Abcam Ltd.) according to 
manufacturer’s instructions. 
4.3.7 Statistical analysis 
Data are presented as mean ± SEM. Data were analysed using the Statistical Package 
for Social Sciences (Version 24, SPSS Inc.). The effect of maternal dietary fatty acid 
ratio and maternal dietary fat content on maternal dependent variables was assessed 
using a two-way ANOVA, with dietary LA:ALA ratio and dietary fat content as factors 
and dams were used as the unit of analysis. Where longitudinal data were analysed, as 
with maternal feed, protein and energy intakes, the impact of maternal dietary 
LA:ALA ratio and maternal dietary fat content was analysed using a two-way 
repeated-measures ANOVA. Offspring data were analysed using a two-way ANOVA, 
with maternal dietary LA:ALA ratio and fat content as factors; where there was no 
overall effect of sex, male and female offspring data were combined. Where data were 
not normally distributed, analyses were performed on log10 transformed data. A value 
of P<0.05 was considered to be statistically significant.  
4.4 Results 
4.4.1 Maternal dietary intakes 
There were no differences in feed intake of dams between treatment groups before or 
during pregnancy. During lactation, dams receiving the 36% fat diets had a lower 
average daily feed intake than those receiving the 18% fat diets, irrespective of dietary 
LA:ALA ratio (P<0.001; Figure 4.1.A). Energy intake was similar between groups 
throughout the experiment (Figure 4.1.B). Protein intake prior to and during pregnancy 
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was affected by both dietary LA:ALA ratio and fat content (P<0.05; Figure 4.1.C), 
however, these effects were small and inconsistent. During lactation, protein intake 
was affected by dietary fat content only (P<0.001; Figure 4.1.C), such that mothers 
receiving 36% fat diets consumed 24% less protein on average compared to those 
consuming 18% fat diets, irrespective of dietary LA:ALA ratio. As expected, all dams 
consumed more food, energy and protein during lactation than before and during 
pregnancy regardless of dietary group (P<0.001). 
4.4.2 Maternal fatty acid profile 
There were no differences in the proportions of either saturated fatty acids (SFA), 
monounsaturated fatty acids (MUFA), omega-6 (Figure 4.2.A) or omega-3 PUFA 
(Figure 4.2.B) in whole blood samples collected from the dams prior to the 
commencement of dietary intervention. After 4 weeks on their respective diets, the 
blood fatty acid profiles were significantly different between treatment groups and 
largely reflected the composition of the experimental diets. Thus, dams fed on high 
LA diets had higher proportions of LA (1.2 fold) and AA (1.4 fold) compared to those 
consuming a low LA diet (P<0.001; Figure 4.2.C). Conversely, dams fed the low LA 
diets had a 5.5 fold higher proportion of ALA and an 8.5 fold higher proportion of 
EPA compared to those consuming a high LA diet (P<0.001; Figure 4.2.D). These 
changes were independent of the total fat content of the diet. DPA and DHA levels 
after the 4 week pre-feeding period were influenced by both dietary LA:ALA ratio and 
total fat content. Thus, the relative proportions of DPA were higher in dams fed the 
low LA compared to high LA diets (P<0.001), and marginally higher in dams 
consuming the 18% vs 36% fat diets (P<0.05). DHA proportions were also higher in 
the low LA group (P<0.001) but, unlike DPA, were modestly but significantly higher 
in dams consuming the 36% fat vs 18% fat diets (P<0.05; Figure 4.2.D). Total blood 
MUFA proportions were higher (1.3-fold) in dams consuming the low LA diet, 
irrespective of dietary fat content (P<0.001; Figure 4.2.D).  
The blood fatty acid profile of the dams at the end of lactation, after a further 6 weeks 
on their respective experimental diets, were similar to those observed after the first 4 
weeks of dietary intervention. A notable difference, however, was that at this time 
point, relative proportions of DHA, as a percentage of total lipids, were not different 
between dietary groups (Figure 4.2.F). LA (1.5-fold), AA (1.8-fold) and total omega-
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6 (1.5-fold) were all higher in dams consuming a high LA diet irrespective of dietary 
fat content (P<0.001; Figure 4.2.E). Conversely, total omega-3 levels were 3-fold 
higher in dams consuming a low LA diet, irrespective of dietary fat content (P<0.001). 
The proportions of ALA were also higher in the groups consuming the low LA diets 
and in rats consuming the 36% vs 18% fat diets in the low LA group only (P<0.05; 
Figure 4.2.F). DPA proportions were higher in the groups consuming the low LA diets, 
however, unlike ALA, DPA proportions were lower, rather than higher, in dams 
consuming the 36% fat diets in the low LA group only (P<0.001; Figure 4.2.F). EPA 
proportions were higher in groups consuming a low LA diet compared to those 
consuming a high LA diet (P<0.001; Figure 4.2.F). EPA proportions were also affected 
by total dietary fat content, and were lower in dams consuming a 36% fat diet 
compared to an 18% fat diet (P<0.001; Figure 4.2.F). Maternal blood total MUFA 
levels at the end of lactation were 1.4-fold higher in the dams consuming a low LA 
diet irrespective of dietary fat content (P<0.001; Figure 4.2.E). 
4.4.3 Maternal weight, body composition and gene expression 
There were no significant differences in dam bodyweight between dietary groups prior 
to the commencement of the dietary intervention or at any time during the experiment 
(data not shown). Dams consuming the 36% fat diets had heavier lungs relative to 
bodyweight at the end of lactation compared to those consuming the 18% fat diets, 
independent of the LA:ALA ratio (P<0.05). There were no differences in the relative 
weight of the heart, liver, brain, kidney, gonadal or retroperitoneal fat pads between 
experimental groups (Table 4.1). 
Analysis of mRNA expression of lipogenic genes indicated that hepatic (3-fold) and 
gonadal fat (7-fold) expression of Fasn was higher in dams consuming an 18% fat diet, 
compared to those on a 36% fat diet, irrespective of dietary fatty acid ratio (P<0.01). 
The mRNA expression of Lpl, Pparg and Srebf1 was not, however, affected by either 
dietary fat content or ratio in either hepatic or gonadal fat tissues (Table 4.1). 
Expression of leptin mRNA in gonadal adipose tissue was not significantly different 
between treatment groups. 
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4.4.4 Birth outcomes and offspring bodyweights 
There were no differences between dietary groups in terms of litter size or sex ratio of 
pups (Table 4.2). Birth weight was lower in offspring of dams fed a 36% fat vs 18% 
fat diets, independent of the dietary LA:ALA ratio (Table 4.2). The lower body weight 
in offspring of dams fed the 36% fat diet persisted during the sucking period such that 
offspring of dams fed the 36% fat diets remained lighter than offspring of dams fed on 
18% fat diets at both 1 and 2 weeks of age; again this was independent of dietary 
LA:ALA ratio (P<0.001; Table 4.3).  
4.4.5 Offspring fatty acid profile 
At 1 week of age, proportions of AA (2.1 fold) were lower in the offspring of the low 
LA compared to high LA dams (P<0.001), and in offspring of dams consuming the 
36% fat vs 18% fat diets (1.4 fold; P<0.001; Figure 4.3.A). Blood ALA proportions 
were 5.9 fold higher in offspring of dams in the low LA groups compared to high LA 
groups (P<0.001; Figure 4.3.B). Offspring EPA and DPA proportions were also higher 
in the low LA group compared to the high LA group. Blood EPA was also influenced 
by total dietary fat content, but only in offspring of dams fed the low LA diet, in which 
EPA levels were lower in offspring of dams fed the 36% fat diets compared to the 18% 
fat diets (EPA, P<0.001; DPA, P<0.01; Figure 4.3.B). DHA proportions were not 
different between groups at 1 week of age (Figure 4.3.B). MUFA proportions were 
higher (1.2-fold) in offspring of dams in the low LA groups (P<0.001), consistent with 
the pattern in maternal blood. However, unlike maternal MUFA, offspring MUFA 
levels were also affected by maternal dietary fat content and were 1.2-fold higher in 
offspring of dams fed the 36% fat vs 18% fat diets (P<0.001; Figure 4.3.A). At 1 week 
of age offspring of dams in the 36% fat diet groups also had lower blood proportions 
of SFA, irrespective of LA:ALA ratio of the maternal diet (P<0.01; Figure 4.3.A).  
The fatty acid profiles of the offspring at 2 weeks of age were similar to those observed 
at 1 week. Thus, blood AA (1.9 fold) and total omega-6 (1.6 fold) proportions were 
lower (Figure 4.3.C) and ALA (6.3 fold), EPA (4.7 fold), DPA (2.4 fold) and total 
omega-3 PUFA (3-fold) proportions (Figure 4.3.D) were higher in offspring of dams 
in the low LA group compared to high LA groups, irrespective of maternal dietary fat 
content (P<0.001). Proportions of LA were higher in offspring of dams fed the 36% 
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fat diets compared to those fed 18% fat diets in the high LA group only (P<0.05; Figure 
4.3.C), while EPA and DPA proportions were lower in the 36% compared to the 18% 
fat diet groups, independent of the dietary LA:ALA ratio (P<0.001; Figure 4.3.D). 
Unlike findings at 1 week of age, the DHA levels in 2 week old offspring of dams 
consuming a 36% fat diet were lower (P<0.05) when compared to 18% fat groups, 
irrespective of maternal dietary fatty acid ratio. As at 1 week, SFA proportions were 
lower (1.2-fold) in offspring of dams fed a 36% fat diet, independent of the LA:ALA 
ratio (P<0.001). MUFA proportions were 1.2 fold higher in offspring of dams fed the 
low LA diets, and 1.2 fold higher in offspring of dams who consumed a 36% fat vs 
18% diet (P<0.001; Figure 4.3.C). 
4.4.6 Offspring organ weight and liver composition 
At 1 week of age, heart weight relative to bodyweight was higher in female offspring 
of dams receiving a 36% fat diet compared to the 18% fat diet, independent of the 
dietary LA:ALA ratio (P<0.05). There were no differences in the relative weight of 
lung or kidney at 1 week of age and no differences in the relative weight of the heart, 
lung, liver, gonadal or retroperitoneal fat pads in the offspring at 2 weeks of age 
between treatment groups in either male or female offspring (Table 4.3). 
Liver weight at 1 week appeared to be influenced by the LA:ALA ratio of the diet to 
a greater extent than total fat level, at least in males. Thus, male offspring of dams 
consuming the low LA diets had smaller livers compared to offspring of dams 
receiving a high LA diet (P<0.01), irrespective of total dietary fat content. The 
glycogen content of the livers was also lower in male offspring of dams consuming 
the low LA diet at 1 week (P<0.05). No effect of maternal diet on offspring liver 
protein or DNA concentration was observed (Table 4.4). These differences were not 
present in females at 1 week of age and no differences in glycogen content were 
observed at two weeks of age in male offspring. DNA concentration in females at two 
weeks of age was marginally increased (1.1-fold) in offspring exposed to a 36% fat 
diet, irrespective of maternal dietary fatty acid ratio (P<0.05).  
4.4.7 Hepatic gene expression 
At 1 week of age, hepatic Fasn expression was influenced by maternal dietary 
intervention in a sex specific manner. Thus, in males, Fasn expression was higher in 
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offspring of dams consuming a 36% fat diet irrespective of maternal LA:ALA ratio 
(P<0.05). In female offspring, however, Fasn expression was higher in offspring of 
dams consuming a low LA diet, independent of dietary fat content (P<0.05). Hepatic 
Lpl mRNA expression in male offspring at 1 week of age was also influenced by 
maternal dietary fat content, with higher expression in offspring of dams consuming a 
36% fat diet vs 18% fat diet (P<0.05). In female offspring, hepatic Srebf1 expression, 
similar to that of Fasn, was higher in offspring of dams consuming a low LA diet at 1 
and 2 weeks of age (P<0.01). Female hepatic expression of Pparg was lower in 
offspring of dams consuming a low LA diet at 2 weeks of age (P<0.05). There were 
no differences in the expression of Fasn or Lpl in female offspring, or expression of 
any hepatic genes in male offspring at this time point (Table 4.3). 
4.5 Discussion 
This study has demonstrated that altering the fat content and/or LA:ALA ratio of the 
maternal diet during pregnancy and lactation resulted in significant alteration in the 
circulating fatty acid profile of dams in the absence of any significant effects on 
maternal bodyweight or body composition. Exposure to a 36% fat diet during gestation 
and lactation was, however, associated with lower offspring bodyweight from birth, 
which persisted to 2 weeks of age. This suggests that increased dietary fat intake during 
pregnancy and lactation can compromise growth of the progeny, irrespective of the 
type of fat consumed. In addition, alterations in the fat content and/or composition of 
the maternal diet had transient effects on offspring body composition and hepatic gene 
expression, effects which were also sex-specific. 
Maternal fatty acid profiles after 4 weeks on the experimental diets largely reflected 
dietary composition, confirming that the dietary intervention had the desired effect on 
maternal circulating fatty acid composition. These changes persisted after a further 6 
weeks of exposure to the diets and, as expected, the dietary LA:ALA ratio had a greater 
impact on the maternal blood omega-6 and omega-3 status than total dietary fat 
content. Consistent with previous studies (Tu et al., 2010, Blank et al., 2002, Brenna 
et al., 2009, Draycott et al., 2019), decreasing the dietary LA:ALA ratio resulted in 
substantial increases in relative maternal ALA and EPA levels but only a very modest 
increase in DHA proportions after a 4-week exposure, and no difference compared to 
the higher LA:ALA ratio after 10 weeks. Interestingly, and independent of dietary 
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LA:ALA ratio, dams appeared to be more efficient at converting DPA to DHA when 
total dietary fat load was higher. One possibility could be that this is simply a result of 
the higher amount of substrate (i.e. ALA) available for conversion to the longer chain 
derivatives such as DPA and DHA in diets containing higher total fat levels. This effect 
did not, however, persist after a further 6 weeks of dietary exposure, at which point 
EPA and DPA were lower in dams consuming a low LA 36% fat diet compared to a 
low LA 18%. This may be a result of saturation of the PUFA metabolic pathway when 
total fat, and therefore PUFA, levels were higher (Tu et al., 2013, Gibson et al., 2013). 
This apparent decrease in capacity to convert ALA through to EPA and DHA during 
consumption of a 36% fat diet coincides with the decreased protein intake observed in 
these groups. It is possible that the lower consumption of protein in rats fed on the 36% 
fat diets may have contributed to reduced conversion of ALA, since previous studies 
have shown reduced desaturase, particularly Δ6-desaturase, expression in the 
mammary gland (Bautista et al., 2013) and liver (Mercuri et al., 1979a) of rats exposed 
to a low protein diet. Maternal whole blood MUFA proportions appeared to be 
influenced by dietary LA:ALA ratio, however, this is most likely a result of the slightly 
higher MUFA content of the low LA diets.   
Offspring fatty acid profiles at 1 and 2 weeks of age largely reflected maternal profiles 
with maternal dietary LA:ALA ratio exhibiting the strongest effect on offspring 
circulating fatty acid proportions. However, the total fat content of the maternal diet 
appeared to have a greater influence on the blood fatty acid composition of the 
offspring as opposed to that observed in the dams. Of particular interest was the finding 
that the proportion of both EPA and DPA in offspring at 1 week of age were higher in 
the low LA (18% fat) vs the low LA (36% fat) group, and that this effect persisted at 
2 weeks of age despite ALA levels being increased in the low LA (36% fat) group at 
this time point. DHA was not different between groups at 1 week of age but was lower 
in offspring exposed to a 36% fat diet at 2 weeks of age. As with the maternal fatty 
acid profiles, this again may be a result of saturation of the PUFA metabolic pathway 
at higher total PUFA intakes, and is in line with findings from numerous studies, both 
human and animal, that indicate that simply increasing the quantity of substrate, i.e. 
ALA, is not an effective strategy for increasing concentrations of its long-chain 
derivatives, in particular DHA (Mantzioris et al., 1994, Blank et al., 2002, Brenna et 
al., 2009, Chan et al., 1993). 
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The total dietary fat content of the maternal diet also had an influence on the proportion 
of SFA in the offspring, such that offspring of dams consuming 36% fat diets exhibited 
lower SFA proportions than offspring of dams consuming the 18% fat diets. Unlike 
the fetus, where fatty acid composition is largely related to maternal dietary intake, 
during suckling, offspring fatty acid composition is largely determined by the 
composition of the milk, which may not fully reflect maternal fatty acid intakes. In a 
study by Mohammad et al. (2014), for example, women consuming diets with a higher 
total fat content (55%en vs. 25%en) exhibited reduced SFA concentrations (C6:0-
C14:0) in breast milk but not in maternal plasma. While milk composition was not 
assessed in the current study, this raises the possibility that SFA content of the milk 
may have been lower in those dams consuming the 36% fat diets, which could in turn 
explain the lower SFA status of the offspring. Alternatively, it may be that increasing 
the fat content of the diets resulted in an increased conversion of SFA to MUFA, since 
high-fat feeding has been associated with increased expression of the enzyme 
responsible for conversion of SFA to MUFA, stearoyl-CoA desaturase 1 (SCD-1) (Hu 
et al., 2004) and could therefore be the reason for the observed effect of fat content on 
offspring MUFA levels in this study. It is important to note, however, that circulating 
fatty acid profiles are a product of both dietary fatty acid intake as well as tissue fatty 
acid production and release. Whilst the collection of blood samples from animals in 
the fed state suggests that the dietary fraction of fatty acids would provide a greater 
contribution to the fatty acid profile of both dams and offspring, the influence of 
hepatic synthesis of fatty acids should not be overlooked as a contributor to the 
observed differences.  
Despite significant shifts in maternal fatty acid profiles and increased fat content of 
the 36% fat diets, we saw no differences in maternal bodyweight or fat deposition. 
This is consistent with our previous study (Draycott et al., 2019) and is likely a result 
of the reduced feed intakes of the dams to compensate for the increased energy density 
of the higher fat diets, a phenomenon consistently seen with dietary intervention trials 
using rodents (Keesey and Hirvonen, 1997). Despite the lack of an effect on maternal 
weight gain and fat deposition, bodyweight was reduced in offspring of dams receiving 
a 36% fat diet, irrespective of maternal dietary LA:ALA ratio. This phenotype was 
consistent across sexes and persisted from birth to 2 weeks of age. Variable results 
have been reported in this regard with some studies reporting no effects (Khan et al., 
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2002, Khan et al., 2005, Dyrskog et al., 2005) or increased weight (Samuelsson et al., 
2008). This finding was, however, consistent with many other studies that reported 
decreased fetal (Taylor et al., 2003, Mark et al., 2011), birth (Howie et al., 2009) and 
weaning weight (Cerf et al., 2006) in offspring of dams exposed to a 36% fat diet 
during gestation and lactation periods. The differential effects of different high-fat 
diets on offspring growth is likely due to differences in composition of the diet as well 
as periods of exposure between studies (Ainge et al., 2011). In those studies that have 
reported lower offspring weights in offspring fed a high-fat diet, lower protein intakes 
in dams consuming a high-fat diet have been cited as a likely contributing factor. 
Further to this, protein restricted diets have been associated with impaired mammary 
gland development (Bautista et al., 2013, Moretto et al., 2011) leading to impaired 
milk synthesis (Moretto et al., 2011), and this may also have contributed to reduced 
offspring growth observed during the suckling period. It is important to note however, 
that the reduction in protein intake in dams consuming a 36% fat diet in the current 
study were more modest (10-25%) than those typically used in low-protein diet studies 
(~50% reduction) (Langley and Jackson, 1994, Langley-Evans and Nwagwu, 1998, 
Ozanne et al., 1998, Malandro et al., 1996).  
The lower Fasn expression in the liver and adipose tissue of dams exposed to a 36% 
fat diet is consistent with the established role of this enzyme in suppressing lipogenesis 
in times of energy excess (Geelen et al., 2001). Surprisingly, this change did not appear 
to be mediated through changes in maternal Srebf1 mRNA expression, a known 
regulator of Fasn expression (Griffin and Sul, 2004). It is important to note that since 
only mRNA expression was measured, we cannot comment on any differences in 
protein expression or activity of this transcription factor although mRNA and protein 
levels have been shown to be closely correlated (Erhuma et al., 2007b). Following this 
up at the protein level is a major priority for future study. In the offspring, however, 
hepatic Fasn expression was not downregulated by exposure to a maternal 36% fat 
diet but was actually higher in male offspring of dams consuming the 36% fat 
compared to the 18% fat diets at 1 week of age and was accompanied by an increase 
in Lpl expression. In female offspring, however, hepatic Fasn and Sbrepf1 expression 
at 1 week were influenced by maternal dietary fatty acid ratio, rather than total fat 
content, with both genes upregulated in offspring of dams fed the low LA diets. In 
both cases, the upregulation of Sbref1, Fasn and Lpl genes would be expected to be 
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associated with an upregulation of both lipogenesis and fatty acid uptake. It is worth 
mentioning that differences in hepatic expression of lipogenic genes in male offspring 
were consistently associated with maternal dietary fat content whereas differences in 
female hepatic expression were consistently associated with maternal dietary fatty acid 
ratio. This suggests that female offspring are more sensitive to changes in the types of 
maternal dietary fat whereas male offspring are more sensitive to gross maternal fat 
consumption. Sex specific effects associated with the programming of disease 
hypothesis have been frequently reported (Gabory et al., 2013). The mechanism by 
which sex influences these effects, however, remains to be elucidated within a larger 
perspective, as well as within the context of this study.  
We found no evidence that these alterations in hepatic gene expression translated to 
increases in liver weight, however whether there was any effect on hepatic fat content 
remains to be determined. In both male and female offspring, relative liver weight was 
increased in offspring of dams fed the high LA diet. In an aim to further elucidate the 
source of this increased weight, we measured liver DNA, protein and glycogen 
composition. Similar to liver weight, glycogen levels were increased in offspring of 
dams fed the high LA diets. This increase in glycogen, however, was not sufficient 
enough to completely account for the differences observed in liver weight but may be 
a contributing factor. Consideration of DNA and protein content of the tissue did not 
indicate significant changes to cell size or number. More detailed analysis is required 
to further elucidate the mechanism by which high maternal dietary omega-6 may 
impact upon offspring liver physiology. 
The majority of the hepatic mRNA expression differences, as well as gross differences 
in liver weight and composition, appeared to be transient and were no longer present 
at 2 weeks of age. A notable exception was the lower expression of Srebf1 mRNA and 
higher expression of Pparg in females of dams exposed to a high LA diet compared to 
the low LA diet, with a similar trend observed in males. Although found in relatively 
low concentrations in the liver, activation of Pparg has been shown to increase hepatic 
lipid storage and is elevated in models of hepatic steatosis (Inoue et al., 2005). As 
such, decreased Pparg expression can alleviate some of the symptoms of hepatic 
steatosis leading to a reduced liver weight in conjunction with a reduction in hepatic 
triglyceride content (Gavrilova et al., 2003). Thus, our finding that female offspring 
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of dams exposed to a high LA diet tended towards to have an increased liver weight at 
one week of age followed by increased hepatic Pparg expression at two weeks of age 
may suggest that the increase in Pparg expression is a potential response to the 
increased liver growth observed a week earlier. Alternatively, parallels may be drawn 
to the effect of low protein diets where fluctuations between an increased and 
decreased lipogenic capacity, chiefly mediated by altered Srebf1 expression, occur in 
early life only to settle into a pattern of upregulated lipogenesis at a later life stage 
(Erhuma et al., 2007b). Further studies would be needed to directly evaluate this 
hypothesis.  
In conclusion, we have demonstrated that exposure to a 36% fat diet during gestation 
and lactation is associated with persistent growth restriction in both male and female 
offspring irrespective of maternal dietary fatty acid composition. Growth restriction 
has been associated with a plethora of metabolic disturbances later in life (Barker, 
1995, Phillips et al., 1994, Holemans et al., 2003) and transient alterations in gene 
expression have been suggested as a mechanism for programming changes in 
metabolic processes within tissues as well as the morphology of the tissues themselves 
(Langley-Evans, 2015) . In this study, offspring are still exposed to the experimental 
diets via the dams milk, and further studies in offspring at older ages are required to 
assess whether the changes in growth, hepatic gene expression and liver weights in the 
current study are associated with phenotypic changes that persist once offspring are no 
longer exposed directly to the altered diet composition. In addition, analysis of 
lipogenic pathway and adipokine targets at the protein level, as well as whole 
transcriptome analysis, may yield useful information about their regulation and the 
extent to which these experimental diets programme other metabolid and regulatory 
pathways in the liver. Finally, the longevity of these perturbations into later life, 
especially when presented with secondary metabolic challenges such as aging, 
prolonged high-fat feeding or in the case of female offspring, pregnancy, remains to 





4.6 Tables and Figures  
Table 4.1 Maternal organ weights and gene expression 
 High LA (18% 
Fat) 
High LA (36% 
Fat) 
Low LA  
(18% Fat) 
Low LA  
(36% Fat) 
Bodyweight (g)  308.75 ± 9.82 288.73 ± 14.95 303.29 ± 11.11 302.23 ± 7.85 
Heart (% BW)  0.35 ± 0.01 0.36 ± 0.01 0.35 ± 0.01 0.35 ± 0.01 
Lungs (% BW)a 0.45 ± 0.02 0.51 ± 0.04 0.42 ± 0.02 0.48 ± 0.02 
Kidney (% BW) 0.78 ± 0.02 0.83 ± 0.03 0.82 ± 0.02 0.79 ± 0.02 
Liver (% BW) 5.01 ± 0.10 4.80 ± 0.28 5.28 ± 0.10 4.88 ± 0.09 
Brain (% BW) 0.59 ± 0.02 0.59 ± 0.02 0.58 ± 0.02 0.59 ± 0.02 
Gonadal Fat (% BW) 1.88 ± 0.35 2.02 ± 0.39 1.65 ± 0.19 1.61 ± 0.11 
Retroperitoneal Fat (% BW) 0.76 ± 0.13 0.76 ± 0.13 0.76 ± 0.08 0.85 ± 0.15 
Liver mRNA Expression 
Fasna* 20.98 ± 6.17 7.03 ± 1.26 25.08 ± 8.12 9.45 ± 1.63 
Lpl 0.20 ± 0.04 0.19 ± 0.04 0.19 ± 0.04 0.13 ± 0.01 
Pparg 0.63 ± 0.22 0.78 ± 0.18 0.41 ± 0.09 0.70 ± 0.16 
Srebf1 3.52 ± 0.91 2.56 ± 0.64 7.85 ± 2.57 3.39 ± 0.61 
Gonadal Fat mRNA Expression 
Fasna* 1.29 ± 0.64 0.18 ± 0.05 2.50 ± 1.16 0.37 ± 0.14 
Lpl 0.90 ± 0.23 0.87 ± 0.06 1.56 ± 0.41 1.48 ± 0.46 
Ppparg 0.91 ± 0.23 1.22 ± 0.20 1.12 ± 0.13 1.16 ± 0.18 
Srebf1 1.80 ± 0.48 1.56 ± 0.31 3.43 ± 1.16 2.21 ± 0.62 
Lep 0.49 ± 0.08 1.00 ± 0.29 1.10 ± 0.31 1.38 ± 0.25 
All values are mean ± SEM and n=6-9 per dietary group. The effect of dietary fatty acid ratio and dietary fat content were assessed using a two-
way ANOVA. a indicates a significant effect of dietary fat content (P<0.05, *P<0.01). Although not statistically significant there was some evidence 
that maternal Srebf1 expression was influenced by the LA (P=0.08) and fat content (P=0.06) of the diet. 
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Table 4.2 Birth outcomes 
All values are mean ± SEM. The effect of dietary fatty acid ratio and dietary fat content 
was assessed using a two-way ANOVA. a indicates a significant effect of maternal 










n 6 8 7 9 
Litter Size 12.83 ± 1.19 13.00 ± 1.21 13.14 ± 0.40 13.33 ± 1.08 
Sex Ratio (male/female) 1.01 ± 0.23 0.97 ± 0.24 1.27 ± 0.28 1.13 ± 0.26 
Male Birthweight (g)a 6.19 ± 0.53 5.19 ± 0.18 5.66 ± 0.14 5.36 ± 0.11 
Female Birthweight (g)a 5.60 ± 0.37 4.85 ± 0.21 5.26 ± 0.14 5.07 ± 0.12 
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Table 4.3 Offspring organ weights and hepatic gene expression 
All values are mean ± SEM. A two-way ANOVA was used to analyse results with maternal dietary fatty acid ratio and maternal dietary fat content 
as factors. Different superscripts denote values which are significantly different (P<0.05). n=4-9 per dietary group. All comparisons are made 



















1 Week Offspring         
Bodyweight (g)  17.52 ± 1.22a 12.85 ± 1.16b 16.61 ± 0.41a 14.20 ± 0.63b 15.79 ± 1.11a 12.44 ± 1.17b 15.66 ± 0.66a 13.40 ± 0.56b 
Heart (% BW)  0.59 ± 0.07 0.67 ± 0.06 0.58 ± 0.04 0.64 ± 0.02 0.56 ± 0.02a 0.70 ± 0.06b 0.57 ± 0.06a 0.69 ± 0.04b 
Lungs (% BW) 1.87 ± 0.05 1.73 ± 0.04 1.89 ± 0.05 1.90 ± 0.06 1.96 ± 0.11 1.92 ± 0.05 1.88 ± 0.12 1.93 ± 0.05 
Kidney (%BW) 1.27 ± 0.08 1.34 ± 0.05 1.19 ± 0.09 1.22 ± 0.02 1.25 ± 0.04 1.38 ± 0.06 1.21 ± 0.10 1.26 ± 0.03 
Liver (% BW) 3.17 ± 0.16a 3.39 ± 0.13a 2.81 ± 0.12b 2.89 ± 0.09b 3.18 ± 0.10 3.20 ± 0.27 2.96 ± 0.13 2.99 ± 0.05 
Liver Fasn 0.21 ± 0.08a 0.24 ± 0.05b 0.18 ± 0.02a 0.38 ± 0.04b 0.15 ± 0.02a 0.22 ± 0.03a 0.32 ± 0.06b 0.35 ± 0.08b 
Liver Lpl 1.09 ± 0.38a 1.26 ± 0.25b 0.76 ± 0.15a 2.01 ± 0.38b 1.26 ± 0.24 1.37 ± 0.46 1.59 ± 0.28 1.81 ± 0.35 
Liver Pparg 0.40 ± 0.16 0.30 ± 0.07 0.46 ± 0.14 0.38 ± 0.08 0.51 ± 0.11 0.52 ± 0.13 0.62 ± 0.16 0.41 ±0 .06 
Liver Srebpf1 0.63 ± 0.16 0.56 ± 0.09 0.51 ± 0.10 0.74 ± 0.10 0.44 ± 0.06a 0.44 ± 0.05a 0.64 ± 0.11b 0.80 ± 0.12b 
2 Week Offspring         
Bodyweight (g)  39.76 ± 1.67a 31.78 ± 2.17b 39.89 ± 0.59a 31.56 ± 1.49b 37.77 ± 1.55a 31.70 ± 2.05b 38.49 ± 0.93a 30.75 ± 1.29b 
Heart (% BW)  0.60 ± 0.01 0.60 ± 0.02 0.61 ± 0.03 0.63 ± 0.01 0.67 ± 0.06 0.67 ± 0.01 0.65 ± 0.03 0.61 ± 0.02 
Lungs (% BW) 1.33 ± 0.20 1.26 ± 0.05 1.25 ± 0.07 1.42 ± 0.07 1.28 ± 0.07 1.32 ± 0.05 1.26 ± 0.08 1.32 ± 0.06 
Kidney (%BW) 1.05 ± 0.02 1.02 ± 0.03 1.06 ± 0.02 1.00 ± 0.03 1.17 ± 0.04 1.15 ± 0.04 1.14 ± 0.01 1.05 ± 0.02 
Gonadal Fat (%BW) 0.22 ± 0.06 0.18 ± 0.02 0.19 ± 0.02 0.18 ± 0.01 0.24 ± 0.02 0.21 ± 0.02 0.23 ± 0.02 0.24 ± 0.03 
Retroperitoneal Fat (%BW) 0.36 ± 0.01 0.41 ± 0.04 0.41 ± 0.02 0.39 ± 0.02 0.33 ± 0.03 0.27 ± 0.02 0.29 ± 0.03 0.27 ± 0.01 
Liver (% BW) 3.01 ± 0.06 3.08 ± 0.14 3.11 ± 0.02 3.03 ± 0.02 3.18 ± 0.09 3.15 ± 0.09 3.23 ± 0.05 3.01 ± 0.10 
Liver Fasn 0.17 ± 0.01 0.18 ± 0.02 0.19 ± 0.02 0.20 ± 0.02 0.19 ± 0.02 0.20 ± 0.03 0.22 ± 0.03 0.24 ± 0.03 
Liver Lpl 1.70 ± 0.25a 1.81 ± 0.29b 1.60 ± 0.13a 2.44 ± 0.23b 1.25 ± 0.16 1.89 ± 0.16 2.01 ± 0.29 1.81 ± 0.08 
Liver Pparg 0.56 ± 0.17 0.66 ± 0.10 0.48 ± 0.10 0.42 ± 0.07 0.79 ± 0.25a 0.58 ± 0.07a 0.31 ± 0.06b 0.43 ± 0.07b 
Liver Srebf1 0.74 ± 0.02 0.71 ± 0.08 0.83 ± 0.06 0.80 ± 0.05 0.68 ± 0.07a 0.68 ± 0.05a 0.83 ± 0.06b 0.95 ± 0.10b 
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Table 4.4 Offspring liver composition 
All values are mean ± SEM. A two-way ANOVA was used to analyse results with maternal dietary fatty acid ratio and maternal dietary fat content 
as factors. Different superscripts denote values which are significantly different (P<0.05). n=4-9 per dietary group. All comparisons are made 



















1 Week Offspring         
Liver DNA (µg/mg tissue) 0.48 ± 0.06 0.54 ± 0.04 0.56 ± 0.06 0.52 ± 0.03 0.51 ± 0.03 0.51 ± 0.04 0.50 ± 0.04 0.52 ± 0.02 
Liver Protein (mg/g tissue) 119.2 ± 12.8 137.7 ± 8.9 135.6 ± 5.2 129.8 ± 4.9 123.8 ± 4.5 138.8 ± 8.3 128.6 ± 3.3 129.5 ± 5.2 
Liver Glycogen (µg/mg tissue) 12.71 ± 0.70a 11.26 ± 1.86a 9.72 ± 1.32b 8.64 ± 0.76b 9.70 ± 0.89 7.73 ± 0.88 9.00 ± 1.43 11.27 ± 1.80 
2 Week Offspring         
Liver DNA (µg/mg tissue) 0.59 ± 0.03 0.53 ± 0.05 0.56 ± 0.04 0.51 ± 0.03  0.52 ± 0.02a 0.61 ± 0.05b 0.52 ± 0.03a 0.57 ± 0.01b 
Liver Protein (mg/g tissue) 115.1 ± 3.6 129.9 ± 13.5 130.2 ± 10.0 117.9 ± 9.4 117.2 ± 9.7 132.3 ± 9.1 120.7 ± 9.4 120.6 ± 6.5 
Liver Glycogen (µg/mg tissue) 9.45 ± 0.61 7.48 ± 0.54 8.35 ± 0.98 9.30 ± 1.75 - - - - 
MANUSCRIPT 2 
115 
Figure 4.1 Maternal average daily (A) feed intake, (B) energy intake and (C) protein 
intake during pre-feeding, pregnancy and lactation fed on either a high LA (18% fat) 
diet (closed circles), high LA (36% fat) diet (open circles), low LA (18% fat) diet 
(closed squares) and a low LA (36% fat) diet (open squares). Values are means ± SEM 
and n=6-9 per group. The effects of dietary fatty acid ratio and dietary fat content was 
determined using a two-way repeated measures ANOVA. * indicates a significant 
effect of dietary fat content (** P<0.01, *** P<0.001). † indicates a significant 
interaction between dietary fat content and fatty acid ratio.  
Figure 4.2 Maternal whole blood fatty acids profile at (A/B) baseline (C/D) after 4 
weeks on experimental diet and (D/E) at the end of lactation (3 weeks post-partum). 
Values are means ± SEM and n=6-9 per group. The effects of dietary fatty acid ratio 
and dietary fat content were determined using a two-way ANOVA (*P<0.05, 
**P<0.01, ***P<0.001). † indicates a significant interaction effect (P<0.05). 
Figure 4.3 Offspring whole blood fatty acids profile at (A/B) one week of age and 
(C/D) at two weeks of age. Values are means ± SEM and n=11-17 per group. The 
effects of maternal dietary fatty acid ratio, maternal dietary fat content and sex were 
determined using a three-way ANOVA. No effect of sex was found for any of the fatty 
acids measured and so male and female samples were combined for further analysis. 
* Indicates significant difference (*P<0.05, **P<0.01, ***P<0.001). † indicates a 
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5 MANUSCRIPT 3: OMEGA-6:OMEGA-3 FATTY ACID RATIO AND 
TOTAL FAT CONTENT OF THE MATERNAL DIET ALTERS 
OFFSPRING GROWTH AND FAT DEPOSITION IN THE RAT 
 
Draycott, SAV, Daniel, Z, Elmes, MJ, Muhlhausler, BS & Langley-Evans, SC (2019). 
Omega-6:omega-3 fatty acid ratio and total fat content of the maternal diet alters 
offspring growth and fat deposition in the rat (prepared manuscript). 
 




Omega-3 long-chain polyunsaturated fatty acids (LCPUFA) have been shown to 
inhibit lipogenesis and adipogenesis in adult rats. Their possible early life effects on 
offspring fat deposition, and whether these effects could persist beyond the immediate 
post-natal period, remains to be established. This study aimed to evaluate the effects 
of maternal consumption of a linoleic acid (LA) to alpha-linolenic acid (ALA) ratio 
similar to modern Western diets (9:1) compared to a lower ratio (1:1.5) on offspring 
adiposity and other health indicators in the post-weaning rat, and to determine any 
cumulative effects by feeding both diets at two total fat levels (18% vs 36% fat 
w/w). Female Wistar rats (n=6-9 per group) were fed one of four diets during 
pregnancy and lactation. Offspring were weaned onto standard laboratory chow. 
Offspring of dams consuming a high-fat diet, irrespective of maternal dietary LA:ALA 
ratio, were lighter (male, 27g lighter; female 19g lighter; P<0.0001) than offspring of 
dams fed on an 18% fat diet from 3-8 weeks of age. Offspring exposed to a low LA 
(18% fat) diet had higher proportions of circulating omega-3 LCPUFA and increased 
gonadal fat mass at 4 weeks of age (P<0.05). Reduced mRNA expression of hepatic 
(P<0.01), gonadal (P<0.05) and retroperitoneal (P<0.05) Srebf1 was observed in 
offspring exposed to a 36% fat diet at 4 weeks of age and in male liver at 8 weeks of 
age (P<0.05). Whilst offspring fat deposition appeared to be sensitive to both maternal 
dietary LA:ALA ratio and total fat content, offspring growth and lipogenic capacity of 




Risk of obesity may be partially attributed to the nutritional environment encountered 
during early life (McMillen and Robinson, 2005). Interventions that target these 
critical life stages exert a greater preventative effect than those applied later in life 
(Blake-Lamb et al., 2016). Epidemiological as well as experimental animal studies 
have shown that exposure to a hypercaloric or high fat diet during early development 
is associated with increased adiposity in the offspring in later life (Armitage et al., 
2005, Hanson and Gluckman, 2014, Wang et al., 2017). Emerging evidence, however, 
suggests that the type of fat an individual is exposed to during development may also 
play a key role in determining their future metabolic health. Of increasing interest, due 
to the significant increase in their consumption over the past 60 years, is the role of 
dietary omega-6 polyunsaturated fatty acids (PUFA) (Ailhaud et al., 2006, Blasbalg et 
al., 2011).   
The biological effects of omega-6 fatty acids (which have pro-adipogenic and pro-
inflammatory properties), as well as the evidence suggesting that increased maternal 
omega-6 PUFA intake is associated with offspring adiposity (Massiera et al., 2010, 
Massiera et al., 2003), has led to the hypothesis that a diet high in omega-6 PUFA may 
be contributing to the increased incidence of obesity (Ailhaud and Guesnet, 2004). 
Furthermore, due to the opposing anti-inflammatory effects the omega-3 PUFA alpha 
linolenic acid (ALA) and its derivatives, which are primarily anti-inflammatory in 
nature, it has been hypothesised that a diet high in these fatty acids may reduce fat 
deposition (Ruzickova et al., 2004, Hill et al., 2007). The substantial increases in 
population level intakes of omega-6 PUFA, in particular linoleic acid (LA; precursor 
to longer omega-6 derivatives) has not coincided with any increases in omega-3 
consumption (Blasbalg et al., 2011), resulting in a significant increase in the ratio of 
omega-6 to omega-3 fatty acids in typical Western diets over this time. Formation of 
longer chain PUFA, such as arachidonic acid (AA; omega-6), eicosapentaenoic acid 
(EPA; omega-3) and docosahexaenoic acid (DHA; omega-3), relies on a common set 
of enzymes utilised by both families of PUFA. As such, competition exists between 
the two families such that the levels of omega-6 PUFA within the body can directly 
affect the levels of omega-3 PUFA, therefore, implying that alterations in the ratio of 
these two families of PUFA, as well as their overall amount, may impact on fat 
deposition and lipogenesis.  
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The potential mechanism through which variation in the omega-6:omega-3 ratio in 
early life may programme metabolic health is unknown. It is possible that early 
changes in the patterns of expression of key genes involved in lipogenesis within the 
liver and adipose tissue have a long-term impact on fat deposition and accumulation. 
These genes include sterol regulatory element-binding protein 1c (Srebf1), peroxisome 
proliferator-activated receptor gamma (Pparg), fatty acid synthase (Fasn), lipoprotein 
lipase (Lpl), and leptin (Lep). Previous studies in adult animals have also demonstrated 
that increased omega-3 PUFA intake can reduce lipid accumulation resulting in an 
overall reduction in body fat (Hill et al., 2007, Ruzickova et al., 2004, Couet et al., 
1997), and that this is mediated through modulation of the expression of Srebf1 (Xu et 
al., 1999) and Pparg (Forman et al., 1997, Kliewer et al., 1997). There have been few 
studies, however, investigating whether these anti-lipogenic effects are observed in 
offspring exposed to a maternal diet that is high in omega-3 fats. Conflicting results 
have been reported in this regard, with some studies reporting decreased (Ibrahim et 
al., 2009, Massiera et al., 2003, Wyrwoll et al., 2006) and others reporting increased 
(Muhlhausler et al., 2011b) offspring adiposity.  
The aim of this study was to investigate the effects of feeding a maternal dietary 
LA:ALA ratio similar to that of the Western diet (9:1) (Blasbalg et al., 2011), 
compared to a proposed ‘ideal’ ratio of ~1:1.5 (Gibson et al., 2011, Lands, 2000) on 
offspring adiposity and other health indicators. To elucidate any additive effects of 
altering the maternal dietary LA:ALA ratio, each diet was fed at either 18% fat w/w 
or at a higher fat content of 36% fat w/w. This paper focusses specifically on the effects 
of pre- and early post-natal exposure to altered dietary fat content and fatty acid ratio 
on offspring that have been weaned onto a standard laboratory diet. As such, offspring 
are no longer directly exposed to the maternal dietary interventions. We hypothesised 
that exposure to a high LA diet during pregnancy and lactation would lead to increased 
adiposity in the offspring, marked by increased expression of lipogenic genes, and that 
this effect may be exacerbated with exposure to a high-fat diet.  
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5.3 Materials and Methods 
5.3.1 Animals 
All animal procedures were performed in accordance with the Animals (Scientific 
Procedures) Act 1986 under Home Office licence and were approved by the Animal 
Ethics Committee of the University of Nottingham, UK. Virgin female Wistar rats 
(n=30; 75-100g; Charles River, UK) were maintained as previously described 
(Draycott et al., 2019). After acclimatisation, a tail vein blood sample was taken from 
each animal for the determination of fatty acid status and individuals were then 
randomly allocated to experimental groups. Animals were maintained on their 
allocated diet for a four week ‘pre-feeding’ period, after which they were mated. 
Conception was confirmed by the presence of a semen plug and this was recorded as 
day 0 of pregnancy. Animals were housed in individual cages and remained on their 
respective diets throughout pregnancy and lactation. All maternal data are reported 
elsewhere (Draycott et al., 2019). 
Litters were standardised to 8 pups within 24 hours of birth (4 males and 4 females, 
where possible). At 1 and 2 weeks of age, one male and one female from each litter 
were euthanised and tissues collected for analyses, the results of which are published 
elsewhere (Draycott et al., 2019). At 3 weeks of age, the remaining offspring were 
weaned and dams were euthanised by CO2 asphyxiation and cervical dislocation for 
collection of maternal blood and tissues. Offspring were weaned onto a standard 
laboratory chow diet (2018 Teklad Global 18% Protein Rodent Diet, Harlan 
Laboratories, UK) and pair housed with the remaining same sex littermate. Offspring 
bodyweight was measured weekly and all animals had blood pressure measured at 4 
weeks of age. At this time, one male and one female were euthanised by CO2 
asphyxiation and cervical dislocation. Blood pressure was measured again at 8 weeks 
of age on all remaining animals after which the experiment ended and all remaining 
animals were euthanised by CO2 asphyxiation and cervical dislocation.  
5.3.2 Diets 
Diets were designed to provide either a high (9:1, high LA) or low (1:1.5, low LA) 
ratio of LA to ALA. For each level of LA, diets containing either 18% or 36% fat 
(w/w) were developed. This resulted in four experimental diets; high LA (18% fat), 
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high LA (36% fat), low LA (18% fat) and low LA (36% fat; n=6-9 per dietary group). 
The list of ingredients and final fatty acid composition of the four experimental diets 
are as reported elsewhere (Draycott et al., 2019). 
5.3.3 Tail cuff plethysmography  
This experiment utilised a non-invasive method for measuring blood pressure 
validated by Feng et al. (2008). A volume pressure recording (VPR) sensor was used 
to measure tail blood volume to deduce systolic, diastolic and mean arterial blood 
pressure as well as heart rate. Prior to blood pressure measurements, animals were 
placed in a heat box set to 30°C for 15 minutes to enhance blood flow to the tail. 
Animals were then restrained in individual restraint tubes with adjustable nose cone, 
fitted with the deflated occlusion and VPR cuff (CODA System, Kent Scientific, 
Torrington, CT) and left to acclimatise to the restraint tube for 10 minutes to minimise 
the impact of stress before measurements began. After acclimatisation, animals 
underwent 10 cycles of blood pressure measurements; of these 10 cycles, the first three 
were disregarded as acclimatisation cycles and an average for each measurement was 
taken from the remaining seven. Animals were restrained for no longer than 30 minutes 
and removed if individuals presented with signs of stress. 
5.3.4 Blood sample and tissue collection 
Blood samples were collected from the offspring at 4 and 8 weeks of age via cardiac 
puncture and ~30µl was spotted onto PUFAcoat™ dried blood spot (DBS) collection 
paper (Liu et al., 2014), allowed to dry at room temperature and stored at -20°C for 
subsequent fatty acid analysis. The remainder of the blood sample was centrifuged at 
13000 rpm for 10 minutes at 4°C. The plasma was isolated from the whole blood 
sample and stored at -80°C until further analysis.  Offspring body and organ weights 
were measured and samples of liver, gonadal fat and retroperitoneal fat were collected 
at each time point. All tissue samples were snap-frozen in liquid nitrogen and stored 




5.3.5 Lipid extraction 
Total lipids were extracted from liver samples of 4 and 8-week-old offspring. For each 
sample, ~300mg of crushed, frozen liver was homogenised in 1.6ml of 0.5M Na2SO4. 
The homogenate was decanted into 5.4ml of hexane-isopropanol (3:2, v/v) and 2ml of 
0.5M Na2SO4 was added. Samples were vortexed and then centrifuged at 3000 rpm for 
15 minutes. The supernatant was removed into a fresh tube, dried under nitrogen and 
the resultant lipid content was weighed. Samples were resuspended in 1ml of hexane 
and 100µl of resuspended sample was removed into a fresh tube, re-dried under 
nitrogen and resuspended in 100µl of isopropanol for the determination of cholesterol 
and triglyceride content. The remaining sample was stored at -20°C for fatty acid 
analysis.  
5.3.6 Determination of circulating and hepatic lipids 
Plasma and liver cholesterol and triacylglycerol (TAG) content was determined by a 
quantitative enzymatic colorimetric assay as per manufacturers protocol (Infinity™ 
cholesterol and Infinity™ triglyceride reagent; Thermo Scientific UK).  
5.3.7 Fatty acid methylation and fatty acid analysis of whole blood and liver 
samples 
Fatty acid composition in maternal and fetal whole blood, and in lipids extracted from 
liver samples from offspring at 4 weeks of age, was determined by Gas 
Chromatography (GC) on a Hewlett-Packard 6890 gas chromatograph using methods 
that have previously been described in detail (Liu et al., 2014, Draycott et al., 2019). 
Individual fatty acid content was calculated based on peak area and response factors 
normalised to total fatty acid content and expressed as a percentage of total fatty acids. 
5.3.8 Isolation of RNA and cDNA synthesis and reverse transcription quantitative 
real-time PCR (qRT-PCR) 
RNA was isolated from crushed snap-frozen samples of ~25mg of liver using the 
Roche High Pure Tissue kit (Roche Diagnostics Ltd., UK). Adipose RNA was 
extracted, after homogenisation of ~100mg of tissue with MagNA Lyser green beads 
and instrument (Roche Diagnostics Ltd.), using the RNeasy Mini Kit (QIAGEN Ltd., 
UK). RNA concentration was determined using a Nanodrop 2000 (Thermo Scientific) 
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and RNA quality was evaluated by agarose gel electrophoresis. cDNA was synthesised 
using a RevertAid™ reverse transcriptase kit (Thermo Fisher Scientific, UK) with 
random hexamer primers. 
Lipogenic pathway and adipokine target genes included; peroxisome proliferator-
activated receptor gamma (Pparg), sterol regulatory element-binding protein (variant 
1c) (Srebf1), fatty acid synthase (Fasn), lipoprotein lipase (Lpl) and leptin (Lep). 
Primer sequences for these gene targets have previously been published elsewhere 
(Draycott et al., 2019). Hepatic expression of delta-5 (Fads1; Rn_Fads1_1_SG 
QuantiTect Primer Assay, Qiagen) and delta-6 (Fads2; Rn_Fads2_1_SG QuantiTect 
Primer Assay, Qiagen) desaturase enzymes were also determined. Cyclophilin A 
(PPIA) and β-actin (Actb) were used as housekeeper genes. Adipocyte and hepatic 
gene expression was quantified using SYBR Green (Roche Diagnostics) in a Light-
Cycler 480 (Roche Diagnostics). Samples were analysed against a standard curve of a 
serially diluted cDNA pool to produce quantitative data and expression was 
normalised to the housekeeping gene using LightCycler® 480 software (version 1.5.1) 
as previously described (Rhinn et al., 2008). The expression of the housekeeper genes 
was not different between treatment groups.  
5.3.9 Statistical analysis 
Data are presented as mean ± SEM. Data were analysed using the Statistical Package 
for Social Sciences (Version 24, SPSS Inc.). The effect of maternal dietary fatty acid 
ratio, maternal dietary fat content and sex on dependent variables was assessed using 
a three-way ANOVA. Where sex had a main effect on variables but no interaction with 
maternal dietary factors, data were split for male and female offspring and a two-way 
ANOVA was used to assess the effect of maternal dietary fat content and fatty acid 
ratio on male and female offspring separately. Where longitudinal data were analysed, 
as with bodyweight, the impact of maternal dietary LA:ALA ratio and maternal dietary 
fat content was analysed using a two-way repeated-measures ANOVA. A value of 





5.4.1 Offspring bodyweight, body composition and blood pressure  
Offspring bodyweights were measured weekly from birth until the end of the 
experiment. Figure 5.1 shows bodyweights of offspring from 3-8 weeks of age. 
Offspring birthweight and bodyweight prior to this are reported elsewhere (Draycott 
et al., 2019) (see Chapter 4). Offspring of dams consuming a 36% fat diet, irrespective 
of maternal dietary LA:ALA ratio, were lighter than offspring of dams fed on an 18% 
fat diet from 3-8 weeks of age in both male (on average 27g lighter) and female (on 
average 19g lighter) offspring (P<0.0001).  
Table 5.1 shows the organ and fat depot weights of male and female offspring at 4 and 
8 weeks of age. At 4 weeks of age, relative heart weight was 5% higher and relative 
liver weight was 4% lower in female offspring of dams exposed to a 36% fat diet 
compared to those exposed to an 18% fat diet, irrespective of maternal dietary 
LA:ALA ratio (P<0.05). Relative liver weight at 4 weeks also tended (P=0.075) to be 
lower in male offspring of dams provided the 36% vs 18% fat diet. A significant 
interaction between maternal dietary fatty acid ratio and maternal dietary fat content 
on relative gonadal fat weight was observed for both male and female offspring at 4 
weeks of age, manifesting as ~30% lower weight of the gonadal fat depots in the low 
LA group, but only if exposed to 36% fat in early life. There were no differences in 
the relative weight of lungs, kidney or retroperitoneal fat pad between experimental 
groups at 4 weeks of age. Differences in relative organ and fat weights measured in 
offspring at 4 weeks of age appeared to be transient as no differences were observed 
at 8 weeks of age for any of these organs or fat depots.  
Blood pressure at 4 weeks of age was not influenced by maternal diet. At 8 weeks of 
age, female offspring exposed to a 36% diet during gestation and lactation had 
significantly lower systolic (16 mmHg; P=0.024) and tended to have lower diastolic 
(11 mmHg; P=0.068) blood pressure than offspring exposed to an 18% fat diet (Table 
5.1). Blood pressure in males was not influenced by either LA:ALA ratio or fat content 
of the maternal diet. 
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5.4.2 Offspring whole blood and hepatic fatty acid profile 
A significant effect of sex was observed for some of the fatty acids measured in whole 
blood and liver at 4 and 8 weeks of age. No interactions were observed between sex 
and maternal dietary treatment, so male and female data were split for further analysis. 
Figure 5.2 shows the fatty acid profile of whole blood in offspring at 4 weeks of age. 
In male offspring, exposure to a 36% fat diet was associated with increased proportions 
of saturated fatty acid (SFA; P<0.05) and monounsaturated fatty acid (MUFA; P<0.05) 
as well as decreased proportions of LA (P<0.05) and AA (P<0.05), resulting in lower 
overall total omega-6 in response to a maternal 36% fat diet. Proportions of MUFA 
and AA were also influenced by maternal dietary fatty acid ratio such that a low LA 
diet was associated with increased MUFA (P<0.01) and decreased AA (P<0.01) levels. 
A similar pattern was observed for the proportions of SFA, MUFA and omega-6 fatty 
acids in whole blood of female offspring. In females, a significant interaction was 
observed for the proportions of long chain omega-3 fatty acids (EPA, P<0.05; DPA, 
P<0.01 and DHA; P<0.05). Interestingly, female offspring exposed to a low LA (18% 
fat) diet had higher proportions of these fatty acids and as a result, higher total omega-
3 proportions. Similar patterns were observed in male offspring, however, only a 
significant main effect of maternal dietary LA:ALA ratio was observed.  
The elevated omega-3 proportions in offspring of dams exposed to a low LA (18% fat) 
diet at 4 weeks of age, prompted investigation into the liver fatty acid profile at this 
time point (Figure 5.3). Interestingly, the composition of fatty acids in the liver did not 
completely reflect that of the whole blood, and were only influenced by maternal 
dietary fatty acid ratio. In male offspring, exposure to a low LA diet during pregnancy 
and lactation was associated with lower proportions of total omega-6, LA and AA and 
higher proportions of total omega-3, ALA, EPA, DHA and total SFA (Figure 5.3.A). 
Similar observations were made for the fatty acid composition of the liver in female 
offspring at this time point. A key difference, however, was that maternal diet appeared 
to have no effect on total SFA in the female offspring (Figure 5.3.B).  
At 8 weeks of age, whole blood fatty acid profile was reassessed (Figure 5.4). In male 
offspring, there were no longer any differences in proportions of SFA, MUFA, total 
omega-6, LA, AA or ALA between experimental groups. Total omega-3 (P<0.001), 
EPA (P<0.01), DPA (P<0.05) and DHA (P=0.052) proportions all remained elevated 
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in male offspring of dams exposed to a low LA diet during pregnancy and lactation. 
Similar observations were made for the fatty acid composition of female whole blood 
at 8 weeks of age. Proportions of AA, and consequently levels of total omega-6, were, 
however, higher in female offspring exposed to a high LA diet, irrespective of maternal 
dietary fat content. In both male and female whole blood, DPA proportions appeared 
to be influenced by maternal dietary fat content such that a 36% fat diet was associated 
with lower proportions of this fatty acid. This was significant in female offspring 
(P<0.05) and tended towards significance in male offspring (P=0.057). Unlike in male 
offspring, DHA proportions in female offspring whole blood at 8 weeks of age were 
not associated with maternal dietary intake. 
5.4.3 Circulating and hepatic lipid profile 
At 4 weeks of age, male offspring exposed to a 36% fat diet had lower circulating 
plasma TAG concentrations (P=0.01) and reduced liver cholesterol concentrations 
(P<0.05) when compared to offspring exposed to an 18% fat diet (Table 5.2). In the 
female liver, however, TAG concentrations were affected by maternal dietary ratio 
such that female offspring exposed to a low LA diet had lower concentrations of liver 
TAG (P<0.05), irrespective of maternal dietary fat level. There was no effect of 
maternal diet on plasma cholesterol or total liver lipid at 4 weeks of age. By 8 weeks 
of age, there were no significant differences in any of the variables measured in female 
offspring. In males, however, there was a significant interaction of maternal dietary fat 
content and fatty acid ratio such that exposure to a high LA (36% fat) diet resulted in 
increased circulating cholesterol (P<0.05) but reduced liver TAG concentrations in 8 
week old male offspring (Table 5.2).  
5.4.4 Gene expression 
An interaction between maternal dietary fatty acid ratio and fat content on hepatic 
expression of Fads1 and Fads2 was observed in female offspring (Table 5.2). This 
resulted in increased expression of both genes in female offspring of dams exposed to 
a high LA (36% fat) diet suggesting an increased capacity for synthesis of long chain 
fatty acids in this group. There were no differences in the expression of these genes in 
male offspring. Expression of key lipogenic genes (Fasn, Lpl, Pparg, Srebf1 and Lep) 
was measured in the liver as well as gonadal and retroperitoneal fat depots (Lep was 
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only measured in the fat depots due to limited hepatic expression). At 4 weeks of age 
(Table 5.3), a consistent effect of maternal dietary fat content on expression of Srebf1 
mRNA was observed. Offspring of dams exposed to a 36% fat diet had lower 
expression of hepatic (P<0.01), gonadal fat (P<0.05; significant in female offspring 
only) and retroperitoneal fat (P<0.05) Srebf1 mRNA compared to offspring of dams 
consuming an 18% fat diet. A similar pattern was observed for other genes in the 
retroperitoneal fat depot, such that offspring of dams exposed to a 36% fat diet 
exhibited lower mRNA expression of Fasn (P<0.01; male offspring only), Lpl 
(P<0.05; male and female offspring) and Lep (P<0.05; male offspring only). At 4 
weeks of age, hepatic Lpl expression was higher in offspring of dams consuming a low 
LA 36% fat diet compared to other groups in both male and female offspring (P<0.05). 
In female offspring at 4 weeks of age, a significant interaction between maternal 
dietary fatty acid ratio and maternal dietary fat content was observed in gonadal fat 
expression of Fasn (P<0.05) and Lep (P<0.05) as well as retroperitoneal fat expression 
of Pparg (P<0.05) and Lep (P<0.01). This interaction manifested as increased 
expression of these genes in offspring exposed to 36% fat with a high LA:ALA ratio, 
but decreased expression when the diet consisted of a low LA:ALA ratio. As such, 
offspring exposed to a low LA (18% fat) diet consistently exhibited the highest 
expression of these genes.  
Table 5.4 summarises the mRNA expression at 8 weeks of age. Male offspring 
exposed to a 36% fat diet during gestation and lactation showed lower hepatic Srebf1 
and gonadal fat Lep mRNA expression (P<0.05) when compared to an 18% fat diet, 
irrespective of maternal dietary fatty acid ratio. In females, and other tissues measured 
in male offspring, the differences in Srebf1 expression observed at 4 weeks of age 
appeared to be transient as no differences were observed between groups at 8 weeks 
of age. Fasn mRNA at 8 weeks of age was significantly higher in female offspring of 
dams consuming a 36% fat diet in both the gonadal (P<0.05) and retroperitoneal 
(P<0.01) fat depots, irrespective of maternal dietary ratio.  
5.5 Discussion 
This study aimed to investigate the effect of an altered maternal dietary LA:ALA ratio, 
as well as total dietary fat content, on offspring growth, adiposity, lipid profiles and 
expression of key genes associated with lipogenesis. We have shown that the maternal 
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dietary LA:ALA ratio is a key driver of the fatty acid profile in offspring whole blood 
and liver. Additionally, we found that exposure to a high fat diet, irrespective of dietary 
LA:ALA ratio, was associated with a persistent reduction in offspring bodyweight 
even after the offspring were weaned onto a standard, nutritionally balanced rodent 
diet. Differences in adipose tissue weight were determined by maternal dietary 
LA:ALA ratio as well as total fat content, whilst the expression of key lipogenic genes 
was predominantly affected by the latter. These data suggest that a maternal diet high 
in fat can have detrimental effects on offspring growth whilst an interaction between 
total fat intake and maternal dietary PUFA ratio appears to affect offspring adiposity 
via alterations in the expression of lipogenic genes. 
We have previously shown that exposure to a varying LA:ALA ratio and fat content 
in the diet influences the circulating fatty acid profile of dams (Draycott et al., 2019) 
as well as offspring directly exposed to the maternal diet (see Chapter 4). In the present 
study, we have demonstrated that the circulating and hepatic fatty acid profiles of 
offspring at 4 weeks of age, as well as the circulating fatty acid profile at 8 weeks of 
age, are still influenced by maternal dietary factors despite the offspring no longer 
being directly exposed to dietary interventions. Of particular interest is the elevated 
proportions of long chain omega-3 PUFA in whole blood samples of offspring exposed 
to a low LA (18% fat) diet but not in those exposed to a low LA (36% fat) diet. The 
experimental diet, as well as the chow diet that offspring were weaned onto, only 
contained the omega-6 and omega-3 precursors, LA and ALA. This implies, therefore, 
that the increased levels of long-chain omega-3 PUFA (LCPUFA) are due to an 
increased capacity of these offspring for conversion of ALA to its longer-chain 
derivatives through elongation and desaturation and/or remnants of preferential 
transfer of these fatty acids from the mother during pregnancy and/or lactation. We are 
inclined to believe this is a result of the latter as our previous study indicated a similar 
fatty acid profile in the dams during the lactation period (see Chapter 4). Further to 
this, studies in other species have provided no evidence of increased desaturation and 
elongation capacity of offspring exposed to higher omega-3 levels (Kanakri et al., 
2017). However, a combination of both of these factors, as well as the possible 
influence of fatty acid release from adipose tissue, is conceivable and should not be 
completely ruled out.  
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This interesting finding in the offspring whole blood fatty acid profile at 4 weeks of 
age encouraged investigation into the hepatic fatty acid profile and capacity for long 
chain PUFA synthesis. Interestingly, and despite evidence of strong correlations 
between circulating and hepatic liver fatty acid profiles (Tu et al., 2013), we found that 
the increased omega-3 LCPUFA observed in whole blood of offspring exposed to a 
low LA (18% fat) diet was not apparent in the liver. Investigation into the desaturation 
and elongation capacity of the liver in these animals revealed some sex-specific 
interactions of maternal diet and key genes associated with this pathway. The 
observation that female offspring exposed to a high LA (36% fat) diet exhibited 
increased levels of Fads1 and Fads2, does in fact suggest that these individuals may 
have an increased capacity for LCPUFA synthesis. This did not, however, appear to 
translate into any physiological differences in the composition of fatty acids in the liver 
between experimental groups and the mRNA levels measured in this study may not be 
reflective of protein levels and/or activity of these enzymes. These findings highlight 
the potential for prolonged biological effects of fatty acids incorporated into 
phospholipid membranes and/or stored in tissues during gestation and lactation. 
Further experiments investigating the longevity of changes in offspring fatty acid 
profile would confirm if there is a programmed effect of increased capacity for 
LCPUFA synthesis or if this is an artefact of direct exposure to the maternal dietary 
intervention. Even if transient, the effects of altered fatty acid composition of tissues, 
restriction of growth and greater adiposity that we have observed are likely to 
potentiate long-term metabolic consequences.  
Offspring of dams exposed to a 36% fat diet exhibited consistently lower bodyweights 
than offspring exposed to an 18% fat diet during gestation and lactation. Importantly, 
this effect was apparent from birth (see Chapter 4) and persisted after the offspring had 
been weaned onto a standard laboratory diet, suggesting a long-term effect of exposure 
to a maternal high-fat diet that is persistent beyond direct dietary exposure. This is 
consistent with many studies reporting decreased fetal (Taylor et al., 2003, Mark et 
al., 2011), birth (Howie et al., 2009) and weaning weight (Cerf et al., 2006) in 
offspring of dams exposed to a high-fat diet during gestation and lactation periods. 
Early life growth restriction is often proceeded by a period of “catch-up” growth in 
which offspring gain weight rapidly and is often associated with increased adiposity 
(Ong et al., 2000) and increased risk of metabolic disease and hypertension in the 
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offspring (Morrison et al., 2010). Surprisingly, further to a reduced bodyweight in 
response to a maternal high-fat diet, female offspring at 8 weeks of age also had 
reduced blood pressure.  This apparent increased sensitivity of female rather than male 
offspring to maternal dietary treatments has been noted previously (Khan et al., 2002), 
although, as in a number of other studies (Samuelsson et al., 2008, Guberman et al., 
2013), maternal high-fat diets resulted in increased as opposed to decreased blood 
pressure. It is important to note, however, that many of these studies utilised a maternal 
diet high in saturated fat and studies using diets high in polyunsaturated fats, as with 
this study, have shown reductions in blood pressure when compared to a maternal diet 
high in saturated fats (Langley-Evans et al., 1996a). In support of this, we have 
previously noted that offspring hypertension associated with low protein feeding 
during rat pregnancy is modified by other components of the experimental diet, 
including the source of fat (Langley-Evans, 2000, Langley-Evans, 1996).  
An unexpected finding of the study was that offspring exposed to a low LA (18% fat) 
diet had the highest relative gonadal fat mass at 4 weeks of age, in conjunction with 
higher Lep mRNA expression in the gonadal fat adipose tissue. This was consistent 
across sexes and conflicted with our hypothesis as well as the evidence linking 
increased omega-3 intake with reduced fat deposition and accumulation in in vitro and 
rodent models (Massiera et al., 2003, Wyrwoll et al., 2006). This finding was, 
however, in line with other rodent studies in which the higher omega-3 exposure was 
restricted to the gestation and lactation periods (Muhlhausler et al., 2011b) and adds 
to the disparity observed in reports of human (Muhlhausler et al., 2010b) as well as 
animal studies (Muhlhausler et al., 2011a) investigating the role of increased maternal 
dietary omega-3 on offspring body composition. The increased gonadal fat weight of 
the low LA (18% fat) group at 4 weeks of age coincided with increased Fasn 
expression in this tissue, suggesting that the higher gonadal fat deposition may have 
been driven by an increased capacity for de novo lipogenesis in this group. 
Interestingly, however, this increased Fasn expression was only observed in females, 
raising the possibility of different underlying mechanisms for increased gonadal fat 
accumulation between males and females which has also been suggested by previous 
work (Vithayathil et al., 2018).  
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Interestingly, and despite no effects on relative mass, expression of lipogenic genes in 
the retroperitoneal fat depot appeared to be more susceptible to maternal dietary effects 
compared to the gonadal fat depot. In both male and female offspring at 4 weeks of 
age, there appeared to be a decrease in lipogenic capacity in offspring of dams fed 
high-fat diets. This apparent reduction in lipogenic capacity may be a compensatory 
response to mitigate the effects of a maternal high-fat diet and limit excessive fat 
accumulation in these groups which has been demonstrated in rodent models directly 
consuming a high-fat diet (Pichon et al., 2006, Ferramosca et al., 2014, Duarte et al., 
2014, Reynés et al., 2014). Indications of reduced lipogenic capacity were also 
apparent in the liver in offspring of dams exposed to a high-fat diet. A significant 
reduction in hepatic Srebf1 expression was observed in offspring of dams receiving a 
36% fat diet; this was accompanied by proportionally lower liver weights in these 
groups at 4 weeks of age. In other models of maternal dietary insult, such as the low 
protein model, studies have shown that early reductions in the lipogenic capacity of 
tissues, through reduced gene expression, are often followed by an upregulation in 
lipogenesis between 9 and 18 months of age (Erhuma et al., 2007b), but can occur 
much earlier if the individual encounters further dietary challenge (Erhuma et al., 
2007a). Whilst this study only followed offspring until 8 weeks of age, some 
indications of this shift in lipogenic capacity were apparent in female offspring at this 
time point. Female offspring of dams exposed to a 36% fat diet exhibited increased 
Fasn levels suggesting increased de novo lipogenesis in these tissues. Long-term 
studies are required to evaluate these findings further.   
In conclusion, we have shown that, despite significant alteration in the ratio of omega-
3 and omega-6 fatty acids in offspring of dams fed either a high or low LA diet, 
offspring growth and lipogenic capacity of adipose tissue are more susceptible to 
changes in the total fat content of the maternal diet rather than changes in the types of 
fats consumed. Whilst there appears to be more robust data supporting the beneficial 
effects of omega-3 fatty acids on mature adipocytes (Hill et al., 2007, Ruzickova et 
al., 2004, Couet et al., 1997), their biological effects on developing adipose tissue are 
far less clear. Evidence suggesting beneficial or detrimental effects of the two families 
of PUFA in the maternal diet on offspring growth and adiposity, have largely been 
based on in vitro studies or animal experiments and recent data have suggested limited 
reproduction of these results in human trials (Meyer et al., 2019). Further studies are 
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required to investigate the effects of maternal dietary PUFA on developing tissues but 
caution should be exercised in the meantime not to extrapolate from data on mature 
tissues and to highlight the detrimental effects of a maternal high-fat intake regardless 








Table 5.1 Offspring body composition and blood pressure at 4 and 8 weeks of age 
All values are mean ± SEM and organ weights are expressed as a percentage of bodyweight (%BW). A two-way ANOVA was used to analyse 
results with maternal dietary fatty acid ratio and maternal dietary fat content as factors, all comparisons are made within sex groups. Different 
superscripts denote values which are significantly different (P<0.05). * indicates a significant interaction effect of maternal dietary fatty acid ratio 



















4 Week Offspring 
        
Heart (% BW)  0.49 ± 0.02 0.53 ± 0.02 0.50 ± 0.02 0.51 ± 0.02 0.52 ± 0.003a 0.55 ± 0.002b 0.51 ± 0.02a 0.53 ± 0.01b 
Lungs (% BW) 1.05 ± 0.07 1.07 ± 0.10 1.02 ± 0.07 1.29 ± 0.06 1.39 ± 0.09 1.28 ± 0.12 1.20 ± 0.11 1.19 ± 0.08 
Kidney (%BW) 1.08 ± 0.03 1.12 ± 0.03 1.10 ± 0.02 1.06 ± 0.01 1.02 ± 0.10 1.11 ± 0.02 1.13 ± 0.04 1.05± 0.02 
Liver (% BW) 5.05 ± 0.15 4.92 ± 0.13 5.05 ± 0.12 4.71 ± 0.10 4.98 ± 0.07a 4.73 ± 0.08b 4.76 ± 0.16a 4.60 ± 0.11b 
Gonadal fat (%BW) * 0.49 ± 0.03 0.52 ± 0.04 0.56 ± 0.03 0.39 ± 0.03 0.64 ± 0.09 0.66 ± 0.05 0.79 ± 0.05 0.54 ± 0.04 
Retroperitoneal fat (%BW) 0.57 ± 0.06 0.52 ± 0.04 0.52 ± 0.07 0.47 ± 0.05 0.42 ± 0.06 0.37 ± 0.03 0.42 ± 0.03 0.34 ± 0.03 
Systolic BP (mmHg) 86.2 ± 4.0 92.6 ± 4.6 89.0 ± 5.9 91.9 ± 3.8 85.8 ± 7.2 87.4 ± 3.3 91.8 ± 4.1 91.3 ± 5.2 
Diastolic BP (mmHg) 65.5 ± 3.6 68.2 ± 3.7 65.4 ± 4.6 68.3 ± 3.3 61.9 ± 7.1 61.1 ± 2.1 68.9 ± 4.1 64.5 ± 2.2 
8 Week Offspring 
        
Brain (%BW) 0.56 ± 0.02 0.57 ± 0.02 0.55 ± 0.02 0.57 ± 0.01 0.80 ± 0.01 0.84 ± 0.02 0.79 ± 0.01 0.79 ± 0.03 
Heart (% BW)  0.34 ± 0.01 0.37 ± 0.01 0.36 ± 0.01 0.38 ± 0.01 0.39 ± 0.01 0.40 ± 0.01 0.39 ± 0.02 0.40 ± 0.01 
Lungs (% BW) 0.61 ± 0.06 0.62 ± 0.05 0.61 ± 0.05 0.63 ± 0.04 0.66 ± 0.04 0.68 ± 0.04 0.60 ± 0.02 0.68 ± 0.05 
Kidney (%BW) 0.83 ± 0.04 0.83 ± 0.02 0.84 ± 0.02 0.88 ± 0.03 0.88 ± 0.03 0.87 ± 0.03 0.85 ± 0.03 0.81 ± 0.02 
Liver (% BW) 4.80 ± 0.08 5.00 ± 0.14 4.96 ± 0.09 5.00 ± 0.08 4.49 ± 0.16 4.63 ± 0.08 4.43 ± 0.10 4.56 ± 0.08 
Gonadal fat (%BW) 1.30 ± 0.10 1.25 ± 0.08 1.34 ± 0.08 1.19 ± 0.09 1.38 ± 0.15 1.56 ± 0.07 1.53 ± 0.19 1.57 ± 0.23 
Retroperitoneal fat (%BW) 1.22 ± 0.09 1.29 ± 0.11 1.32 ± 0.11 1.16 ± 0.10 0.88 ± 0.10 0.94 ± 0.11 0.94 ± 0.09 0.86 ± 0.08 
Systolic BP (mmHg) 116.0 ± 5.0 109.1 ± 5.2 113.4 ± 3.4 105.8 ± 6.6 122.7 ± 10.1a 103.2 ± 3.0b 120.4 ± 8.2a 107.4 ± 5.9b 
Diastolic BP (mmHg) 82.9 ± 0.2 73.5 ± 5.3 80.3 ± 3.3 74.4 ± 5.7 82.3 ± 5.1 71.8 ± 2.3 86.0 ± 7.1 74.5 ± 6.3 
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 Table 5.2 Offspring lipid and liver characteristics at 4 and 8 weeks of age 
All values are mean ± SEM. A two-way ANOVA was used to analyse results with maternal dietary fatty acid ratio and maternal dietary fat content 
as factors; all comparisons are made within sex group. Different superscripts denote values which are significantly different (P<0.05). A significant 





















4 Week Offspring 
        
Plasma cholesterol (mmol/L) 2.93 ± 0.13 3.08 ± 0.10 3.08 ± 0.13 2.90 ± 0.15 2.83 ± 0.09 2.90 ± 0.18 2.80 ± 0.14 2.55 ± 0.10 
Plasma TAG (mmol/L) 0.89 ± 0.07a 0.74 ± 0.03b 1.03 ± 0.12a 0.75 ± 0.06b 0.72 ± 0.06 0.76 ± 0.05 0.83 ± 0.09 0.80 ± 0.09 
Liver lipid (mg/g tissue) 30.59 ± 4.37 33.60 ± 3.51 28.55 ± 6.07 33.53 ± 1.28 34.33 ±7.35 36.61 ± 3.25 26.03 ± 3.01 28.57 ± 4.00 
Liver cholesterol (mg/g tissue) 1.93 ± 0.20a 1.46 ± 0.12b 1.78 ± 0.15a 1.63 ± 0.11b 1.63 ± 0.18 1.58 ± 0.12 1.56 ± 0.15 1.55 ± 0.09 
Liver TAG (mg/g tissue) 18.01 ± 1.71 16.40 ± 1.54 16.01 ± 2.64 13.23 ± 1.90 17.05 ± 2.42a 15.75 ± 1.37a 13.99 ± 1.03b 11.56 ± 0.85b 
Liver Fads1# 0.99 ± 0.15 1.31 ± 0.21 0.88 ± 0.07 0.97 ± 0.20 1.09 ± 0.06 1.48 ± 0.21 1.02 ± 0.10 0.82 ± 0.08 
Liver Fads2# 1.08 ± 0.13 1.42 ± 0.18 1.27 ± 0.19 1.16 ± 0.16 1.19 ± 0.06 1.54 ± 0.16 1.33 ± 0.19 0.95 ± 0.06 
8 Week Offspring 
        
Plasma cholesterol (mmol/L)* 2.39 ± 0.14 3.47 ± 0.33 2.87 ± 0.14 2.97 ± 0.15 2.30 ± 0.30 2.72 ± 0.21 2.72 ± 0.17 2.64 ± 0.15 
Plasma TAG (mmol/L) 1.57 ± 0.18 1.48 ± 0.17 1.42 ± 0.09 1.51 ± 0.11 1.10 ± 0.16 0.92 ± 0.06 1.11 ± 0.13 1.03 ± 0.11 
Liver lipid (mg/g tissue) 37.56  ± 3.69 36.18 ± 6.82 28.22 ± 10.63 26.27 ± 3.47 26.81 ± 2.27 32.73 ± 6.80 30.99 ± 5.70 37.27 ± 7.01 
Liver cholesterol (mg/g tissue) 1.20 ± 0.06 1.06 ± 0.12 1.11 ± 0.12 0.97 ± 0.10 0.87 ± 0.13 1.16 ± 1.38 0.89 ± 0.17 0.94 ± 0.12 
Liver TAG (mg/g tissue)* 19.87 ± 1.80 9.81 ± 1.13 13.68 ± 1.99 12.50 ± 1.87 14.53 ± 1.29 12.15 ± 2.53 11.72 ± 0.89 8.91 ± 1.24 
MANUSCRIPT 3 
139 
Table 5.3 Offspring lipogenic gene expression in male and female offspring at 4 weeks of age 
Values are means ± SEM and n=6-9 per group. The effects of maternal dietary fatty acid ratio and maternal dietary fat content were analysed using 
a two-way ANOVA; all comparisons are made within sex group. Different superscripts denote statistical different (P<0.05). A significant 
interaction of maternal dietary fat content and maternal dietary fatty acid is denoted for †males (P<0.05) and #females (P<0.05). Fasn, fatty acid 
synthase; Lpl, lipoprotein lipase; Pparg, peroxisome proliferator-activated receptor gamma; Srebf1, sterol regulatory element-binding protein 



















4 Week Offspring 
        
Liver   
Fasn 0.91 ± 0.12 0.93 ± 0.15 1.49 ± 0.42 0.66 ± 0.08 0.97 ± 0.14 1.08 ± 0.10 1.12 ± 0.19 0.90 ± 0.08  
Lpl†# 0.12 ± 0.01 0.13 ± 0.01 0.10 ± 0.01 0.18 ± 0.02 0.15 ± 0.02 0.11 ± 0.01 0.10 ± 0.01 0.18 ± 0.03  
Pparg 0.95 ± 0.18 0.91 ± 0.11 0.94 ± 0.17 0.91 ± 0.17 0.96 ± 0.22 0.78 ± 0.12 0.70 ± 0.10 0.75 ± 0.13  
Srebf1 0.82 ± 0.13a 0.64 ± 0.02b 0.89 ± 0.11a 0.52 ± 0.07b 0.86 ± 0.10a 0.65 ± 0.07b 0.79 ± 0.10a 0.40 ± 0.05b 
Gonadal Fat  
Fasn# 3.23 ± 1.17 2.22 ± 0.52 2.36 ± 0.37 1.17 ± 0.06 0.85 ± 0.16 2.42 ± 0.46 3.08 ± 0.47 2.29 ± 0.59  
Lpl 0.90 ± 0.05 0.94 ± 0.13 1.30 ± 0.33 0.80 ± 0.12 1.04 ± 0.30 0.88 ± 0.04 1.47 ± 0.27 1.07 ± 0.17  
Pparg 0.84 ± 0.04 0.87 ± 0.08 0.95 ± 0.12 0.86 ± 0.03 0.68 ± 0.14 0.80 ± 0.12 0.81 ± 0.06 0.56 ± 0.09  
Srebf1 3.12 ± 0.65 3.05 ± 0.50 3.29 ± 0.51 2.21 ± 0.27 3.15 ± 0.64a 2.23 ± 0.18b 3.68 ± 0.63a 2.57 ± 0.45b  




Fasn 5.19 ± 1.09a 2.35 ± 0.37b 3.01 ± 0.37a 2.19 ± 0.45b 1.86 ± 0.42 2.11 ± 0.47 2.13 ± 0.16 1.77 ± 0.57  
Lpl 1.67 ± 0.16a 1.13 ± 0.17b 1.46 ± 0.11a 1.19 ± 0.18b 1.21 ± 0.14a 0.99 ± 0.11b 1.41 ± 0.13a 0.86 ± 0.04b  
Pparg# 0.72 ± 0.03 0.95 ± 0.09 1.03 ± 0.20 1.15 ± 0.25 0.70 ± 0.07 1.01 ± 0.11 1.12 ± 0.22 0.71 ± 0.05  
Srebf1 2.71 ± 0.19a 1.89 ± 0.10b 2.47 ± 0.33a 1.74 ± 0.15b 2.93 ± 0.53a 2.27 ± 0.17b 2.61 ± 0.40a 1.77 ± 0.20b  
Lep# 2.23 ± 0.39a 1.31 ± 0.10b 1.84 ± 0.15a 1.43 ± 0.20b 1.00 ± 0.08 1.03 ± 0.11 1.77 ± 0.13 0.95 ± 0.17 
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Table 5.4 Offspring lipogenic gene expression in male and female offspring at 8 weeks of age 
Values are means ± SEM and n=6-9 per group. The effects of maternal dietary fatty acid ratio and maternal dietary fat content were analysed using 
a two-way ANOVA; all comparisons are made within sex group. Different superscripts denote statistical different (P<0.05). † Indicates a significant 
interaction of maternal dietary fat content and maternal dietary fatty acid in male offspring (P<0.05). Fasn, fatty acid synthase; Lpl, lipoprotein 



















Liver   
Fasn† 1.40 ± 0.14 2.23 ± 0.5 2.20 ± 0.34 1.58 ± 0.13 1.75 ± 0.16 2.45 ± 0.45 1.59 ± 0.29 2.43 ± 0.40  
Lpl 0.12 ± 0.01 0.13 ± 0.02 0.12 ± 0.01 0.12 ± 0.01 0.13 ± 0.01 0.12 ± 0.02 0.10 ± 0.01 0.13 ± 0.01  
Pparg 2.57 ± 0.53 2.25 ± 0.30 2.03 ± 0.22 1.71 ± 0.07 1.43 ±0.43  1.16 ± 0.29 0.85 ±0.15 0.94 ± 0.15  
Srebf1 1.80 ± 0.21a 1.63 ± 0.12b 2.12 ± 0.25a 1.56 ± 0.07b 1.39 ± 0.21 1.27 ± 0.14 1.10 ± 0.18 1.20 ± 0.17 
Gonadal Fat  
Fasn 2.24 ± 0.64 2.70 ± 0.53 2.83 ± 0.51 4.03 ± 0.88 1.22 ± 0.35a 2.54 ± 0.23b 2.06 ± 0.59a 4.36 ± 1.10b  
Lpl 2.91 ± 0.31 3.55 ± 0.52 3.50 ± 0.63 3.12 ± 0.36 2.00 ± 0.38 3.65 ± 0.78 3.06 ± 0.43 3.27 ± 0.53  
Pparg 1.02 ± 0.08 0.90 ± 0.11 0.82 ± 0.06 1.00 ± 0.09 0.92 ± 0.07 0.94 ± 0.12 0.89 ± 0.14 1.02 ± 0.11  
Srebf1 3.18 ± 0.46 2.98 ± 0.17 3.65 ± 0.47 3.33 ± 0.56 2.48 ± 0.27 2.97 ± 0.33 3.14 ± 0.55 3.81 ± 0.69  
Lep 4.79 ± 0.76a 4.12 ± 0.52b 5.82 ± 0.83a 3.58 ± 0.44b 2.34 ± 0.53 2.99 ± 0.47 4.44 ± 0.87 3.31 ± 0.58 
Retroperitoneal Fat  
Fasn 1.58 ± 0.34 1.85 ± 0.31 1.75 ± 0.17 2.25 ± 0.37 0.64 ± 0.11a 2.24 ± 0.43b 1.11 ± 0.36a 1.53 ± 0.26b  
Lpl 2.05 ± 0.45 2.01 ± 0.32 2.01 ± 0.19 2.41 ± 0.42 1.30 ± 0.21 2.08 ± 0.28 1.68 ± 0.21 1.54 ± 0.18  
Pparg 0.94 ± 0.17 0.92 ± 0.04 0.88 ± 0.05 1.00 ± 0.06 0.92 ± 0.14 1.07 ± 0.09 1.06 ± 0.13 1.01 ± 0.04  
Srebf1 1.58 ± 0.30 1.48 ± 0.23 1.64 ± 0.10 1.79 ± 0.24 1.06 ± 0.07 1.81 ± 0.24 1.30 ± 0.12 1.29 ± 0.21  
Lep 2.98 ± 0.68 2.62 ± 0.49 2.85 ± 0.33 2.47 ± 0.47 1.49 ± 0.33 1.95 ± 0.21 1.72 ± 0.24 1.49 ± 0.17 
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Figure 5.1 Body weights of (A) male and (B) female offspring post-weaning up to 8 
weeks of age exposed to either a high LA (18% fat) diet (closed circles), high LA (36% 
fat) diet (open circles), low LA (18% fat) diet (closed squares) or a low LA (36% fat) 
diet (open squares) during gestation and lactation. Offspring weaned onto a chow diet. 
Values are means ± SEM and n =6–9 per group. The effects of dietary fatty acid ratio 
and dietary fat content were determined using a two-way repeated measures ANOVA 
and a significant effect of maternal dietary fat content (P<0.0001) on body weight was 
observed for both male and female offspring.  
Figure 5.2 Whole blood fatty acid profile in (A) male and (B) female offspring at 4 
weeks of age. Values are means ± SEM and n=6-9 per group. The effects of maternal 
dietary fatty acid ratio and maternal dietary fat content were determined using a two-
way ANOVA; all comparisons were made within sex group. *Indicates significant 
difference (*P<0.05, **P<0.01, ***P<0.001). † indicates a significant interaction 
effect (P<0.05). SFA, saturated fatty acid; MUFA, monounsaturated fatty acid; LA, 
linoleic acid; AA, arachidonic acid; ALA, alpha-linolenic acid; EPA, eicosapentaenoic 
acid; DPA, docosapentaenoic acid; DHA, docosahexaenoic acid. 
Figure 5.3 Liver fatty acid profile in (A) male and (B) female offspring at 4 weeks of 
age. Values are means ± SEM and n=6-9 per group. The effects of maternal dietary 
fatty acid ratio and maternal dietary fat content were determined using a two-way 
ANOVA; all comparisons were made within sex group. *Indicates significant 
difference (*P<0.05, **P<0.01, ***P<0.001). SFA, saturated fatty acid; MUFA, 
monounsaturated fatty acid; LA, linoleic acid; AA, arachidonic acid; ALA, alpha-
linolenic acid; EPA, eicosapentaenoic acid; DPA, docosapentaenoic acid; DHA, 
docosahexaenoic acid. 
Figure 5.4 Offspring whole blood fatty acid profile in (A) male and (B) female 
offspring at 8 weeks of age. Values are means ± SEM and n=6-9 per group. The effects 
of maternal dietary fatty acid ratio and maternal dietary fat content were determined 
using a two-way ANOVA. All comparisons were made within sex group. *Indicates 
significant difference (*P<0.05, **P<0.01, ***P<0.001). SFA, saturated fatty acid; 
MUFA, monounsaturated fatty acid; LA, linoleic acid; AA, arachidonic acid; ALA, 
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Evidence suggests that sub-optimal maternal nutrition has implications for the 
developing offspring. We have previously shown that exposure to a low-protein diet 
during gestation was associated with upregulation of genes associated with cholesterol 
transport and packaging within the placenta. This study aimed to elucidate the effect 
of altering maternal dietary linoleic acid (LA; omega-6):alpha-linolenic acid (ALA; 
omega-6) ratios as well as total fat content on placental expression of genes associated 
with cholesterol transport. The potential for maternal BMI to be associated with 
expression of these genes in human placental samples was also evaluated. Placentas 
were collected from 24 Wistar rats at 20d gestation (term=21-22d gestation) that had 
been fed one of four diets containing varying fatty acid compositions during 
pregnancy, and from 62 women at the time of delivery. Expression of 14 placental 
genes associated with cholesterol packaging and transfer were assessed in rodent and 
human samples by qRT-PCR. In rats, placental mRNA expression of ApoA2, ApoC2, 
Cubn, Fgg, Mttp and Ttr was significantly elevated (3-30 fold) in animals fed a high 
LA (36% fat) diet, suggesting increased cholesterol transport across the placenta in 
this group. In women, maternal BMI was associated with fewer inconsistent alterations 
in gene expression. In summary, sub-optimal maternal nutrition is associated with 
alterations in the expression of genes associated with cholesterol transport in a rat 
model. This may contribute to altered fetal development and potentially programme 
disease risk in later life. Further investigation of human placenta in response to specific 




Maternal nutrition can have a profound impact on fetal development and future 
physiological function and metabolic health (Langley-Evans, 2015). A number of 
dietary perturbations, including maternal undernutrition and low protein diets, have 
been associated with increased risk of obesity and cardiovascular disease in the adult 
offspring (Le Clair et al., 2009, Langley-Evans, 2013). In the context of the growing 
epidemic of obesity, focus has shifted towards understanding the effects of nutritional 
excess and obesity on offspring programming of disease. Studies have consistently 
demonstrated that these exposures are associated with a substantial increase in the risk 
of poor metabolic health in the offspring in both humans (Godfrey et al., 2017) and 
animal models (Ribaroff et al., 2017). There is emerging evidence from animal studies, 
however, that maternal high-fat diets also have the potential to program metabolic 
outcomes in the offspring independent of the effects of maternal obesity. In addition, 
these effects appear to depend not only on the amount of fat in the diet (Ainge et al., 
2011), but also on the fatty acid composition (Muhlhausler and Ailhaud, 2013, 
Ramsden et al., 2013a). The majority of studies to date that have investigated the 
effects of a maternal high fat diet have utilised diets high in saturated fat. However, 
due to changes in population level patterns in dietary consumption (Blasbalg et al., 
2011, Sioen et al., 2017), attention has now shifted toward the roles of polyunsaturated 
fats within the diet. 
The mechanisms underlying this early life programming of obesity and metabolic 
disease are not completely understood. However, as the sole interface between the 
mother and the fetus, structural and functional changes within the placenta have been 
implicated as playing a key role (Tarrade et al., 2015). Cholesterol is present in every 
cell of the human body and an adequate supply is therefore critical for supporting 
normal fetal development. As the precursor for all steroid hormone synthesis, 
cholesterol also plays an important role in placental function. During pregnancy, the 
fetus obtains cholesterol via endogenous synthesis as well as transfer across the 
placenta from the maternal circulation, disturbances to either of these processes have 
negative impacts on fetal growth, cell proliferation, metabolism and the organisation 
of tissues (Singh et al., 2013, Fernandez et al., 2005). The endogenous synthesis of 
cholesterol appears to be most critical for the developing fetus, as defects in this 
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pathway are known to be lethal (Porter, 2002). Sub-optimal maternal contribution of 
cholesterol across the placenta, however, has been associated with lower birthweight 
(Maymunah et al., 2014, Edison et al., 2007) and microcephaly (Edison et al., 2007) 
in humans, highlighting the importance of this exogenous cholesterol supply.  
Transport of cholesterol across the placenta is a complex process in both humans and 
rodents (Baardman et al., 2013, Woollett, 2011). Briefly, the majority of cholesterol 
circulates the body in the form of HDL, LDL and VLDL cholesterol, which are 
associated with specific structural apolipoproteins (ApoA2, ApoB and ApoC2 
respectively). The layer of trophoblast cells, located closest to maternal circulation, 
take in LDL and VLDL through their respective receptors. HDL cholesterol can be 
taken up via a specific receptor (scavenger receptor class B type 1; SR-B1) or by 
binding to proteins such as megalin and cubilin (Cubn). Once within the cell, 
cholesterol is hydrolysed into free cholesterol, bound to sterol carrier proteins and then 
transferred to the basolateral membrane where it passes through the fetoplacental 
endothelium. The processes governing cholesterol efflux from the endothelial layer 
are poorly understood, although it has been shown that exogenous cholesterol is 
secreted into fetal circulation, through association with various transporters (Stefulj et 
al., 2009), where it is repackaged into fetal lipoproteins. This process is facilitated by 
microsomal triglyceride transfer protein (Mttp). The finding that the placenta expresses 
and secretes its own apolipoproteins such as ApoB (Madsen et al., 2004) also raises 
the possibility that cholesterol is repackaged into HDL, LDL and VLDL cholesterol 
within the placenta itself. 
In addition to its critical role in fetal growth and development, there is emerging 
evidence that alterations in placental cholesterol transfer capacity may also be a 
contributing factor to metabolic programming. In a previous study (Daniel et al., 
2016), we showed providing rats with a low protein diet until day 13 of gestation, a 
dietary treatment previously associated with programming of obesity, hypertension 
and glucose intolerance in adult offspring (Langley and Jackson, 1994, Erhuma et al., 
2007b), resulted in increased placental expression of a number of genes associated 
with cholesterol and lipoprotein transport and metabolism in the rat.  
Given the similarity in the metabolic phenotype induced by maternal 
obesity/nutritional excess and low protein diets, we hypothesised that programming of 
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health and disease is driven by perturbations of a small set of common ‘gatekeeper’ 
processes (Swali et al., 2011, McMullen et al., 2012) and changes in placental 
cholesterol transfer and metabolism may be common mechanisms underlying 
metabolic programming by different dietary exposures.  Therefore, the aim of this 
current study was to investigate the effect of a high maternal dietary omega-6:omega-
3 fatty acid ratio, associated with decreased placental weight (Draycott et al., 2019), 
against a lower ratio as well as total fat intake, on the expression of genes associated 
with cholesterol and lipoprotein transport, known to be affected by maternal diet, in 
the mature placenta of the rat. We also aimed to investigate whether placental 
expression of these same genes differed according to maternal body mass index (BMI) 
in a cohort of pregnant women. 
6.3 Materials and Methods 
6.3.1 Animal experiments and sample collection  
This paper reports data from the analysis of placentas that were collected as part of a 
previous study (Draycott et al., 2019). Virgin female Wistar rats (n = 24; 75-100 g; 
Charles River, UK) were housed on wood shavings in individually ventilated cages 
under a 12 h light/12 h dark cycle at a temperature of 20–22 °C and had ad libitum 
access to food and water throughout the experiment. Female rats were allowed to 
acclimatise to the unit for 1–2 weeks, during which time they were fed on standard 
laboratory chow (2018 Teklad Global 18% Protein Rodent Diet, Harlan Laboratories, 
UK). After acclimatisation, a tail vein blood sample was taken from each animal for 
the determination of fatty acid status. The rats were then randomly assigned to one of 
4 dietary groups designed to provide either a high (9:1, high LA) or low (1:1.5 low 
LA) ratio of linoleic acid (LA) to alpha-linolenic acid (ALA), achieved by altering the 
amounts of flaxseed and sunflower oil included in the fat component of the feed. The 
levels of saturated fatty acids (SFA) and monounsaturated fatty acids (MUFA) were 
comparable in all diets, achieved by adjusting the amounts of coconut (SFA source) 
and macadamia (MUFA source) oils in the diets. For each level of LA, diets containing 
either 18% or 36% fat by weight were developed. This resulted in four experimental 
diets; high LA (18% fat), high LA (36% fat), low LA (18% fat) and low LA (36% fat; 
n =5–7 per dietary group). The list of ingredients and final fatty acid composition of 
the four experimental diets have been published previously (Draycott et al., 2019). 
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All animal procedures were performed in accordance with the Animals (Scientific 
Procedures) Act 1986 under Home Office licence and were approved by the Animal 
Ethics Committee of the University of Nottingham, UK. Animals were pair housed 
from the start of the experiment until mating, after confirmation of conception animals 
were individually housed until completion of the experiment. Animals were 
maintained on their allocated diet for a four week ‘feed-in’ period after which they 
were mated. Conception was confirmed by the presence of a semen plug and this was 
recorded as day 0 of pregnancy. Female rats remained on their respective diets until 
day 20 of gestation (full term = 22 days) at which time rat dams were euthanised by 
CO2 asphyxiation and cervical dislocation and fetuses by cervical dislocation and 
exsanguination. All fetuses were weighed and sexed via measurement of anogenital 
distance. Placentas from male fetuses were collected for analysis and a tail sample 
from the fetus was collected for sex-genotyping by PCR for the SRY gene (McClive 
and Sinclair, 2001). Any samples found to be female or inconclusive (n = 5) were not 
included in placental gene expression analysis. Full details of maternal weight gain, 
food intake and the effect of the diets on fetal and placental weight are published 
elsewhere (Draycott et al., 2019). 
6.3.2 Human placental sample collection 
Ethical approval for the study was obtained from the Derbyshire Research Ethics 
Committee (Ref: 09/H0401/90). Placental samples were obtained from patients 
attending the Department of Obstetrics and Gynaecology, Royal Derby Hospital, 
Derby, UK. Patients provided informed, written consent prior to undergoing elective 
caesarean section at term gestation (>37 weeks), indications for which were maternal 
request, previous elective section or breech presentation while cases with diabetes, 
hypertension, pre-eclampsia were excluded. Placentae, once checked by the midwife 
and with the cord clamped, were transported to the lab within 20 minutes of delivery, 
where placental villous samples were taken midway between the cord insertion site 
and placental periphery and frozen at -80°C prior to extraction of RNA.  Participants 
were stratified based on a BMI measurement taken during an antenatal clinic 
appointment, resulting in 3 groups of women; BMI <25 kg/m2 (n=20), BMI 25-35 
kg/m2 (n=21) and BMI >35 kg/m2 (n=21). 
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6.3.3 Sample preparation and PCR 
RNA was isolated from 20-25mg of crushed snap-frozen human or rat placental tissue 
using the Roche High Pure Tissue kit (Roche Diagnostics Ltd., UK) according to 
manufacturer’s instructions. RNA concentration was determined using a Nanodrop 
2000 (Thermo Scientific) and RNA quality was evaluated by agarose gel 
electrophoresis. cDNA was synthesised using a RevertAid™ reverse transcriptase kit 
(Thermo Fisher Scientific, UK) with random hexamer primers. 
Gene targets were chosen based on our previous data (Daniel et al., 2016) where 
RNASeq analysis of day 13 rat placentas revealed differential expression of 91 genes 
in response to maternal protein restriction. Ingenuity pathway analysis identified 8 
pathways that were significantly affected (P<0.001), 6 of which were closely related 
functionally with a strong emphasis of cholesterol uptake and efflux across the 
placenta. Genes were selected based upon the ingenuity analysis (ApoA2, ApoB, 
ApoC2, Ttr, Fgg, serpin G1 and Rbp4). Additional genes were chosen that were shown 
to be differentially expressed in the protein restricted condition (Vil1, Gpc3, Prf1, 
Cubn, Mttp) but not associated with pathways identified by Ingenuity analysis. Tagln 
and Tbp gene targets were also chosen as preliminary RNASeq analysis suggested that 
they may be sensitive to maternal dietary factors, resulting in 14 target genes for 
analysis. Real-time PCR primers were designed using Primer Express software 
(version 1.5; Applied Biosystems) from the RNA sequence, checked using BLAST 
(National Centre for Biotechnology Information) and were purchased from Sigma 
(UK). The primer sequences can be found in Supplementary Table 6.4. Real-time PCR 
was performed on a LightCycler 480 (Roche, Burgess Hill, UK) using the 384 well 
format. Each reaction contained 5μl of cDNA with the following reagents: 7.5μl SYBR 
green master mix (Roche), 0.45μl forward and reverse primers (final concentration 
0.3μM each) and 1.6μl RNase-free H2O. Samples were pre-incubated at 95°C for 5 
min followed by 45 PCR amplification cycles (denaturation, 95°C for 10 seconds; 
annealing, 60°C for 15 seconds; elongation, 72°C for 15 seconds). Transcript 
abundance was determined using a standard curve generated from serial dilutions of a 
pool of cDNA made from all samples. Expression was normalised against the 




6.3.4 Statistical Analysis 
Data are presented as mean ± SEM. Data were analysed using the Statistical Package 
for Social Sciences (Version 24, SPSS Inc.). For animal data, the effect of maternal 
dietary fatty acid ratio and maternal dietary fat content on placental expression of 
target genes was assessed using a two-way ANOVA, with dietary fat level and 
LA:ALA ratio as factors. Human data were analysed using a one-way ANOVA with 
maternal BMI as a factor. Possible co-variates were identified and corrected for within 
the analysis. A value of P<0.05 was considered statistically significant.  
6.4 Results 
6.4.1 Rat placenta 
The results of the gene expression analyses in the rodent placentas are shown in Table 
6.1. Expression was measured for 13 genes (ApoB excluded), however, Tbp expression 
was not detectable in any of the samples (data not shown) and so could not be included 
in the analysis.  
Placental Mttp mRNA expression was significantly increased (3 fold; P<0.01) in dams 
consuming a high LA compared to a low LA diet, independent of total dietary fat 
content (Table 6.1). There was a significant interaction between the effects of maternal 
total dietary fat and LA content in relation to mRNA expression of ApoA2, ApoC2, 
Cubn, Fgg, Rbp4 and Ttr (P<0.05), such that expression of these genes was 
significantly increased in rats consuming the high LA diets, but only when dietary fat 
content was also high (36% fat w/w). The magnitude of this effect was greatest for 
Cubn (30-fold increase in the high LA (36% fat) group when compared to the low LA 
(36% fat) group). A similar pattern was observed for other key cholesterol-transport 
and metabolism genes in the placenta (Gpc3, P=0.072; Vil1, P=0.054), with 1.5-7 fold 
higher expression in placentas of dams exposed to a high LA diet, but only when 
dietary fat content was also high. Placental expression of Prf1, SerpinG1 and Tagln 
was not affected by either maternal dietary fatty acid ratio or fat content.  
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6.4.2 Human placenta 
The sociodemographic and clinical characteristics of the women who provided 
placental samples for this study are summarised in Table 6.2. The average age, parity 
and gestation length of women within this study were similar between women in the 
three BMI groups, however the birth weights of infants born to women with a BMI 
>25 kg/m2 were significantly greater than those of women in the normal BMI range. 
The results of the gene expression analyses in the human placentas are shown in Table 
6.3. All 14 genes were measured and detected in these samples. Women with a BMI 
in the 25-35 kg/m2 range (overweight to obese) exhibited a 2-6 fold higher mRNA 
expression of ApoB in their placental samples compared to women with a BMI either 
<25 or >35 kg/m2. The expression of Rbp4 was significantly lower in placentas 
obtained from women with a BMI >25 kg/m2 compared to those with a BMI <25 kg/m2 
(85% down-regulation, P=0.001). A similar pattern was also observed for Ttr, with 71-
88% down-regulation of expression in women with a BMI >25 kg/m2, although this 
was not statistically significant (P=0.053). The mRNA of other placental genes was 
not different between BMI groups. 
6.5 Discussion 
This experiment aimed to test the hypothesis that maternal diet, specifically, fatty acid 
composition and quantity, and obesity would influence the expression of genes 
associated with cholesterol uptake and transport in rat and human placenta. The results 
of the rat studies suggested clear effects of maternal dietary fat content and 
composition, such that maternal consumption of a higher-fat, high LA maternal diet 
was associated with increased expression of key genes associated with these pathways, 
suggesting enhanced cholesterol transport to the fetus in this group. In the human 
study, however, only two of these genes were differentially expressed in placentas 
from women in different BMI categories, suggesting that maternal obesity had a 
limited impact on placental cholesterol transport at the level of gene expression.  
Within this study, we have shown that exposure to a high LA, high-fat diet resulted in 
increased expression of genes involved in the formation of apolipoproteins, cholesterol 
uptake and cholesterol repackaging. These differences were not observed when either 
the fat content and/or the fatty acid ratio was altered, suggesting a strong interaction 
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between these variables. Importantly, the effects observed on the placental gene 
expression profiles show striking resemblances to our previous findings (Daniel et al., 
2016) where upregulation of these genes was observed in the placentas of dams 
exposed to a low protein diet. These data suggest that, not only do these differences 
persist to a late stage placenta (day 20), but, despite different dietary interventions, the 
similarities in results suggest a common mechanism of action. The upregulation of key 
genes in the rat placenta observed in this study suggests a state of increased cholesterol 
uptake and efflux. While the potential impacts of this in the current study are not clear, 
it has been demonstrated in previous studies that exposure to excess cholesterol during 
fetal development can be associated with adverse outcomes. In rodent models, 
maternal hypercholesterolemia has been associated with growth restriction (Bhasin et 
al., 2009), altered liver development  (El-Sayyad et al., 2014) and atherosclerosis  
(Napoli et al., 2002, Goharkhay et al., 2007). In humans, maternal 
hypercholesterolaemia has been associated with the development of fatty streaks in 
fetal arteries and cholestasis during pregnancy is associated with programming of an 
overweight, insulin resistant phenotype in the child (Papacleovoulou et al., 2013, 
Napoli et al., 1997). It will therefore be important in future studies to determine the 
longer term consequence of the changes in placental gene expression for the postnatal 
offspring.  
Based on the substantial impact of maternal high-fat high LA feeding, a dietary pattern 
commonly observed in the modern Western diet, we extended our study to determine 
if there was any evidence to suggest an effect of maternal obesity on cholesterol 
transfer in the human. There were, however, relatively few differences in the 
expression of key genes associated with different BMI categories in human placental 
samples, although there were some subtle differences in the expression of 3 genes 
(ApoB, Rbp4 and Ttr) between BMI categories. Ttr is a protein that binds to and 
transports Rbp4. In the bound state, Rbp4 is protected from glomerular filtration and 
so levels of these two proteins are often correlated. As such, the similar patterns of 
expression across these two genes observed in this study was anticipated. What was 
surprising, however, was our finding that women with a BMI above the normal range 
(>25 kg/m2, overweight or obese) exhibited decreased placental expression of these 
genes since elevated levels of circulating Rbp4 have been associated with many of the 
co-morbidities linked to obesity including hypertension (Solini et al., 2009), insulin 
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resistance and type 2 diabetes (Yang et al., 2005, Graham et al., 2006). It is important 
to note, however, that these observations have all been associated with circulating 
levels of Rbp4, whereas we measured gene expression in the placenta. There is limited 
literature evaluating the role of Rbp4 within the placenta during pregnancy, 
particularly in association with maternal obesity. It may be, however, that in obese 
mothers, placental expression is reduced to compensate for the increased maternal 
circulating levels and therefore avoiding fetal exposure to high quantities of Rbp4. 
Further experimentation is required to determine expression of Rbp4 and Ttr in both 
the mother, fetus and the placenta throughout pregnancy and their association with 
maternal obesity.  
Placental ApoB expression was increased in women whose BMI was above the normal 
range (>25 kg/m2). A study by Dube and colleagues (Dube et al., 2012), showed 
increased circulating ApoB concentrations in new-born infants of obese mothers, 
compared to mothers of normal weight, in the absence of any difference in maternal 
circulating concentrations. It is therefore possible that the high ApoB concentrations in 
infants of obese mothers may have been the result of increased placental ApoB 
expression. If this abnormal lipoprotein profile is present in the offspring and persists 
through childhood, it may contribute to increased risk of cardiovascular disease in later 
life. 
One key limitation of the current study is that direct measurements of cholesterol 
transport or measurement of the genes of interest at the level of protein were not 
analysed, and so care must be taken when extrapolating the findings to functional 
outcomes. Further to this, human participants within this study were stratified based 
on BMI whereas the animal experiments utilised specific dietary interventions. There 
are many factors that can affect BMI and, although nutrition is a key element, there is 
still a huge variety of nutritional habits that can lead to individuals resulting in similar 
BMIs. As such, assumptions cannot be made about specific nutrient intakes of the 
women based on these data. Finally, it is important to note that, whilst there are many 
similarities between placental physiology and function in the rat and humans, there are 
some key differences. Of particular importance to this study is the difference in 
circulating progesterone levels at the end of pregnancy. In rodents there is a dramatic 
decrease in circulating progesterone (Barkley et al., 1979), whereas in humans, 
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progesterone levels are increased or at least maintained at the time of parturition (Tal 
et al., 2000). Progesterone is a key steroid produced from cholesterol within the 
placenta and has been shown to regulate the expression of some genes including Rbp4 
in other tissues (Mullen et al., 2012). As such, careful consideration of the differences 
in placental hormone production, particularly steroid hormones, between the two 
species should be made when drawing comparisons.  
In conclusion, this study aimed to elucidate whether differences in placental expression 
of genes involved in cholesterol transport and efflux were associated with altered 
maternal nutrition in a manner similar to our previous observations in the low-protein 
model. We demonstrated that exposure to high levels of omega-6 as part of a high-fat 
diet elicited a similar pattern of placental gene expression, suggesting an increase in 
cholesterol transport across the placenta. This highlights the potential for a common 
mechanism by which sub-optimal maternal nutrition during pregnancy alters placental 
function, and potentially fetal development, resulting in increased risk of disease in 
later life. We then carried out a preliminary study which aimed to establish if similar 
alterations were observed in human placentas. Although BMI was associated with 
some changes in expression, these observations were not consistent and further 
experimentation is required on placental samples where the specific nutrient intake of 






Table 6.1 Rat placental gene expression at day 20 gestation 
* Indicates a significant interaction effect of maternal dietary LA:ALA ratio and total 
dietary fat content on placental gene expression (P<0.05). Different superscript 
indicate significant differences between groups (P<0.01).  








ApoA2* 0.75 ± 0.24 3.24 ± 1.13 0.52 ± 0.08 0.33 ± 0.20 
ApoC2* 0.72 ± 0.27 2.91 ± 1.00 0.56 ± 0.08 0.34 ± 0.21 
Cubn* 0.81 ± 0.35 2.92 ± 1.15 0.35 ± 0.06 0.10 ± 0.04 
Fgg* 0.76 ± 0.30 2.97 ± 1.09 0.36 ± 0.06 0.12 ± 0.05 
Gpc3 0.96 ± 0.28 1.46 ± 0.43 0.56 ± 0.09 0.50 ± 0.09 
Mttp 0.66 ± 0.25a 2.12 ± 0.77a 0.28 ± 0.05b 0.22 ± 0.09b 
Prf1 1.65 ± 0.42 0.73 ± 0.14 1.17 ± 0.12 1.15 ± 0.31 
Rbp4* 0.69 ± 0.29 2.34 ± 1.17 0.48 ± 0.12 0.13 ± 0.05 
SerpinG1 1.03 ± 0.26 1.00 ± 0.13 0.84 ± 0.21 1.20 ± 0.33 
Tagln 0.95 ± 0.13 0.87 ± 0.06 0.67 ± 0.04 1.09 ± 0.17 
Ttr* 0.65 ± 0.22 2.43 ± 0.81 0.52 ± 0.08 0.32 ± 0.17 
Vil1 1.23 ± 0.42 2.67 ± 0.97 0.51 ± 0.10 0.54 ± 0.22 
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Table 6.2 Human participant characteristics 
Data are shown as mean ± SEM for N observations per group. *ANOVA indicated 
that, with adjustment for gestational age, birthweight was influenced by maternal BMI 
(P=0.021).  
BMI (kg/m2) <25  25-35  >35  
Age (years) 34.29 ± 1.28 33.55 ± 1.07 31.25 ± 1.04 
BMI 21.88 ± 0.36 29.70 ± 0.70 40.10 ± 1.07 
Parity 1.05 ± 0.11 0.75 ± 0.14 1.20 ± 0.19 
Gestation length (weeks) 38.63 ± 0.23 38.68 ± 0.18 38.65 ± 0.20 
Birthweight (g)* 3236 ± 88 3537 ± 112 3565 ± 108 
Sex (% male) 45 45 65 
N 21 20 20 
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Table 6.3 Human placental gene expression 
* Indicates a significant effect of maternal BMI on placental gene expression 
(**P<0.01). 
 
BMI (kg/m2) BMI <25 BMI 25-35 BMI >35 
ApoA2 1.04 ± 0.21 1.22 ± 0.27 0.53 ± 0.06 
ApoB** 0.34 ± 0.06 2.19 ± 0.55 1.04 ± 0.25 
ApoC2 0.90 ± 0.15 1.02 ± 0.25 0.76 ± 0.13 
Cubn 1.22 ± 0.21 1.15 ± 0.15 0.86 ± 0.09 
Fgg 0.48 ± 0.14 0.82 ± 0.41 0.65 ± 0.42 
Gpc3 0.97 ± 0.20 1.30 ± 0.20 0.83 ± 0.19 
Mttp 0.57 ± 0.08 1.23 ± 0.37 0.42 ± 0.08 
Prf1 1.14 ± 0.19 0.85 ± 0.10 1.03 ± 0.17 
Rbp4** 0.50 ± 0.13 0.07 ± 0.01 0.08 ± 0.01 
SerpinG1 1.45 ± 0.24 0.90 ± 0.07 0.90 ± 0.11 
Tagln 0.97 ± 0.11 1.04 ± 0.10 1.11 ± 0.10 
Tbp 1.02 ± 0.11 1.16 ± 0.11 1.00 ± 0.07 
Ttr 1.92 ± 0.90 0.23 ± 0.08 0.56 ± 0.20 
Vil1 1.14 ± 0.20 1.82 ± 0.33 1.01 ± 0.18 
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Supplementary Table 6.4 Primer sequences used for the determination of gene expression by RT-qPCR 
Forward (FWD) and reverse (REV) primer sequences designed using Primer Express software (version 1.5; Applied Biosystems) 
Target Genes  Rat Human 






















































































7 GENERAL DISCUSSION 
As discussed in Chapter 1, the well-established phenomenon that changes in the 
maternal diet can have a lasting impact on the offspring has resulted in the 
investigation into the role of a wide range of dietary insults (caloric restriction, low 
protein diets, cafeteria diets, high-fat diets) on offspring disease risk in later life. 
Animal models have been critical in establishing biological feasibility of the DOHaD 
hypothesis due to the ability to precisely control dietary intakes in experimental animal 
studies in a way that is not possible in human trials, and also offer the means to 
investigate mechanistic drivers. The reproducibility of common offspring phenotypes 
associated with the MetS, as a result of a wide variety of nutritional insults during early 
development, provides a strong evidence base to support the role of these dietary 
influences in early-life programming of metabolic disturbance. It also alludes to the 
potential of a common underlying mechanism linking different maternal dietary 
perturbations to increased lifelong risk of obesity and metabolic disease in the 
offspring (McMullen et al., 2012).  
Increases in the intake of LA in Western populations has been documented in several 
large scale studies (Blasbalg et al., 2011, Ailhaud et al., 2006) and has coincided with 
large increases in the prevalence of obesity (WHO, 2017a). As such, the number of 
women of reproductive age who are consuming a high omega-6:omega-3 ratio, in the 
context of an obesogenic dietary pattern, has increased drastically over the last 60 years 
and this coincides with increases in the levels of LA in breast milk (Ailhaud et al., 
2006). The pro-inflammatory and pro-adipogenic effects of omega-6 fatty acids and 
their eicosanoid derivatives have been characterized through in vitro and experimental 
animal studies (Massiera et al., 2003, Massiera et al., 2010). This has led to the 
hypothesis that increased consumption of omega-6 PUFA, relative to omega-3 PUFA, 
in many Western countries, including the UK, Australia and the US, is contributing to 
the intergenerational cycle of obesity and prevalence of inflammatory conditions 
including diabetes as CVD.  
Observational studies in humans and experimental animal studies that have attempted 
to elucidate the role of high omega-6 intakes during pregnancy on the offspring 
provide some evidence to suggest that this dietary pattern is associated with negative 
effects on the metabolic health of the progeny (Massiera et al., 2010, Korotkova et al., 
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2002, Much et al., 2013). However, the number of studies investigating the effect of 
altering the maternal omega-6:omega-3 ratio on offspring body composition has been 
limited. Animal studies specifically investigating the impact of increased maternal 
dietary omega-3 intake on offspring adiposity, however, have produced conflicting 
results, with some studies reporting decreased (Massiera et al., 2003, Wyrwoll et al., 
2006, Donahue et al., 2011) and others reporting increased (Muhlhausler et al., 2011b) 
offspring fat mass. 
The lack of studies in this area and inconsistencies between study designs (including 
dose and timing of dietary interventions) and reported outcomes has been highlighted 
as a key issue for drawing clear conclusions regarding the potential role of omega-3 
and omega-6 PUFA, and the ratio between them, in cardiometabolic programming 
(Muhlhausler et al., 2011a). One of the key limitations of most existing animal studies 
in this area is the use of diets with much higher omega-6:omega-3 PUFA (>200:1; 
Korotkova et al. (2002)) than that encountered in typical human diets. These diets are 
often also fed in the context of a low overall fat content (~5% energy), owing to the 
composition of most commercially available rodent diets, making translation of 
findings to humans difficult. In addition, in most studies, offspring continued to have 
access to the same diet as their mother after weaning, so that any effects observed 
cannot be clearly attributed to dietary fatty acid exposure during the gestation and 
lactation periods (Muhlhausler et al., 2011b, Ibrahim et al., 2009, Muhlhausler et al., 
2011a). Finally, no studies prior to this thesis had examined the effects of an increased 
maternal omega-6:omega-3 ratio on maternal, placental and fetal outcomes before 
birth. The central aim of this thesis, therefore, was to investigate the role of the omega-
6:omega-3 ratio in the maternal diet on offspring health outcomes (such as growth, fat 
deposition, tissue composition and blood pressure) taking into consideration these 
limitations and addressing the identified gaps in knowledge.  
A key feature of the work described in this thesis was that the diets designed for the 
experiments were novel and overcame many of the limitations of diets used in previous 
studies as they were designed to reflect current intakes and recommendations typical 
of human diets. The LA:ALA ratio of 9:1 was comparable with current estimations of 
population intakes in the US (Blasbalg et al., 2011) and the ratio of 1:1.5 was selected 
to represent an ‘ideal’ ratio and was based on maximal conversion of precursor fatty 
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acids to biologically active long-chain derivatives (Gibson et al., 2011, Lands, 2000, 
Gibson et al., 2013). The total fat, as well as the composition of SFA, MUFA and total 
PUFA in the 18% fat w/w diets, was in line with recommended intakes for a healthy 
diet (FAO and WHO, 2008) and the high-fat diet used in the experiments represented 
a doubling of this amount, which is more consistent with the higher fat diets in the 
human context than semi-synthetic high-fat rodent diets.  
Taken together the results from maternal whole blood fatty acid analysis in 
experimental Chapters 3 and 4 confirmed that manipulation of the fatty acid 
composition of the diet was reflected in the circulating fatty acid profile of the dams. 
Consistent with previous studies (Tu et al., 2010, Blank et al., 2002, Brenna et al., 
2009), we demonstrated that lowering the LA:ALA ratio was not sufficient to produce 
sustained increases in DHA synthesis at either levels of total PUFA tested. A possible 
reason for this was that the amount of ALA in the low LA:ALA ratio groups (5-9%en) 
was sufficient to saturate the Δ6-desaturase enzyme that is utilised for both the 
conversion of ALA to EPA and DPA to DHA (Figure 1.5). In support of this, the level 
was notably higher than ALA levels in a number of previous studies that had achieved 
increases in DHA synthesis (Tu et al., 2010, Gibson et al., 2013, Gibson et al., 2011) 
where increases in DHA production were only observed when ALA was <2% energy. 
This adds to the hypothesis that, despite achieving a low LA:ALA ratio in the diet, the 
conversion of ALA to DHA is inhibited when total ALA (%en) is high (Chan et al., 
1993, Mantzioris et al., 1994, Cleland et al., 1992). Despite a maintained increase in 
the production of EPA in response to a low LA:ALA ratio in these studies, the inability 
of the diets to increase levels of DHA may help to explain some of the findings as 
DHA has been shown to be central to many of the beneficial effects observed with 
respect to omega-3 fatty acids. In future experiments, diets would be designed with the 
aim to maintain a low LA:ALA ratio, but also to ensure that the overall ALA (% 
energy) was low.  
The finding that diets containing 36% w/w fat did not lead to increases in bodyweight 
and fat mass in the dams was surprising and may be cause for criticism as to whether 
these studies are representative of the human population, where consumption of a high-
fat diet is often coupled with obesity. However, since maternal obesity has been shown 
to exert effects independent of the maternal diet (White et al., 2009), the animal model 
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in this thesis provides an opportunity to examine the effects of dietary manipulation 
independent of the effects associated with maternal obesity. Therefore, it was possible 
investigate hypotheses under the assumption that any observed responses were results 
of the specific changes in dietary composition applied, rather than mediated via the 
effects on maternal bodyweight and metabolism.  
Whilst establishing the maternal state in response to the dietary interventions was 
important due to the novelty of the formulated diets, assessing the fetal and offspring 
response was the primary aim of this research. Taken together, the results of Chapters 
3 and 6 characterised the fetal and placental response to in utero exposure to the 
experimental diets. To our knowledge this was the first time that the effects of an 
increased LA:ALA ratio on offspring outcomes before birth had been investigated. 
When taken in the context of the complete works of this thesis, it appears that the 
increased fetal weight in response to exposure to a low LA:ALA ratio in utero was 
transient, and that the total fat content of the diet is a much more potent influencer of 
postnatal growth than the changes in dietary fatty acid ratio investigated in this thesis.  
This growth restriction of offspring exposed to a high-fat diet was prevalent at all post-
natal life stages and a novel finding of this research. The majority of existing studies 
reporting decreases in offspring weight in response to a maternal high-fat diet in 
rodents, utilise diets predominantly rich in SFA which are successful in producing 
animal models of maternal obesity. What we have shown here is that maternal diets in 
which SFA is not the predominant fat source, which are a recommendation of UK and 
Australian governments, still elicit unfavourable outcomes in the offspring that are 
independent of any maternal weight gain. This is important and could potentially 
impact on recommendations to expectant mothers around reducing the quantity of fat 
within their diet even if it has not had any unfavourable phenotypic effects on the 
individuals themselves.  
It is important to note that, before any extrapolations of this research can be made to 
human populations, comparable studies must first be undertaken in a human cohort. A 
potential limitation of this study is that reductions in offspring weight in response to a 
high-fat diet is not a typical feature of human pregnancies. In fact, and as was shown 
in experimental Chapter 6, exposure to a high-fat diet during gestation and lactation 
often, but not always (Knudsen et al., 2008), leads to increased offspring weight in 
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human studies. The observational nature and limitations associated with human studies 
have resulted in very few, if any, studies that have reliably separated the effects of 
high-fat diets with maternal obesity. Further to this, accurate information on dietary 
intakes is difficult to collect and assess. As such, the translation of findings between 
animal and human studies is difficult.  
It is notable that studies focussed on metabolic programming have indicated that the 
same phenotypes, including hypertension, insulin resistance and/or obesity can be 
produced by a range of different nutritional insults, raising the possibility of a common 
underlying mechanism. In addition, these phenotypes can be observed in the adult 
offspring independent of whether the nutritional treatment results in changes in 
offspring birthweight. In this thesis, as in most pre-clinical studies in the programming 
field, the measured endpoints (fat mass, blood pressure etc.) are important indicators 
of an altered metabolic phenotype but cannot alone indicate whether these changes 
manifest into a disease state in later life. As such, another limitation of this research 
was the short duration of the experiment and lack of establishment of an overt 
phenotype in the offspring. We measured indicators of obesity and hypertension in the 
offspring, however, in human populations these phenotypes, particularly hypertension, 
do not often develop until later life. At 8 weeks of age, the oldest offspring in these 
experiments were equivalent in development to a human teenager. Therefore, in future, 
these hypotheses should be tested in offspring preferably up to 24 months in age to be 
able to confidently determine whether a disease state would be established as the 
animals age.  
Whilst maternal dietary fat content was clearly a key determinant of offspring post-
natal growth, an altered maternal dietary LA:ALA ratio appeared to have some 
transient effects on offspring liver weight, hepatic and adipose tissue lipogenesis as 
well as more long-lasting effects on circulating fatty acid profiles. Many of these 
observed differences, however, were no longer apparent at 8 weeks of age suggesting 
that the maternal dietary influence was only capable of exerting a transient effect on 
all variables measured besides post-natal growth. Whether the prolonged effect of 
maternal diet on offspring growth, or indeed the transient effects of fat deposition, 
lipogenesis and liver composition, have repercussions later in life remains to be 
established. In addition, and despite evidence of the potential effects of increased 
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omega-3 consumption for weight loss in adult populations, this research established 
no lasting benefit to decreasing the maternal LA:ALA ratio on offspring adiposity. It 
was in fact the low LA, low fat diet that resulted in increased fat mass in the offspring. 
This was consistent with another animal study investigating the effect of maternal 
DHA supplementation that reported increased fat mass in the offspring (Muhlhausler 
et al., 2011b). Further to this, recent studies investigating the effects of maternal 
omega-3 supplementation in human populations, have mostly reported no association 
between maternal omega-3 intake and early-life adiposity (Li et al., 2018, Vahdaninia 
et al., 2018). Studies in human populations currently only have the scope to investigate 
early life indicators of adiposity and later disease risk. As such, whilst there appears to 
be little advantage to increasing the omega-3 status of pregnant women with respect 
to offspring risk of obesity and disease at this current time, long-term follow-up of 
these human cohorts already exposed to alterations in maternal dietary fatty acid 
composition is key to establishing whether this dietary pattern has any associations 
with disease in later life. However, the results of this thesis, as well as other studies 
(Muhlhausler et al., 2011b), suggest this is unlikely to be true.  
That many of the observations at 4 weeks of age, such as changes in lipogenic capacity 
and offspring adiposity, were seemingly ‘corrected’ for by 8 weeks of age may result 
in them being regarded as inconsequential. However, other long-term studies 
investigating maternal dietary insults, such as the well-established low-protein model, 
have demonstrated that early transient alterations in tissue structure and function, 
particularly alterations in the expression of lipogenic genes, can be greatly exacerbated 
in later life and have been shown to be associated with hepatic steatosis in adult rats  
(Erhuma et al., 2007b). This further reiterates the importance of long-term follow-up 
studies to test this hypothesis in the context of this research, as well as in the larger 
perspective of the field. It is important to note that throughout this research many 
similarities have been drawn to other maternal dietary insults, but particularly to a low 
protein maternal diet. To assume that the results of this thesis are solely attributable to 
the total PUFA content and fatty acid composition of the maternal diet may be naïve. 
As demonstrated by Chapter 3, and particularly 4, alteration in the fat content of the 
maternal diet led to alterations in the protein intake of dams. Although not measured 
in this study, this could have resulted in reduced fetal exposure to protein as well as 
changes in milk composition which could have contributed to the observed differences. 
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Formulating a diet that only changes a single nutrient component is near impossible 
and, although useful for examining specific responses, is not representative of normal 
situations. As such, interpretation of the results of nutritional intervention studies 
should be open minded as changes in one dietary variable will inevitably affect 
another.  
The extrapolation of rodent data to human cohorts should be carefully considered and 
the conclusions drawn from the data presented in this thesis may not be true of human 
populations. However, a significant advantage of utilising an animal model is the 
ability to investigate the potential mechanisms underlying the observed outcomes. The 
uniformity of outcomes and considerable conservation of many metabolic processes 
across mammals suggests that the mechanisms underlying the DOHaD hypothesis 
would be similar between species. Epigenetic modifications of the fetal genome have 
been well explored whilst the role of the placenta in fetal programming has been 
somewhat overlooked. Experimental Chapter 6 highlighted that placental function was 
sensitive to changes in the maternal diet and adds weight to the concept that 
dysregulation of nutrient transfer across the placenta may be contributing to fetal 
programming and long-term health. Human placentas were also examined in an 
attempt to examine comparability between animal and human studies. Limitations in 
the retrospective data available from the human participants, however, made 
comparisons difficult. Despite this, Chapter 6 did highlight that changes in the 
maternal diet, as inferred from differences in maternal BMI, is associated with altered 
transcriptome in the human placenta which may lead to altered fetal development and 
increased disease risk in later life.  
In conclusion, previous data supporting the beneficial effects of omega-3 fatty acids 
on adipocytes have largely been based on in vitro studies and have used mature, as 
opposed to developing, adipocytes (Couet et al., 1997, Hill et al., 2007, Ruzickova et 
al., 2004). These, as well as studies in animals and humans, often focus on omega-3 
dietary supplementation rather than trying to improve the omega-3 status by reducing 
the amount of omega-6 in the diet (Middleton et al., 2018, Wood et al., 2018, Meyer 
et al., 2019, Hauner et al., 2009). As such, the findings of this thesis demonstrated for 
the first time that improving the omega-3 status of offspring, through manipulation of 
the LA:ALA ratio in the mother, had no lasting beneficial effect on offspring adiposity 
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in the time-frame of this research. However, whether early-life alterations in tissue 
function and structure elicit long-term consequences for individuals remains to be 
established and should be a focus of future studies. Further to this we have identified 
that a maternal high-fat diet, where saturated fats were not the predominant fat source, 
leads to restricted offspring growth throughout early life which may impact upon 
disease risk in later life. Finally, the mechanistic investigations provide a platform for 
further examination of the placenta and the processes within it that may lead to the 
identification of potential biomarkers that indicate nutritional programming of disease. 
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Harlan Laboratories 
 
Teklad Global 18% Protein Rodent Diet 
 
Product Description- 2018 is a fixed formula, non-autoclavable diet 
manufactured with high quality ingredients and designed to support 
gestation, lactation, and growth of rodents. 2018 does not contain alfalfa, 
thus lowering the occurrence of natural phytoestrogens. Typical isoflavone 
concentrations (daidzein + genistein aglycone equivalents) range from 150 
to 250 mg/kg. Exclusion of alfalfa reduces chlorophyll, improving optical 
imaging clarity. Absence of animal protein and fish meal minimizes the 
presence of nitrosamines. Also available certified (2018C) and 
irradiated (2918). For autoclavable diet, refer to 2018S (Sterilizable) or 
2018SX (Extruded & Sterilizable). 
Ingredients (in descending order of inclusion)- Ground wheat, ground corn, 
wheat middlings, dehulled soybean meal, corn gluten meal, soybean oil, 
calcium carbonate, dicalcium phosphate, brewers dried yeast, iodized salt, L- 
lysine, DL-methionine, choline chloride, kaolin, magnesium oxide, vitamin E 
acetate, menadione sodium bisulfite complex (source of vitamin K activity), 
manganous oxide, ferrous sulfate, zinc oxide, niacin, calcium pantothenate, 
copper sulfate, pyridoxine hydrochloride, riboflavin, thiamin mononitrate, 
vitamin A acetate, calcium iodate, vitamin B12 supplement, folic acid, biotin, 
vitamin D3 supplement, cobalt carbonate. 
 




 Crude Protein % 18.6 Vitamin A e, f IU/g 15.0 
Fat (ether extract) 
a 
% 6.2 Vitamin D e, g IU/g 1.5 
Carbohydrate (available) b % 44.2  Vitamin E  IU/kg 110 
Crude Fiber %  3.5 Vitamin K3 (menadione) mg/kg  50 
Neutral Detergent Fiber 
c 
% 14.7 Vitamin B  (thiamin) mg/kg 17 
Ash % 5.3 Vitamin B2 (riboflavin) mg/kg 15 
Energy Density d kcal/g (kJ/g) 3.1 (13.0)  Niacin (nicotinic acid) mg/kg 70 
Calories from Protein  %  24 Vitamin B6 (pyridoxine) mg/kg 18 
Calories from Fat % 18 Pantothenic Acid mg/kg 33 
Calories from Carbohydrate % 58  Vitamin B12 (cyanocobalamin) mg/kg 0.08 
Biotin mg/kg 0.40 
Calcium % 1.0 Folate mg/kg 4 
Phosphorus % 0.7 Choline mg/kg 1200 
Non-Phytate Phosphorus % 0.4 
Sodium % 0.2 C16:0 Palmitic % 0.7 
Potassium % 0.6 C18:0 Stearic % 0.2 
Chloride % 0.4 C18:1ω9 Oleic % 1.2 
Magnesium % 0.2 C18:2ω6 Linoleic % 3.1 
Zinc mg/kg 70 C18:3ω3 Linolenic % 0.3 
Manganese mg/kg 100 Total Saturated % 0.9 
Copper mg/kg 15 Total Monounsaturated % 1.3 
Iodine mg/kg 6 Total Polyunsaturated % 3.4 
Iron mg/kg 200 
Selenium mg/kg 0.23 Cholesterol mg/kg -- 
 
 
Aspartic Acid % 1.4 
 
Glutamic Acid % 3.4 
 
 Alanine % 1.1 
 Glycine % 0.8 
Threonine % 0.7 
 
 Proline % 1.6 
 Serine % 1.1 
 Leucine % 1.8 
 Isoleucine % 0.8 
 Valine % 0.9 
 Phenylalanine % 1.0 
Tyrosine % 0.6 
 
 Methionine % 0.4 






a Ether extract is used to measure fat in pelleted diets, while an acid hydrolysis 
method is required to recover fat in extruded diets. Compared to ether   
extract, the fat value for acid hydrolysis will be approximately 1% point higher. 
 
b Carbohydrate (available) is calculated by subtracting neutral detergent fiber 
from total carbohydrates. 
c Neutral detergent fiber is an estimate of insoluble fiber, including cellulose, 
hemicellulose, and lignin. Crude fiber methodology underestimates total fiber. 
d Energy density is a calculated estimate of metabolizable energy based on the 
Atwater factors assigning 4 kcal/g to protein, 9 kcal/g to fat, and 4 kcal/g to 
available carbohydrate. 
 
e Indicates added amount but does not account for contribution from other 
ingredients. 
 Lysine % 0.9 f 1 IU vitamin A = 0.3 µg retinol 
 Histidine % 0.4 g 1 IU vitamin D = 25 ng cholecalciferol 
Arginine % 1.0 For nutrients not listed, insufficient data is available to quantify. 
 
 Tryptophan % 0.2 Nutrient data represent the best information available, calculated from 
published values and direct analytical testing of raw materials and finished 
product. Nutrient values may vary due to the natural variations in the 
ingredients, analysis, and effects of processing. 
Teklad Diets are designed and manufactured for research 
purposes only. 
Harlan, Harlan Laboratories, Helping you do research better, 
and the Harlan logo are trademarks and trade names of Harlan 
Laboratories, Inc. © 2008 Harlan Laboratories, Inc. 
 








Appendix B  
Fatty acid composition of Tecklad Global 18% Protein Rodent Diet (Harlan 
Laboratories) 
















Total MUFA 20.9 
18:3n-3 (LA) 6.0 
18:2n-6 (ALA) 52.7 
Total PUFA 58.7 
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Omega-6 fatty acids have been shown to exert pro-adipogenic effects whereas omega-3 fatty 
acids work in opposition. Increasing intakes of LA (linoleic acid; omega-6) vs ALA (alpha-
linolenic acid; omega-3) in Western diets has led to the hypothesis that consumption of this 
diet during pregnancy may be contributing to adverse offspring health. This study 
investigated the effects of feeding a maternal dietary LA:ALA ratio similar to that of the 
Western diet (9:1) compared to a proposed ‘ideal’ ratio (~1:1.5), at two total fat levels (18% 
vs 36% fat w/w), on growth and lipogenic gene expression in the offspring. Female Wistar 
rats were assigned to one of the four experimental groups throughout gestation and lactation. 
Offspring were culled at 1 and 2 weeks of age for sample collection. Offspring of dams 
consuming a -36% fat diet were ~20% lighter than those exposed to a 18% fat diet (P<0.001). 
Male, but not female, liver weight at 1 week was ~13% heavier, and had increased glycogen 
(P<0.05), in offspring exposed to high LA (P<0.01). Hepatic expression of lipogenic genes 
suggested an increase in lipogenesis in male offspring exposed to a 36% fat maternal diet and 
in female offspring exposed to a low LA diet, via increases in the expression of Fasn and 
Srebf1. Sexually dimorphic responses to altered maternal diet appeared to persist until two 
weeks-of-age. In conclusion, whilst maternal total fat content predominantly affected 
offspring growth, fatty acid ratio and total fat content had sexually dimorphic effects on 
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Accumulating evidence suggests that the nutritional environment experienced by an 
individual during fetal and early infant development has long-lasting impacts on their 
metabolic health 
(1)
. In the context of the global epidemic of obesity and nutritional excess, 
there has been considerable interest in determining the effects of maternal overnutrition on 
the metabolic health of the offspring. The majority of these studies have utilised animal 
models and have consistently reported that maternal high-fat feeding during pregnancy has 
detrimental effects on the metabolic health of both the mother and her offspring 
(2,3)
. As a 
result, excess maternal fat consumption has been implicated as a key contributor to metabolic 
programming of long-term health and disease risk.  
There is increasing evidence, however, that the impact of a high-fat diet on the metabolic 
health of the offspring depends not only on the amount of fat in the diet, but also on the fatty 
acid composition 
(4,5)
. There has been particular interest in the role of two classes of 
polyunsaturated fatty acids (PUFA), due to the substantive increase in the amounts of omega-
6 PUFA, predominately linoleic acid (LA), being consumed in the diets of many Western 
countries over the past few decades 
(6,7)
. This increase in the intake of LA has not been 
accompanied by substantial changes in the consumption of omega-3 PUFA such as alpha-
linolenic acid (ALA) and has therefore resulted in increases in the ratio of omega-6:omega-3 
PUFA consumed in the diets of many Western countries 
(6,8)
.  
The increasing dominance of omega-6 over omega-3 PUFA in modern Western diets has 
considerable biological significance, since the omega-6 and omega-3 fatty acid families 
utilise the same enzymes for production of longer chain bioactive derivatives such as 
arachidonic acid (AA; omega-6), eicosapentaenoic acid (EPA; omega-3), docosapentaenoic 
acid (DPA; omega-3) and docosahexaenoic acid (DHA; omega-3), and also compete for 
incorporation into cell membranes. As a result, excess consumption of LA leads to a decrease 
in the production and incorporation of omega-3 fatty acids through simple substrate 
competition, and this effect is exacerbated when total dietary PUFA is high 
(9,10)
. The omega-
3 and omega-6 long-chain polyunsaturated fatty acids (LCPUFA) derivatives also have 
opposing physiological actions, with those from the omega-3 family predominately 
exhibiting anti-inflammatory properties (for example via the suppression of the pro-
inflammatory transcription factor nuclear factor kappa B and activation of the anti-
inflammatory transcription factor peroxisome proliferator activated receptor γ 
(11)
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from the omega-6 family exhibiting more pro-inflammatory and pro-adipogenic properties 
(12)
. This has led to the hypothesis that the increasing ratio of omega-6 to omega-3 fatty acids 
in modern Western diets may have negative effects on conditions characterised by low-grade 
inflammation, including obesity and the metabolic syndrome, and may potentially be 
contributing to an intergenerational cycle of obesity 
(8)
.  
Data from observational studies in humans and animal models provide supporting evidence 
that suggests high intakes of omega-6 PUFA during pregnancy could have negative effects on 
metabolic health of the progeny 
(13,14,15)
. However, the results of these studies have not been 
consistent. The results of pre-clinical studies are also limited by the use of diets with much 
higher omega-6:omega-3 PUFA ratios and/or absolute PUFA contents than those encountered 
in typical human diets. Furthermore, offspring often continue to have access to the same diet 
as their mother so that any effects observed cannot be clearly attributed to dietary fatty acid 
exposure during the gestation and lactation periods 
(16,17,18)
.  The aim of this study, therefore, 
was to investigate the effects of feeding a maternal dietary LA:ALA ratio similar to that of 
the Western diet (9:1) 
(6)
, compared to a proposed ‘ideal’ ratio of 1:1.5 
(19,20)
 on growth and 
lipogenic gene expression in the offspring. Since total dietary PUFA intake also influences 
PUFA metabolism 
(9,10)
, we also investigated the effect of feeding each dietary fat ratio at 
either 18% fat w/w (in line with dietary recommendations 
(21)
) or at a higher fat level of 36% 
fat w/w. A rat model was utilised to achieve the study objectives by allowing for tight control 
of dietary manipulation as well as invasive end points. 
 
Materials and Methods 
Animals 
All animal procedures were performed in accordance with the Animals (Scientific 
Procedures) Act 1986 under Home Office licence and were approved by the Animal Ethics 
Committee of the University of Nottingham, UK. Virgin female Wistar rats (n=30; 75-100g; 
Charles River, UK) were housed on wood shavings in individually ventilated cages under a 
12 hour light/12 hour dark cycle at a temperature of 20-22°C and had ad libitum access to 
food and water throughout the experiment. Female rats were allowed to acclimatise to the 
unit for 1-2 weeks, during which time they were fed standard laboratory chow (2018 Teklad 
Global 18% Protein Rodent Diet, Harlan Laboratories, UK). After acclimatisation, a tail vein 
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were then randomly assigned to one of 4 dietary groups (details provided below). Animals 
were maintained on their allocated diet for a four week ‘pre-feeding’ period, after which they 
were mated. Conception was confirmed by the presence of a semen plug and this was 
recorded as day 0 of pregnancy. Animals were housed in individual cages and remained on 
their respective diets throughout pregnancy and lactation.  
 
Litters were standardised to 8 pups within 24 hours of birth (4 males and 4 females, where 
possible). At 1 and 2 weeks of age, one randomly selected male and one randomly selected 
female from each litter were culled via cervical dislocation and exsanguination for blood and 
tissue collection. At 3 weeks of age, the remaining offspring were weaned and dams were 
then euthanised by CO2 asphyxiation and cervical dislocation for collection of maternal blood 
and tissues. All dams were weighed and had feed intake measured daily throughout the 
experiment and offspring bodyweight was measured weekly.  
 
Diets 
Diets were designed to provide either a high (9:1, high LA) or low (1:1.5, low LA) ratio of 
LA (cis/cis isomer) to ALA, achieved by altering the amounts of flaxseed and sunflower oil 
included in the fat component of the feed. The levels of saturated and monounsaturated fatty 
acids were comparable in all diets, achieved by adjusting the amounts of coconut (saturated 
fat source) and macadamia (monounsaturated fat source) oils in the diets. For each level of 
LA, diets were developed to contain either 18% fat (w/w), in line with government 
recommendations 
(21)
, or 36% fat (w/w) to highlight any additive effects (38.6 vs 63.5% of 
dietary energy respectively). This resulted in four experimental diets (n=6-9 per dietary 
group); high LA (18% fat), high LA (36% fat), low LA (18% fat) and low LA (36% fat). The 





Blood sample and tissue collection 
Blood samples were collected from dams prior to the start of the experiment and after the 4 
week ‘feed-in’ period (tail vein sample) and at the end of lactation (via cardiac puncture 
following CO2 asphyxiation and cervical dislocation). Truncal blood samples were also 
collected from one randomly selected male and one randomly selected female at 1 and 2 
weeks of age. In all cases, samples of whole blood (~30µl) from non-fasted animals were 
spotted onto PUFAcoat™ dried blood spot (DBS) collection paper 
(22)
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room temperature and stored at -20°C for subsequent fatty acid analysis. Maternal tissues 
were weighed and samples of whole liver, retroperitoneal and gonadal adipose tissues 
collected. Offspring body and organ weights were measured and whole liver samples were 
collected from one randomly selected male and female pup at both time points. At 2 weeks of 
age, samples of gonadal and retroperitoneal fat were also collected from one male and one 
female pup per litter. All tissue samples were snap-frozen in liquid nitrogen and stored at -
80°C until determination of gene expression by quantitative reverse transcriptase PCR (qRT-
PCR). 
 
Fatty acid methylation and analysis 
Fatty acid composition in maternal and fetal blood was determined as previously described 
(22)
. Briefly, whole DBS samples were directly transesterified with 2ml of 1% H2SO4 in 
methanol and the fatty acid methyl esters (FAME) were extracted with heptane. Samples 
were separated and analysed by a Hewlett-Packard 6890 gas chromatograph (GC) equipped 
with a capillary column (30m x 0.25mm) coated with 70% cyanopropyl polysilphenylene-
siloxane (BPX-70; 0.25µm film thickness) which was fitted with a flame ionization detector 
(FID). FAMEs were identified in unknown samples based on the comparison of retention 
times with an external lipid standard (Standard 463, Nu-check prep Inc., MN, USA) using 
Agilent Chemstation software (Agilent Technologies Australia Pty Ltd). Individual fatty acid 
content was calculated based on peak area and response factors normalised to total fatty acid 
content and expressed as a percentage of total fatty acids. 
 
Isolation of RNA and cDNA synthesis and quantitative reverse transcription real-time PCR 
(qRT-PCR) 
RNA was isolated from crushed snap-frozen samples of ~25mg of liver using the Roche High 
Pure Tissue kit (Roche Diagnostics Ltd., UK). Adipose RNA was extracted, after 
homogenisation of ~100mg of tissue with MagNA lyser green beads and instrument (Roche 
Diagnostics Ltd.), using the RNeasy Mini Kit (QIAGEN Ltd., UK). RNA concentration was 
determined using a Nanodrop 2000 (Thermo Scientific) and RNA quality was evaluated by 
agarose gel electrophoresis. cDNA was synthesised using a RevertAid™ reverse transcriptase 
kit (Thermo Fisher Scientific, UK) with random hexamer primers. 
 
Lipogenic pathway and adipokine target genes were chosen based on previous data from our 
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included; peroxisome proliferator-activated receptor gamma (Pparg), sterol regulatory 
element-binding protein (variant 1c; Srebf1), fatty acid synthase (Fasn), lipoprotein lipase 
(Lpl) and leptin (Lep), with β-actin (Actb) as the housekeeper. Primer efficiency ranged from 
85%-108% and sequences have previously been published elsewhere 
(5)
. Adipocyte and 
hepatic gene expression was quantified using SYBR Green (Roche Diagnostics) in a Light-
Cycler 480 (Roche Diagnostics). Samples were analysed against a standard curve of a serially 
diluted cDNA pool to produce quantitative data and expression was normalised to the 
housekeeping gene using LightCycler® 480 software (version 1.5.1) as previously described 
(24)
. The expression of the housekeeper gene was not different between treatment groups.  
 
Determination of liver DNA, protein and glycogen content 
For determination of DNA and protein content of liver samples, approximately 100mg of 
frozen crushed sample was added to 1ml of 0.05M trisodium citrate buffer. Samples were 
homogenised and centrifuged at 2500rpm for 10 minutes at 4°C. Supernatant was used for 
further analyses. DNA concentration (ug/ml) was measured using a Hoechst fluorimetric 
method and protein content (ug/well), modified for a 96 well plate format, was measured as 
described by Lowry et al. 
(25)
. Measurements were normalised to the exact amount of tissue 
used for measurements. Liver glycogen was measured using the Colorimetric Glycogen 
Assay Kit II (Abcam Ltd.) according to manufacturer’s instructions. 
 
Statistical analysis 
Data are presented as mean ± SEM. Data were analysed using the Statistical Package for 
Social Sciences (Version 24, SPSS Inc.). The effect of maternal dietary fatty acid ratio and 
maternal dietary fat content on maternal dependent variables was assessed using a two-way 
ANOVA, with dietary LA:ALA ratio and dietary fat content as factors and dams were used as 
the unit of analysis. Where longitudinal data were analysed, as with maternal feed, protein 
and energy intakes, the impact of maternal dietary LA:ALA ratio and maternal dietary fat 
content was analysed using a two-way repeated-measures ANOVA. Offspring data were 
analysed using a two-way ANOVA, with maternal dietary LA:ALA ratio and fat content as 
factors; where there was no overall effect of sex, male and female offspring data were 
combined. Where data were not normally distributed, analyses were performed on log10 
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Maternal dietary intakes 
There were no differences in feed intake of dams between treatment groups before or during 
pregnancy. During lactation, dams receiving the 36% fat diets had a lower average daily feed 
intake than those receiving the 18% fat diets, irrespective of dietary LA:ALA ratio (P<0.001; 
Fig 1a). Energy intake was similar between groups throughout the experiment (Fig. 1b). 
Protein intake prior to and during pregnancy was affected by both dietary LA:ALA ratio and 
fat content (P<0.05; Fig. 1c), however, these effects were small and inconsistent. During 
lactation, protein intake was affected by dietary fat content only (P<0.001; Fig. 1c), such that 
mothers receiving 36% fat diets consumed 24% less protein on average compared to those 
consuming 18% fat diets, irrespective of dietary LA:ALA ratio. As expected, all dams 
consumed more food, energy and protein during lactation than before and during pregnancy 
regardless of dietary group (P<0.001). 
 
Maternal fatty acid profile 
There were no differences in the proportions of either saturated fatty acids (SFA), 
monounsaturated fatty acids (MUFA), omega-6 (Fig. 2a) or omega-3 PUFA (Fig. 2b) in 
whole blood samples collected from the dams prior to the commencement of dietary 
intervention. After 4 weeks on their respective diets, the blood fatty acid profiles were 
significantly different between treatment groups and largely reflected the composition of the 
experimental diets. Thus, dams fed on high LA diets had higher proportions of LA (1.2 fold) 
and AA (1.4 fold) compared to those consuming a low LA diet (P<0.001; Fig. 2c). 
Conversely, dams fed the low LA diets had a 5.5 fold higher proportion of ALA and an 8.5 
fold higher proportion of EPA compared to those consuming a high LA diet (P<0.001; Fig. 
2D). These changes were independent of the total fat content of the diet. DPA and DHA 
levels after the 4 week pre-feeding period were influenced by both dietary LA:ALA ratio and 
total fat content. Thus, the relative proportions of DPA were higher in dams fed the low LA 
compared to high LA diets (P<0.001), and marginally higher in dams consuming the 18% vs 
36% fat diets (P<0.05). DHA proportions were also higher in the low LA group (P<0.001) 
but, unlike DPA, were modestly but significantly higher in dams consuming the 36% fat vs 
18% fat diets (P<0.05; Fig. 2D). Total blood MUFA proportions were higher (1.3-fold) in 
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The blood fatty acid profile of the dams at the end of lactation, after a further 6 weeks on 
their respective experimental diets, were similar to those observed after the first 4 weeks of 
dietary intervention. A notable difference, however, was that at this time point, relative 
proportions of DHA, as a percentage of total lipids, were not different between dietary groups 
(Fig. 2F). LA (1.5-fold), AA (1.8-fold) and total omega-6 (1.5-fold) were all higher in dams 
consuming a high LA diet irrespective of dietary fat content (P<0.001; Fig. 2E). Conversely, 
total omega-3 levels were 3-fold higher in dams consuming a low LA diet, irrespective of 
dietary fat content (P<0.001). The proportions of ALA were also higher in the groups 
consuming the low LA diets and in rats consuming the 36% vs 18% fat diets in the low LA 
group only (P<0.05; Fig 2F). DPA proportions were higher in the groups consuming the low 
LA diets, however, unlike ALA, DPA proportions were lower, rather than higher, in dams 
consuming the 36% fat diets in the low LA group only (P<0.001; Fig. 2F). EPA proportions 
were higher in groups consuming a low LA diet compared to those consuming a high LA diet 
(P<0.001; Fig. 2F). EPA proportions were also affected by total dietary fat content, and were 
lower in dams consuming a 36% fat  diet compared to an 18% fat diet (P<0.001; Fig. 2F). 
Maternal blood total MUFA levels at the end of lactation were 1.4-fold higher in the dams 
consuming a low LA diet irrespective of dietary fat content (P<0.001; Fig. 2E). 
 
Maternal weight, body composition and gene expression 
There were no significant differences in dam bodyweight between dietary groups prior to the 
commencement of the dietary intervention or at any time during the experiment (data not 
shown). Dams consuming the 36% fat diets had heavier lungs relative to bodyweight at the 
end of lactation compared to those consuming the 18% fat diets, independent of the LA:ALA 
ratio (P<0.05). There were no differences in the relative weight of the heart, liver, brain, 
kidney, gonadal or retroperitoneal fat pads between experimental groups (Table 1). 
 
Analysis of mRNA expression of lipogenic genes indicated that hepatic (3-fold) and gonadal 
fat (7-fold) expression of Fasn was higher in dams consuming an 18% fat diet, compared to 
those on a 36% fat diet, irrespective of dietary fatty acid ratio (P<0.01). The mRNA  
expression of Lpl, Pparg and Srebf1 was not, however, affected by either dietary fat content 
or ratio in either hepatic or gonadal fat tissues (Table 1). Expression of leptin mRNA in 
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Birth outcomes and offspring bodyweights 
There were no differences between dietary groups in terms of litter size or sex ratio of pups 
(Table 2). Birth weight was lower in offspring of dams fed a 36% fat vs 18% fat diets, 
independent of the dietary LA:ALA ratio (Table 2). The lower body weight in offspring of 
dams fed the 36% fat diet persisted during the sucking period such that offspring of dams fed 
the 36% fat diets remained lighter than offspring of dams fed on 18% fat diets at both 1 and 2 
weeks of age; again this was independent of dietary LA:ALA ratio (P<0.001; Table 3).  
 
Offspring fatty acid profile 
At 1 week of age, proportions of AA (2.1 fold) were lower in the offspring of the low LA 
compared to high LA dams (P<0.001), and in offspring of dams consuming the 36% fat vs 
18% fat diets (1.4 fold; P<0.001; Fig. 3A). Blood ALA proportions were 5.9 fold higher in 
offspring of dams in the low LA groups compared to high LA groups (P<0.001; Fig. 3B). 
Offspring EPA and DPA proportions were also higher in the low LA group compared to the 
high LA group. Blood EPA was also influenced by total dietary fat content, but only in 
offspring of dams fed the low LA diet, in which EPA levels  were lower in offspring of dams 
fed the 36% fat diets compared to the 18% fat diets (EPA, P<0.001; DPA, P<0.01; Fig. 3B). 
DHA proportions were not different between groups at 1 week of age (Fig. 3B). MUFA 
proportions were higher (1.2-fold) in offspring of dams in the low LA groups (P<0.001), 
consistent with the pattern in maternal blood. However, unlike maternal MUFA, offspring 
MUFA levels were also affected by maternal dietary fat content and were 1.2-fold higher in 
offspring of dams fed the 36% fat vs 18% fat diets (P<0.001; Fig. 3A). At 1 week of age 
offspring of dams in the 36% fat diet groups also had lower blood proportions of SFA, 
irrespective of LA:ALA ratio of the maternal diet (P<0.01; Fig. 3A).  
 
The fatty acid profiles of the offspring at 2 weeks of age were similar to those observed at 1 
week. Thus, blood AA (1.9 fold) and total omega-6 (1.6 fold) proportions were lower (Fig. 
3C) and ALA (6.3 fold), EPA (4.7 fold), DPA (2.4 fold) and total omega-3 PUFA (3-fold) 
proportions (Fig. 3D) were higher in offspring of dams in the low LA group compared to 
high LA groups, irrespective of maternal dietary fat content (P<0.001). Proportions of LA 
were higher in offspring of dams fed the 36% fat diets compared to those fed 18% fat diets in 
the high LA group only (P<0.05; Fig 3C), while EPA and DPA proportions were lower in the 
36% compared to the 18% fat diet groups, independent of the dietary LA:ALA ratio 
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of dams consuming a 36% fat diet were lower (P<0.05) when compared to 18% fat groups, 
irrespective of maternal dietary fatty acid ratio. As at 1 week, SFA proportions were lower 
(1.2-fold) in offspring of dams fed a 36% fat  diet, independent of the LA:ALA ratio 
(P<0.001). MUFA proportions were 1.2 fold higher in offspring of dams fed the low LA 
diets, and 1.2 fold higher in offspring of dams who consumed a 36% fat vs 18% diet 
(P<0.001; Fig. 3C). 
 
Offspring organ weight and liver composition 
At 1 week of age, heart weight relative to bodyweight was higher in female offspring of dams 
receiving a 36% fat diet compared to the 18% fat diet, independent of the dietary LA:ALA 
ratio (P<0.05). There were no differences in the relative weight of lung or kidney at 1 week 
of age and no differences in the relative weight of the heart, lung, liver, gonadal or 
retroperitoneal fat pads in the offspring at 2 weeks of age between treatment groups in either 
male or female offspring (Table 3). 
 
Liver weight at 1 week appeared to be influenced by the LA:ALA ratio of the diet to a greater 
extent than total fat level, at least in males. Thus, male offspring of dams consuming the high 
LA diets had increased liver weights compared to offspring of dams receiving a low LA diet  
(P<0.01), irrespective of total dietary fat content. The glycogen content of the livers was also 
higher in male offspring of dams consuming the high LA diets at 1 week of age (P<0.05). No 
effect of maternal diet on offspring liver protein or DNA concentration was observed (Table 
4). These differences were not present in females at 1 week of age and no differences in 
glycogen content were observed at two weeks of age in male offspring. DNA concentration 
in females at two weeks of age was marginally increased (1.1-fold) in offspring exposed to a 
36% fat diet, irrespective of maternal dietary fatty acid ratio (P<0.05).  
 
Hepatic gene expression 
At 1 week of age, hepatic Fasn expression was influenced by maternal dietary intervention in 
a sex specific manner. Thus, in males, Fasn expression was higher in offspring of dams 
consuming a 36% fat  diet irrespective of maternal LA:ALA ratio (P<0.05). In female 
offspring, however, Fasn expression was higher in offspring of dams consuming a low LA 
diet, independent of dietary fat content (P<0.05). Hepatic Lpl mRNA expression in male 
offspring at 1 week of age was also influenced by maternal dietary fat content, with higher 
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offspring, hepatic Srebf expression, similar to that of Fasn, was higher in offspring of dams 
consuming a low LA diet at 1 and 2 weeks of age (P<0.01). Female hepatic expression of 
Pparg was lower in offspring of dams consuming a low LA diet at 2 weeks of age (P<0.05). 
There were no differences in the expression of Fasn or Lpl in female offspring, or expression 
of any hepatic genes in male offspring at this time point (Table 3). 
 
Discussion 
This study has demonstrated that altering the fat content and/or LA:ALA ratio of the maternal 
diet during pregnancy and lactation resulted in significant alteration in the circulating fatty 
acid profile of dams in the absence of any significant effects on maternal bodyweight or body 
composition. Exposure to a 36% fat diet during gestation and lactation was, however, 
associated with lower offspring bodyweight from birth, which persisted to 2 weeks of age. 
This suggests that increased dietary fat intake during pregnancy and lactation can 
compromise growth of the progeny, irrespective of the type of fat consumed. In addition, 
alterations in the fat content and/or composition of the maternal diet had transient effects on 
offspring body composition and hepatic gene expression, effects which were also sex-
specific. 
 
Maternal fatty acid profiles after 4 weeks on the experimental diets largely reflected dietary 
composition, confirming that the dietary intervention had the desired effect on maternal 
circulating fatty acid composition. These changes persisted after a further 6 weeks of 
exposure to the diets and, as expected, the dietary LA:ALA ratio had a greater impact on the 
maternal blood omega-6 and omega-3 status than total dietary fat content. Consistent with 
previous studies 
(5,9,26,27)
, decreasing the dietary LA:ALA ratio resulted in substantial 
increases in relative maternal ALA and EPA levels but only a very modest increase in DHA 
proportions after a 4-week exposure, and no difference compared to the higher LA:ALA ratio 
after 10 weeks. Interestingly, and independent of dietary LA:ALA ratio, dams appeared to be 
more efficient at converting DPA to DHA when total dietary fat load was higher. One 
possibility could be that this is simply a result of the higher amount of substrate (i.e. ALA) 
available for conversion to the longer chain derivatives such as DPA and DHA in diets 
containing higher total fat levels. This effect did not, however, persist after a further 6 weeks 
of dietary exposure, at which point EPA and DPA were lower in dams consuming a low LA 
36% fat diet compared to a low LA 18% fat diet. This may be a result of saturation of the 
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apparent decrease in capacity to convert ALA through to EPA and DHA during consumption 
of a 36% fat diet coincides with the decreased protein intake observed in these groups. It is 
possible that the lower consumption of protein in rats fed on the 36% fat diets may have 
contributed to reduced conversion of ALA, since previous studies have shown reduced 
desaturase, particularly Δ6-desaturase, expression in the mammary gland 
(29)
 and liver 
(30)
 of 
rats exposed to a low protein diet. Maternal whole blood MUFA proportions appeared to be 
influenced by dietary LA:ALA ratio, however, this is most likely a result of the slightly 
higher MUFA content of the low LA diets.   
 
Offspring fatty acid profiles at 1 and 2 weeks of age largely reflected maternal profiles with 
maternal dietary LA:ALA ratio exhibiting the strongest effect on offspring circulating fatty 
acid proportions. However, the total fat content of the maternal diet appeared to have a 
greater influence on the blood fatty acid composition of the offspring as opposed to that 
observed in the dams. Of particular interest was the finding that the proportion of both EPA 
and DPA in offspring at 1 week of age were higher in the low LA (18% fat) vs the low LA 
(36% fat) group, and that this effect persisted at 2 weeks of age despite ALA levels being 
increased in the low LA (36% fat) group at this time point. DHA was not different between 
groups at 1 week of age but was lower in offspring exposed to a 36% fat diet at 2 weeks of 
age. As with the maternal fatty acid profiles, this again may be a result of saturation of the 
PUFA metabolic pathway at higher total PUFA intakes, and is in line with findings from 
numerous studies, both human and animal, that indicate that simply increasing the quantity of 
substrate, i.e. ALA, is not an effective strategy for increasing concentrations of its long-chain 




The total dietary fat content of the maternal diet also had an influence on the proportion of 
SFA in the offspring, such that offspring of dams consuming 36% fat diets exhibited lower 
SFA proportions than offspring of dams consuming the 18% fat diets. Unlike the fetus, where 
fatty acid composition is largely related to maternal dietary intake, during suckling, offspring 
fatty acid composition is largely determined by the composition of the milk, which may not 
fully reflect maternal fatty acid intakes. In a study by Mohammad et al. 
(33)
, for example, 
women consuming diets with a higher total fat content (55%en vs. 25%en) exhibited reduced 
SFA concentrations (C6:0-C14:0) in breast milk but not in maternal plasma. While milk 
composition was not assessed in the current study, this raises the possibility that SFA content 








bridge.org/core . Bodleian Libraries of the U
niversity of O
xford , on 25 Feb 2020 at 14:05:11 , subject to the Cam
bridge Core term







turn explain the lower SFA status of the offspring. Alternatively, it may be that increasing the 
fat content of the diets resulted in an increased conversion of SFA to MUFA, since high-fat 
feeding has been associated with increased expression of the enzyme responsible for 
conversion of SFA to MUFA, stearoyl-CoA desaturase 1 (SCD-1) 
(34)
 and could therefore be 
the reason for the observed effect of fat content on offspring MUFA levels in this study. It is 
important to note, however, that circulating fatty acid profiles are a product of both dietary 
fatty acid intake as well as tissue fatty acid production and release. Whilst the collection of 
blood samples from animals in the fed state suggests that the dietary fraction of fatty acids 
would provide a greater contribution to the fatty acid profile of both dams and offspring, the 
influence of hepatic synthesis of fatty acids should not be overlooked as a contributor to the 
observed differences.  
 
Despite significant shifts in maternal fatty acid profiles and increased fat content of the 36% 
fat diets, we saw no differences in maternal bodyweight or fat deposition. This is consistent 
with our previous study 
(5)
 and is likely a result of the reduced feed intakes of the dams to 
compensate for the increased energy density of the higher fat diets, a phenomenon 
consistently seen with dietary intervention trials using rodents 
(35)
. Despite the lack of an 
effect on maternal weight gain and fat deposition, bodyweight was reduced in offspring of 
dams receiving a 36% fat  diet, irrespective of maternal dietary LA:ALA ratio. This 
phenotype was consistent across sexes and persisted from birth to 2 weeks of age. Variable 





. This finding was, however, consistent with many other studies that 




 and weaning weight 
(43)
 in offspring of dams exposed 
to a 36% fat diet during gestation and lactation periods. The differential effects of different 
36% fat diets on offspring growth is likely due to differences in composition of the diet as 
well as periods of exposure between studies 
(3)
. In those studies that have reported lower 
offspring weights in offspring fed a high-fat diet, lower protein intakes in dams consuming a 
high-fat diet have been cited as a likely contributing factor. Further to this, protein restricted 
diets have been associated with impaired mammary gland development 
(29,44)
 leading to 
impaired milk synthesis 
(44)
, and this may also have contributed to reduced offspring growth 
observed during the suckling period. It is important to note however, that the reduction in 
protein intake in  dams consuming a 36% fat diet in the current study were more modest (10-
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The lower Fasn expression in the liver and adipose tissue of dams exposed to a 36% fat diet 
is consistent with the established role of this enzyme in suppressing lipogenesis in times of 
energy excess 
(49)
. Surprisingly, this change did not appear to be mediated through changes in 
maternal Srebf1 mRNA expression, a known regulator of Fasn expression 
(50)
. It is important 
to note that since only mRNA expression was measured, we cannot comment on any 
differences in protein expression or activity of this transcription factor although mRNA and 
protein levels have been shown to be closely correlated 
(23)
.  Following this up at the protein 
level is a major priority for future study. In the offspring, however, hepatic Fasn expression 
was not downregulated by exposure to a maternal 36% fat diet but was actually higher in 
male offspring of dams consuming the 36% fat compared to the 18% fat diets at 1 week of 
age and was accompanied by an increase in Lpl expression. In female offspring, however, 
hepatic Fasn and Sbrepf1 expression at 1 week were influenced by maternal dietary fatty acid 
ratio, rather than total fat content, with both genes upregulated in offspring of dams fed the 
low LA diets. In both cases, the upregulation of Sbref1, Fasn and Lpl genes would be 
expected to be associated with an upregulation of both lipogenesis and fatty acid uptake. It is 
worth mentioning that differences in hepatic expression of lipogenic genes in male offspring 
were consistently associated with maternal dietary fat content whereas differences in female 
hepatic expression were consistently associated with maternal dietary fatty acid ratio. This 
suggests that female offspring are more sensitive to changes in the types of maternal dietary 
fat whereas male offspring are more sensitive to gross maternal fat consumption. Sex specific 
effects associated with the programming of disease hypothesis have been frequently reported 
(51)
. The mechanism by which sex influences these effects, however, remains to be elucidated 
within a larger perspective, as well as within the context of this study.  
 
We found no evidence that these alterations in hepatic gene expression translated to increases 
in liver weight, however whether there was any effect on hepatic fat content remains to be 
determined. In both male and female offspring, relative liver weight was increased in 
offspring of dams fed the high LA diet. In an aim to further elucidate the source of this 
increased weight, we measured liver DNA, protein and glycogen composition. Similar to 
liver weight, glycogen levels were increased in offspring of dams fed the high LA diets. This 
increase in glycogen, however, was not sufficient enough to completely account for the 
differences observed in liver weight but may be a contributing factor. Consideration of DNA 
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More detailed analysis is required to further elucidate the mechanism by which high maternal 
dietary omega-6 may impact upon offspring liver physiology. 
 
The majority of the hepatic mRNA expression differences, as well as gross differences in 
liver weight and composition, appeared to be transient and were no longer present at 2 weeks 
of age. A notable exception was the lower expression of Srebf1 mRNA and higher expression 
of Pparg in females of dams exposed to a high LA diet compared to the low LA diet, with a 
similar trend observed in males. Although found in relatively low concentrations in the liver, 
activation of Pparg has been shown to increase hepatic lipid storage and is elevated in 
models of hepatic steatosis 
(52)
. As such, decreased Pparg expression can alleviate some of 
the symptoms of hepatic steatosis leading to a reduced liver weight in conjunction with a 
reduction in hepatic triglyceride content 
(53)
. Thus, our finding that female offspring of dams 
exposed to a high LA diet tended towards to have an increased liver weight at one week of 
age followed by increased hepatic Pparg expression at two weeks of age may suggest that the 
increase in Pparg expression is a potential response to the increased liver growth observed a 
week earlier. Alternatively, parallels may be drawn to the effect of low protein diets where 
fluctuations between an increased and decreased lipogenic capacity, chiefly mediated by 
altered Srebf1 expression, occur in early life only to settle into a pattern of upregulated 
lipogenesis at a later life stage 
(23)
. Further studies would be needed to directly evaluate this 
hypothesis.  
 
In conclusion, we have demonstrated that exposure to a 36% fat diet during gestation and 
lactation is associated with persistent growth restriction in both male and female offspring 
irrespective of maternal dietary fatty acid composition. Growth restriction has been 
associated with a plethora of metabolic disturbances later in life 
(54,55,56)
 and transient 
alterations in gene expression have been suggested as a mechanism for programming changes 
in metabolic processes within tissues as well as the morphology of the tissues themselves 
(1)
 . 
In this study, offspring are still exposed to the experimental diets via the dams milk, and 
further studies in offspring at older ages are required to assess whether the changes in growth, 
hepatic gene expression and liver weights in the current study are associated with phenotypic 
changes that persist once offspring are no longer exposed directly to the altered diet 
composition. In addition, analysis of lipogenic pathway and adipokines targets at the protein 
level, as well as whole transcriptome analysis, may yield useful information about their 
regulation and the extent to which these experimental diets programme other metabolic and 
regulatory pathways in the liver. Finally, the longevity of these perturbations into later life, 
especially when presented with secondary metabolic challenges such as aging, prolonged 
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Table 1. Maternal organ weights and gene expression 
All values are mean ± SEM and n=6-9 per dietary group. The effect of dietary fatty acid ratio 
and dietary fat content were assessed using a two-way ANOVA. 
a
 indicates a significant 
effect of dietary fat content (P<0.05, *P<0.01). Although not statistically significant there 
was some evidence that maternal Srebpf1 expression was influenced by the LA (P=0.08) and 
fat content (P=0.06) of the diet.  




Low LA (18% 
Fat) 
Low LA (36% 
Fat) 
Bodyweight (g)  308.75 ± 9.82 288.73 ± 14.95 303.29 ± 11.11 302.23 ± 7.85 











Kidney (% BW) 0.78 ± 0.02 0.83 ± 0.03 0.82 ± 0.02 0.79 ± 0.02 
Liver (% BW)
 
5.01 ± 0.10 4.80 ± 0.28 5.28 ± 0.10 4.88 ± 0.09 
Brain (% BW) 0.59 ± 0.02 0.59 ± 0.02 0.58 ± 0.02 0.59 ± 0.02 
Gonadal Fat (% BW) 1.88 ± 0.35 2.02 ± 0.39 1.65 ± 0.19 1.61 ± 0.11 













Lpl 0.20 ± 0.04 0.19 ± 0.04 0.19 ± 0.04 0.13 ± 0.01 
Pparg 0.63 ± 0.22 0.78 ± 0.18 0.41 ± 0.09 0.70 ± 0.16 
Srebf1 3.52 ± 0.91 2.56 ± 0.64 7.85 ± 2.57 3.39 ± 0.61 









0.37 ± 0.14 
Lpl 0.90 ± 0.23 0.87 ± 0.06 1.56 ± 0.41 1.48 ± 0.46 
Ppparg 0.91 ± 0.23 1.22 ± 0.20 1.12 ± 0.13 1.16 ± 0.18 
Srebf1 1.80 ± 0.48 1.56 ± 0.31 3.43 ± 1.16 2.21 ± 0.62 
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Table 2. Birth outcomes 
All values are mean ± SEM. The effect of dietary fatty acid ratio and dietary fat content was 
assessed using a two-way ANOVA. 
a 











n 6 8 7 9 
Litter Size 12.83 ± 1.19 13.00 ± 1.21 13.14 ± 0.40 13.33 ± 1.08 
Sex Ratio (male/female) 1.01 ± 0.23 0.97 ± 0.24 1.27 ± 0.28 1.13 ± 0.26 
Male Birthweight (g)
a 
6.19 ± 0.53 5.19 ± 0.18 5.66 ± 0.14 5.36 ± 0.11 
Female Birthweight (g)
a 
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Table 3. Offspring organ weights and hepatic gene expression 
All values are mean ± SEM. A two-way ANOVA was used to analyse results with maternal dietary fatty acid ratio and maternal dietary fat 
content as factors. Different superscripts denote values which are significantly different (P<0.05). n=4-9 per dietary group. All comparisons are 



















1 Week Offspring         










 12.44 ± 1.17
b
 15.66 ± 0.66
a
 13.40 ± 0.56
b
 










 0.70 ± 0.06
b
 0.57 ± 0.06
a
 0.69 ± 0.04
b
 
Lungs (% BW) 1.87 ± 0.05 1.73 ± 0.04 1.89 ± 0.05 1.90 ± 0.06 1.96 ± 0.11 1.92 ± 0.05 1.88 ± 0.12 1.93 ± 0.05 
Kidney (%BW) 1.27 ± 0.08 1.34 ± 0.05 1.19 ± 0.09 1.22 ± 0.02 1.25 ± 0.04 1.38 ± 0.06 1.21 ± 0.10 1.26 ± 0.03 
Liver (% BW) 3.17 ± 0.16
a
 3.39 ± 0.13
a
 2.81 ± 0.12
b
 2.89 ± 0.09
b
































1.26 ± 0.24 1.37 ± 0.46 1.59 ± 0.28 1.81 ± 0.35 




0.51 ± 0.11 0.52 ± 0.13 0.62 ± 0.16 0.41 ±0 .06 












2 Week Offspring         
Bodyweight (g)  39.76 ± 1.67
a
 31.78 ± 2.17
b
 39.89 ± 0.59
a
 31.56 ± 1.49
b
 37.77 ± 1.55
a




 30.75 ± 1.29
b
 
Heart (% BW)  0.60 ± 0.01 0.60 ± 0.02 0.61 ± 0.03 0.63 ± 0.01 0.67 ± 0.06 0.67 ± 0.01 0.65 ± 0.03 0.61 ± 0.02 
Lungs (% BW) 1.33 ± 0.20 1.26 ± 0.05 1.25 ± 0.07 1.42 ± 0.07 1.28 ± 0.07 1.32 ± 0.05 1.26 ± 0.08 1.32 ± 0.06 
Kidney (%BW) 1.05 ± 0.02 1.02 ± 0.03 1.06 ± 0.02 1.00 ± 0.03 1.17 ± 0.04 1.15 ± 0.04 1.14 ± 0.01 1.05 ± 0.02 
































Liver (% BW) 3.01 ± 0.06 3.08 ± 0.14 3.11 ± 0.02 3.03 ± 0.02 3.18 ± 0.09 3.15 ± 0.09 3.23 ± 0.05 3.01 ± 0.10 
Liver Fasn 0.17 ± 0.01 0.18 ± 0.02 0.19 ± 0.02 0.20 ± 0.02 0.19 ± 0.02 0.20 ± 0.03 0.22 ± 0.03 0.24 ± 0.03 








1.25 ± 0.16 1.89 ± 0.16 2.01 ± 0.29 1.81 ± 0.08 
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Table 4. Offspring liver composition 
All values are mean ± SEM. A two-way ANOVA was used to analyse results with maternal dietary fatty acid ratio and maternal dietary fat 
content as factors. Different superscripts denote values which are significantly different (P<0.05). n=4-9 per dietary group. All comparisons are 



















1 Week Offspring         
Liver DNA  
(µg/mg tissue) 
0.48 ± 0.06 0.54 ± 0.04 0.56 ± 0.06 0.52 ± 0.03 0.51 ± 0.03 0.51 ± 0.04 0.50 ± 0.04 0.52 ± 0.02 
Liver Protein  
(mg/g tissue) 












9.70 ± 0.89 7.73 ± 0.88 9.00 ± 1.43 11.27 ± 1.80 
2 Week Offspring     
    
Liver DNA (µg/mg 
tissue) 








Liver Protein  
(mg/g tissue) 
115.1 ± 3.6 129.9 ± 13.5 130.2 ± 10.0 117.9 ± 9.4 117.2 ± 9.7 132.3 ± 9.1 120.7 ± 9.4 120.6 ± 6.5 
Liver Glycogen 
(µg/mg tissue) 
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Figure 1. Maternal average daily (A) feed intake, (B) energy intake and (C) protein intake 
during pre-feeding, pregnancy and lactation fed on either a high LA (18% fat) diet (closed 
circles), high LA (36% fat) diet (open circles), low LA (18% fat) diet (closed squares) and a 
low LA (36% fat) diet (open squares). Values are means ± SEM and n=6-9 per group. The 
effects of dietary fatty acid ratio and dietary fat content were determined using a two-way 
repeated measures ANOVA. * indicates a significant effect of dietary fat content (** P<0.01, 
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Figure 2. Maternal whole blood fatty acids profile at (A/B) baseline (C/D) after 4 weeks on 
experimental diet and (D/E) at the end of lactation (3 weeks post-partum). Values are means 
± SEM and n=6-9 per group. The effects of dietary fatty acid ratio and dietary fat content 
were determined using a two-way ANOVA (*P<0.05, **P<0.01, ***P<0.001). † indicates a 
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Figure 3. Offspring whole blood fatty acids profile at (A/B) one week of age and (C/D) at 
two weeks of age. Values are means ± SEM and n=11-17 per group. The effects of maternal 
dietary fatty acid ratio, maternal dietary fat content and sex were determined using a three-
way ANOVA. No effect of sex was found for any of the fatty acids measured and so male 
and female samples were combined for further analysis. * Indicates significant difference 
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Abstract 17 
Evidence suggests that sub-optimal maternal nutrition has implications for the developing 18 
offspring. We have previously shown that exposure to a low-protein diet during gestation was 19 
associated with upregulation of genes associated with cholesterol transport and packaging 20 
within the placenta. This study aimed to elucidate the effect of altering maternal dietary linoleic 21 
acid (LA; omega-6):alpha-linolenic acid (ALA; omega-6) ratios as well as total fat content on 22 
placental expression of genes associated with cholesterol transport. The potential for maternal 23 
BMI to be associated with expression of these genes in human placental samples was also 24 
evaluated. Placentas were collected from 24 Wistar rats at 20d gestation (term=21-22d 25 
gestation) that had been fed one of four diets containing varying fatty acid compositions during 26 
pregnancy, and from 62 women at the time of delivery. Expression of 14 placental genes 27 
associated with cholesterol packaging and transfer were assessed in rodent and human samples 28 
by qRT-PCR. In rats, placental mRNA expression of ApoA2, ApoC2, Cubn, Fgg, Mttp and Ttr 29 
was significantly elevated (3-30 fold) in animals fed a high LA (36% fat) diet, suggesting 30 
increased cholesterol transport across the placenta in this group. In women, maternal BMI was 31 
associated with fewer inconsistent alterations in gene expression. In summary, sub-optimal 32 
maternal nutrition is associated with alterations in the expression of genes associated with 33 
cholesterol transport in a rat model. This may contribute to altered fetal development and 34 
potentially programme disease risk in later life. Further investigation of human placenta in 35 
response to specific dietary interventions is required. 36 
Key Words: Cholesterol, maternal nutrition, omega, placenta, pregnancy  37 
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Introduction 38 
Maternal nutrition can have a profound impact on fetal development and future physiological 39 
function and metabolic health (1). A number of dietary perturbations, including maternal 40 
undernutrition and low protein diets, have been associated with increased risk of obesity and 41 
cardiovascular disease in the adult offspring (2). In the context of the growing epidemic of 42 
obesity, focus has shifted towards understanding the effects of nutritional excess and obesity 43 
on offspring programming of disease. Studies have consistently demonstrated that these 44 
exposures are associated with a substantial increase in the risk of poor metabolic health in the 45 
offspring in both humans (3) and animal models (4). There is emerging evidence from animal 46 
studies, however, that maternal high-fat diets also have the potential to program metabolic 47 
outcomes in the offspring independent of the effects of maternal obesity. In addition, these 48 
effects appear to depend not only on the amount of fat in the diet (5), but also on the fatty acid 49 
composition (6). The majority of studies to date that have investigated the effects of a maternal 50 
high fat diet have utilised diets high in saturated fat. However, due to changes in population 51 
level patterns in dietary consumption (7), attention has now shifted toward the roles of 52 
polyunsaturated fats within the diet. 53 
The mechanisms underlying this early life programming of obesity and metabolic disease are 54 
not completely understood. However, as the sole interface between the mother and the fetus, 55 
structural and functional changes within the placenta have been implicated as playing a key 56 
role (8). Cholesterol is present in every cell of the human body and an adequate supply is 57 
therefore critical for supporting normal fetal development. As the precursor for all steroid 58 
hormone synthesis, cholesterol also plays an important role in placental function. During 59 
pregnancy, the fetus obtains cholesterol via endogenous synthesis as well as transfer across 60 
the placenta from the maternal circulation, disturbances to either of these processes have 61 
negative impacts on fetal growth, cell proliferation, metabolism and the organisation of 62 
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tissues (9). The endogenous synthesis of cholesterol appears to be most critical for the 63 
developing fetus, as defects in this pathway are known to be lethal (10). Sub-optimal maternal 64 
contribution of cholesterol across the placenta, however, has been associated with lower 65 
birthweight (11, 12) and microcephaly (12) in humans, highlighting the importance of this 66 
exogenous cholesterol supply.  67 
Transport of cholesterol across the placenta is a complex process in both humans and rodents 68 
(13). Briefly, the majority of cholesterol circulates the body in the form of HDL, LDL and 69 
VLDL cholesterol, which are associated with specific structural apolipoproteins (ApoA2, 70 
ApoB and ApoC2 respectively). The layer of trophoblast cells, located closest to maternal 71 
circulation, take in LDL and VLDL through their respective receptors. HDL cholesterol can 72 
be taken up via a specific receptor (scavenger receptor class B type 1; SR-B1) or by binding 73 
to proteins such as megalin and cubilin (Cubn). Once within the cell, cholesterol is 74 
hydrolysed into free cholesterol, bound to sterol carrier proteins and then transferred to the 75 
basolateral membrane where it passes through the fetoplacental endothelium. The processes 76 
governing cholesterol efflux from the endothelial layer are poorly understood, although it has 77 
been shown that exogenous cholesterol is secreted into fetal circulation, through association 78 
with various transporters (14), where it is repackaged into fetal lipoproteins. This process is 79 
facilitated by microsomal triglyceride transfer protein (Mttp). The finding that the placenta 80 
expresses and secretes its own apolipoproteins such as ApoB (15) also raises the possibility that 81 
cholesterol is repackaged into HDL, LDL and VLDL cholesterol within the placenta itself. 82 
 83 
In addition to its critical role in fetal growth and development, there is emerging evidence 84 
that alterations in placental cholesterol transfer capacity may also be a contributing factor to 85 
metabolic programming. In a previous study(16), we showed providing rats with a low protein 86 
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diet until day 13 of gestation, a dietary treatment previously associated with programming of 87 
obesity, hypertension and glucose intolerance in adult offspring (17), resulted in increased 88 
placental expression of a number of genes associated with cholesterol and lipoprotein 89 
transport and metabolism in the rat.  90 
Given the similarity in the metabolic phenotype induced by maternal obesity/nutritional 91 
excess and low protein diets, we hypothesised that programming of health and disease is 92 
driven by perturbations of a small set of common ‘gatekeeper’ processes (18) and changes in 93 
placental cholesterol transfer and metabolism may be common mechanisms underlying 94 
metabolic programming by different dietary exposures.  Therefore, the aim of this current 95 
study was to investigate the effect of a high maternal dietary omega-6:omega-3 fatty acid 96 
ratio, associated with decreased placental weight (19), against a lower ratio as well as total fat 97 
intake, on the expression of genes associated with cholesterol and lipoprotein transport, 98 
known to be affected by maternal diet, in the mature placenta of the rat. We also aimed to 99 
investigate whether placental expression of these same genes differed according to maternal 100 
body mass index (BMI) in a cohort of pregnant women. 101 
Materials and Methods 102 
Animal Experiments and sample collection  103 
This paper reports data from the analysis of placentas that were collected as part of a previous 104 
study (19). Virgin female Wistar rats (n = 24; 75-100 g; Charles River, UK) were housed on 105 
wood shavings in individually ventilated cages under a 12 h light/12 h dark cycle at a 106 
temperature of 20–22 °C and had ad libitum access to food and water throughout the 107 
experiment. Female rats were allowed to acclimatise to the unit for 1–2 weeks, during which 108 
time they were fed on standard laboratory chow (2018 Teklad Global 18% Protein Rodent 109 
Diet, Harlan Laboratories, UK). After acclimatisation, a tail vein blood sample was taken 110 
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from each animal for the determination of fatty acid status. The rats were then randomly 111 
assigned to one of 4 dietary groups designed to provide either a high (9:1, high LA) or low 112 
(1:1.5 low LA) ratio of linoleic acid (LA) to alpha-linolenic acid (ALA), achieved by altering 113 
the amounts of flaxseed and sunflower oil included in the fat component of the feed. The 114 
levels of saturated fatty acids (SFA) and monounsaturated fatty acids (MUFA) were 115 
comparable in all diets, achieved by adjusting the amounts of coconut (SFA source) and 116 
macadamia (MUFA source) oils in the diets. For each level of LA, diets containing either 117 
18% or 36% fat by weight were developed. This resulted in four experimental diets; high LA 118 
(18% fat), high LA (36% fat), low LA (18% fat) and low LA (36% fat) (n =5–7 per dietary 119 
group). The list of ingredients and final fatty acid composition of the four experimental diets 120 
have been published previously (19). 121 
All animal procedures were performed in accordance with the Animals (Scientific 122 
Procedures) Act 1986 under Home Office licence and were approved by the Animal Ethics 123 
Committee of the University of Nottingham, UK. Animals were pair housed from the start of 124 
the experiment until mating, after confirmation of conception animals were individually 125 
housed until completion of the experiment. Animals were maintained on their allocated diet 126 
for a four week ‘feed-in’ period after which they were mated. Conception was confirmed by 127 
the presence of a semen plug and this was recorded as day 0 of pregnancy. Female rats 128 
remained on their respective diets until day 20 of gestation (full term = 22 days) at which 129 
time rat dams were euthanised by CO2 asphyxiation and cervical dislocation and fetuses by 130 
cervical dislocation and exsanguination. All fetuses were weighed and sexed via 131 
measurement of anogenital distance. Placentas from male fetuses were collected for analysis 132 
and a tail sample from the fetus was collected for sex-genotyping by PCR for the SRY gene 133 
(20). Any samples found to be female or inconclusive (n = 5) were not included in placental 134 
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gene expression analysis. Full details of maternal weight gain, food intake and the effect of 135 
the diets on fetal and placental weight are published elsewhere (19). 136 
Human placental sample collection 137 
Ethical approval for the study was obtained from the Derbyshire Research Ethics Committee 138 
(Ref: 09/H0401/90). Placental samples were obtained from patients attending the Department 139 
of Obstetrics and Gynaecology, Royal Derby Hospital, Derby, UK. Patients provided 140 
informed, written consent prior to undergoing elective caesarean section at term gestation 141 
(>37 weeks), indications for which were maternal request, previous elective section or breech 142 
presentation while cases with diabetes, hypertension, pre-eclampsia, were excluded. 143 
Placentae, once checked by the midwife and with the cord clamped, were transported to the 144 
lab within 20 minutes of delivery, where placental villous samples were taken midway 145 
between the cord insertion site and placental periphery and frozen at -80°C prior to extraction 146 
of RNA.  Participants were stratified based on a BMI measurement taken during an antenatal 147 
clinic appointment, resulting in 3 groups of women; BMI <25 kg/m2 (n=20), BMI 25-35 148 
kg/m2 (n=21) and BMI >35 kg/m2 (n=21). 149 
Sample Preparation and PCR 150 
RNA was isolated from 20-25mg of crushed snap-frozen human or rat placental tissue using 151 
the Roche High Pure Tissue kit (Roche Diagnostics Ltd., UK) according to manufacturer’s 152 
instructions. RNA concentration was determined using a Nanodrop 2000 (Thermo Scientific) 153 
and RNA quality was evaluated by agarose gel electrophoresis. cDNA was synthesised using 154 
a RevertAid™ reverse transcriptase kit (Thermo Fisher Scientific, UK) with random hexamer 155 
primers. 156 
Gene targets were chosen based on our previous data (16) where RNASeq analysis of day 13 157 
rat placentas revealed differential expression of 91 genes in response to maternal protein 158 
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restriction. Ingenuity pathway analysis identified 8 pathways that were significantly affected 159 
(P<0.001), 6 of which were closely related functionally with a strong emphasis of cholesterol 160 
uptake and efflux across the placenta. Genes were selected based upon the ingenuity analysis 161 
(ApoA2, ApoB, ApoC2, Ttr, Fgg, serpin G1 and Rbp4). Additional genes were chosen that 162 
were shown to be differentially expressed in the protein restricted condition (Vil1, Gpc3, 163 
Prf1, Cubn, Mttp) but not associated with pathways identified by Ingenuity analysis. Tagln 164 
and Tbp gene targets were also chosen as preliminary RNASeq analysis suggested that they 165 
may be sensitive to maternal dietary factors, resulting in 14 target genes for analysis. Real-166 
time PCR primers were designed using Primer Express software (version 1.5; Applied 167 
Biosystems) from the RNA sequence, checked using BLAST (National Centre for 168 
Biotechnology Information) and were purchased from Sigma (UK). The primer sequences 169 
can be found in supplementary table S1. Real-time PCR was performed on a Lightcycler 480 170 
(Roche, Burgess Hill, UK) using the 384 well format. Each reaction contained 5μl of cDNA 171 
with the following reagents: 7.5μl SYBR green master mix (Roche), 0.45μl forward and 172 
reverse primers (final concentration 0.3μM each) and 1.6μl RNase-free H2O. Samples were 173 
pre-incubated at 95°C for 5 min followed by 45 PCR amplification cycles (denaturation, 174 
95°C for 10 seconds; annealing, 60°C for 15 seconds; elongation, 72°C for 15 seconds). 175 
Transcript abundance was determined using a standard curve generated from serial dilutions 176 
of a pool of cDNA made from all samples. Expression was normalised against the expression 177 
of cyclophilin A, which was not significantly different between experimental groups. 178 
Statistical Analysis 179 
Data are presented as mean ± SEM. Data were analysed using the Statistical Package for 180 
Social Sciences (Version 24, SPSS Inc.). For animal data the effect of maternal dietary fatty 181 
acid ratio and maternal dietary fat content on placental expression of target genes was 182 
assessed using a two-way ANOVA, with dietary fat level and LA:ALA ratio as factors. 183 
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Human data were analysed using a one-way ANOVA with maternal BMI as a factor. Possible 184 
co-variates were identified and corrected for within the analysis. A value of P<0.05 was 185 
considered statistically significant.  186 
Results 187 
Rat placenta 188 
The results of the gene expression analyses in the rodent placentas is shown in Table 1. 189 
Expression was measured for 13 genes (ApoB excluded), however, Tbp expression was not 190 
detectable in any of the samples (data not shown) and so could not be included in the 191 
analysis.  192 
Placental Mttp mRNA expression was significantly increased (3 fold; P<0.01) in dams 193 
consuming a high LA compared to a low LA diet, independent of total dietary fat content 194 
(Table 1). There was a significant interaction between the effects of maternal total dietary fat 195 
and LA content in relation to mRNA expression of ApoA2, ApoC2, Cubn, Fgg, Rbp4 and Ttr 196 
(P<0.05), such that expression of these genes was significantly increased in rats consuming 197 
the high LA diets, but only when dietary fat content was also high (36% fat w/w). The 198 
magnitude of this effect was greatest for Cubn (30-fold increase in the high LA (36% fat) 199 
group when compared to the low LA (36% fat) group). A similar pattern was observed for 200 
other key cholesterol-transport and metabolism genes in the placenta (Gpc3, P=0.072; Vil1, 201 
P=0.054), with 1.5-7 fold higher expression in placentas of dams exposed to a high LA diet, 202 
but only when dietary fat content was also high. Placental expression of Prf1, SerpinG1 and 203 
Tagln was not affected by wither maternal dietary fatty acid ratio or fat content.  204 
Human placenta 205 
The sociodemographic and clinical characteristics of the women who provided placental 206 
samples for this study are summarised in Table 2. The average age, parity and gestation 207 
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length of women within this study was similar between women in the three BMI groups, 208 
however the birth weights of infants born to women with a BMI >25 kg/m2 were significantly 209 
greater than those of women in the normal BMI range. 210 
The results of the gene expression analyses in the human placentas is shown in Table 3. All 211 
14 genes were measured and detected in these samples. Women with a BMI in the 25-35 212 
kg/m2 range (overweight to obese) exhibited a 2-6 fold higher mRNA expression of ApoB in 213 
their placental samples compared to women with a BMI either <25 or >35 kg/m2. The 214 
expression of Rbp4 was significantly lower in placentas obtained from women with a BMI 215 
>25 kg/m2 compared to those with a BMI <25 kg/m2 (85% down-regulation, P=0.001). A 216 
similar pattern was also observed for Ttr, with 71-88% down-regulation of expression in 217 
women with a BMI >25 kg/m2, although this did was not statistically significant (P=0.053). 218 
The mRNA of other placental genes was not different between BMI groups. 219 
Discussion 220 
This experiment aimed to test the hypothesis that maternal diet, specifically, fatty acid 221 
composition and quantity, and obesity would influence the expression of genes associated 222 
with cholesterol uptake and transport in rat and human placenta. The results of the rat studies 223 
suggested clear effects of maternal dietary fat content and composition, such that maternal 224 
consumption of a higher-fat, high LA maternal diet was associated with increased expression 225 
of key genes associated with these pathways, suggesting enhanced cholesterol transport to the 226 
fetus in this group. In the human study, however, only two of these genes were differentially 227 
expressed in placentas from women in different BMI categories, suggesting that maternal 228 
obesity had a limited impact on placental cholesterol transport at the level of gene expression.  229 
Within this study we have shown that exposure to a high LA, high-fat diet resulted in 230 
increased expression of genes involved in the formation of apolipoproteins, cholesterol 231 
Draycott et al.                                    High-fat diet and placental CHO transport 
uptake and cholesterol repackaging. These differences were not observed when either the fat 232 
content and/or the fatty acid ratio was altered, suggesting a strong interaction between these 233 
variables. Importantly, the effects observed on the placental gene expression profiles show 234 
striking resemblances to our previous findings (16) where upregulation of these genes was 235 
observed in the placentas of dams exposed to a low protein diet. These data suggest that, not 236 
only do these differences persist to a late stage placenta (day 20), but, despite different 237 
dietary interventions, the similarities in results suggest a common mechanism of action. The 238 
upregulation of key genes in the rat placenta observed in this study suggests a state of 239 
increased cholesterol uptake and efflux. While the potential impacts of this in the current 240 
study are not clear, it has been demonstrated in previous studies that, exposure to excess 241 
cholesterol during fetal development can be associated with adverse outcomes. In rodent 242 
models, maternal hypercholesterolemia has been associated with growth restriction (21), 243 
altered liver development  (22) and atherosclerosis  (23). In humans, maternal 244 
hypercholesterolaemia has been associated with the development of fatty streaks in fetal 245 
arteries and cholestasis during pregnancy is associated with programming of an overweight, 246 
insulin resistant phenotype in the child (24). It will therefore be important in future studies to 247 
determine the longer term consequence of the changes in placental gene expression for the 248 
postnatal offspring.  249 
Based on the substantial impact of maternal high-fat high LA feeding, a dietary pattern 250 
commonly observed in the modern Western diet, we extended our study to determine if there 251 
was any evidence to suggest an effect of maternal obesity on cholesterol transfer in the 252 
human. There were, however, relatively few differences in the expression of key genes 253 
associated with different BMI categories in human placental samples, although there were 254 
some subtle differences in the expression of 3 genes (ApoB, Rbp4 and Ttr) between BMI 255 
categories. Ttr is a protein that binds to and transports Rbp4. In the bound state, Rbp4 is 256 
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protected from glomerular filtration and so levels of these two proteins are often correlated. 257 
As such, the similar patterns of expression across these two genes observed in this study was 258 
anticipated. What was surprising, however, was our finding that women with a BMI above 259 
the normal range (>25 kg/m2, overweight or obese) exhibited decreased placental expression 260 
of these genes since elevated levels of circulating Rbp4 have been associated with many of 261 
the co-morbidities linked to obesity including hypertension (25), insulin resistance and type 2 262 
diabetes (26). It is important to note, however, that these observations have all been associated 263 
with circulating levels of Rbp4, whereas we measured gene expression in the placenta. There 264 
is limited literature evaluating the role of Rbp4 within the placenta during pregnancy, 265 
particularly in association with maternal obesity. It may be, however, that in obese mothers, 266 
placental expression is reduced to compensate for the increased maternal circulating levels 267 
and therefore avoiding fetal exposure to high quantities of Rbp4. Further experimentation, is 268 
required to determine expression of Rbp4 and Ttr in both the mother, fetus and the placenta 269 
throughout pregnancy and their association with maternal obesity.  270 
Placental ApoB expression was increased in women whose BMI was above the normal range 271 
(>25 kg/m2 ). A study by Dube and colleagues (27), showed increased circulating ApoB 272 
concentrations in new-born infants of obese mothers, compared to mothers of normal weight, 273 
in the absence of any difference in maternal circulating concentrations. It is therefore possible 274 
that the high ApoB concentrations in infants of obese mothers may have been the result of 275 
increased placental ApoB expression. If this abnormal lipoprotein profile is present in the 276 
offspring and persists through childhood it may contribute to increased risk of cardiovascular 277 
disease in later life. 278 
One key limitation of the current study is that direct measurements of cholesterol transport or 279 
measurement of the genes of interest at the level of protein were not analysed, and so care 280 
must be taken when extrapolating the findings to functional outcomes. Further to this, human 281 
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participants within this study were stratified based on BMI whereas the animal experiments 282 
utilised specific dietary interventions. There are many factors that can affect BMI and, 283 
although nutrition is a key element, there is still a huge variety of nutritional habits that can 284 
lead to individuals resulting in similar BMIs. As such, assumptions cannot be made about 285 
specific nutrient intakes of the women based on this data. Finally, it is important to note that, 286 
whilst there are many similarities between placental physiology and function in the rat and 287 
humans, there are some key differences. Of particular importance to this study is the 288 
difference in circulating progesterone levels at the end of pregnancy. In rodents there is a 289 
dramatic decrease in circulating progesterone (28), whereas in humans, progesterone levels are 290 
increased or at least maintained at the time of parturition (29). Progesterone is a key steroid 291 
produced from cholesterol within the placenta and has been shown to regulate the expression 292 
of some genes including Rbp4 in other tissues (30). As such, careful consideration of the 293 
differences in placental hormone production, particularly steroid hormones, between the two 294 
species should be made when drawing comparisons.  295 
In conclusion, this study aimed to elucidate whether differences in placental expression of 296 
genes involved in cholesterol transport and efflux were associated with altered maternal 297 
nutrition in a manner similar to our previous observations in the low-protein model. We 298 
demonstrated that exposure to high levels of omega-6 as part of a high-fat diet elicited a 299 
similar pattern of placental gene expression, suggesting an increase in cholesterol transport 300 
across the placenta. This highlights the potential for a common mechanism by which sub-301 
optimal maternal nutrition during pregnancy alters placental function, and potentially fetal 302 
development, resulting in increased risk of disease in later life. We then carried out a 303 
preliminary study which aimed to establish if similar alterations were observed in human 304 
placentas. Although BMI was associated with some changes in expression, these observations 305 
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were not consistent and further experimentation is required on placental samples where the 306 
specific nutrient intake of the participants are known.  307 
  308 
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Table 1 Rat placental gene expression at day 20 gestation 444 
* Indicates a significant interaction effect of maternal dietary LA:ALA ratio and total dietary 445 
fat content on placental gene expression (P<0.05). 446 
Different superscript indicate significant differences between groups (P<0.01).  447 
 High LA (18% 
Fat) 
High LA (36% 
Fat) 
Low LA (18% 
Fat) 
Low LA (36% 
Fat) 
ApoA2* 0.75 ± 0.24 3.24 ± 1.13 0.52 ± 0.08 0.33 ± 0.20 
ApoC2* 0.72 ± 0.27 2.91 ± 1.00 0.56 ± 0.08 0.34 ± 0.21 
Cubn* 0.81 ± 0.35 2.92 ± 1.15 0.35 ± 0.06 0.10 ± 0.04 
Fgg* 0.76 ± 0.30 2.97 ± 1.09 0.36 ± 0.06 0.12 ± 0.05 
Gpc3 0.96 ± 0.28 1.46 ± 0.43 0.56 ± 0.09 0.50 ± 0.09 
Mttp 0.66 ± 0.25a 2.12 ± 0.77a 0.28 ± 0.05b 0.22 ± 0.09b 
Prf1 1.65 ± 0.42 0.73 ± 0.14 1.17 ± 0.12 1.15 ± 0.31 
Rbp4* 0.69 ± 0.29 2.34 ± 1.17 0.48 ± 0.12 0.13 ± 0.05 
SerpinG1 1.03 ± 0.26 1.00 ± 0.13 0.84 ± 0.21 1.20 ± 0.33 
Tagln 0.95 ± 0.13 0.87 ± 0.06 0.67 ± 0.04 1.09 ± 0.17 
Ttr* 0.65 ± 0.22 2.43 ± 0.81 0.52 ± 0.08 0.32 ± 0.17 
Vil1 1.23 ± 0.42 2.67 ± 0.97 0.51 ± 0.10 0.54 ± 0.22 
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Table 2 Human participant characteristics 448 
BMI (kg/m2) <25  25-35  >35  
Age (years) 34.29 ± 1.28 33.55 ± 1.07 31.25 ± 1.04 
BMI 21.88 ± 0.36 29.70 ± 0.70 40.10 ± 1.07 
Parity 1.05 ± 0.11 0.75 ± 0.14 1.20 ± 0.19 
Gestation length (weeks) 38.63 ± 0.23 38.68 ± 0.18 38.65 ± 0.20 
Birthweight (g)* 3236 ± 88 3537 ± 112 3565 ± 108 
Sex (% male) 45 45 65 
N 21 20 20 
Data are shown as mean ± SEM for N observations per group. *ANOVA indicated that, with 449 
adjustment for gestational age, birthweight was influenced by maternal BMI (P=0.021)  450 
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Table 3 Human placental gene expression 451 
* Indicates a significant effect of maternal BMI on placental gene expression (**P<0.01). 452 
  453 
 BMI <25 BMI 25-35 BMI >35 
ApoA2 1.04 ± 0.21 1.22 ± 0.27 0.53 ± 0.06 
ApoB** 0.34 ± 0.06 2.19 ± 0.55 1.04 ± 0.25 
ApoC2 0.90 ± 0.15 1.02 ± 0.25 0.76 ± 0.13 
Cubn 1.22 ± 0.21 1.15 ± 0.15 0.86 ± 0.09 
Fgg 0.48 ± 0.14 0.82 ± 0.41 0.65 ± 0.42 
Gpc3 0.97 ± 0.20 1.30 ± 0.20 0.83 ± 0.19 
Mttp 0.57 ± 0.08 1.23 ± 0.37 0.42 ± 0.08 
Prf1 1.14 ± 0.19 0.85 ± 0.10 1.03 ± 0.17 
Rbp4** 0.50 ± 0.13 0.07 ± 0.01 0.08 ± 0.01 
SerpinG1 1.45 ± 0.24 0.90 ± 0.07 0.90 ± 0.11 
Tagln 0.97 ± 0.11 1.04 ± 0.10 1.11 ± 0.10 
Tbp 1.02 ± 0.11 1.16 ± 0.11 1.00 ± 0.07 
Ttr 1.92 ± 0.90 0.23 ± 0.08 0.56 ± 0.20 
Vil1 1.14 ± 0.20 1.82 ± 0.33 1.01 ± 0.18 
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Supplementary Table S1 Primer sequences used for the determination of gene expression by 454 
RT-qPCR 455 
Forward (FWD) and reverse (REV) primer sequences designed using Primer Express 456 
























































































REV:  CGGACTCAGCCCCATCATT 
CTGAGCGCCCAAGTCAAAG 
CATGGCCTCGATCCTCCATA 
